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General Introduction 
                        Chapter 1
2
  
 
 
Osteoporosis is the major metabolic bone disease seen worldwide and resulting 
fragility fractures are recognized as a major public health issue (1). According to the 
WHO working group estimations in 1994, nearly 30% of European women over 50 
years have osteoporosis (2). In general, osteoporosis is commoner among Caucasians 
and Asians while women of Afro-Caribbean descent have a less likelihood to develop 
the disease (2).  
 
It is estimated that, 30 to 50% of women and 15 to 30% of men experience an 
osteoporosis-related fracture during their lifetime (3). Osteoporosis-related fractures 
are associated with increased mortality, morbidity and reduced quality of life (4). A 
study in Switzerland showed that the annual costs of hospitalization for osteoporosis-
related fractures were greater than those of other non-communicable diseases 
including stroke, myocardial infarction and breast cancer (5) .  
 
Osteoporosis-related fractures  
 
Osteoporosis-related fractures create a huge economic burden on current health care 
systems. In 2000, 3.79 million osteoporosis-related fractures occurred in Europe, of 
which 0.89 million were hip fractures (6). The total direct costs involved with 
osteoporosis-related fractures were estimated to be 21 billion US dollars and, based 
on the projected demographic changes in Europe, this is expected to reach 51 billion 
US dollars in 2050 (6).   
 
Although fracture at any site could be attributed to osteoporosis, fractures of the 
spine, proximal femur and distal forearm are the most frequent osteoporosis-related 
fractures. Osteoporotic fractures are commonly seen in postmenopausal women with 
each fracture type showing specific epidemiological and etiological properties. 
 
Of all fractures, hip fracture is the most sinister complication of osteoporosis as it is 
associated with increased morbidity and mortality. In women,  the age-standardized 
mortality ratios (ratios of observed deaths to expected deaths in the age-matched 
population) for hip, vertebral and other major osteoporotic fractures are 2.32, 1.66 and 
3
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1.92, respectively, while the corresponding figures in men are 3.17, 2.38 and 2.22 (7). 
The survivors of hip fracture experience chronic pain, reduced mobility and 
increasing degree of dependence (4). The direct and indirect costs involved with hip 
fractures alone are substantial. It is estimated that, in Europe, 179,000 men and 
611,000 women sustain hip fractures each year and the estimated cost is Euro 25 
billion (8).  
 
Osteoporosis-related vertebral fractures commonly occur in the lower thoracic or 
upper lumbar vertebrae. The incidence of vertebral fracture increases with age. In one 
analysis, the age-standardized incidence of vertebral fracture among women and men 
were 10.7 and 5.7 per 1000 person-years, respectively (9). The true prevalence of 
vertebral fracture is not known as only one third of vertebral fractures come to clinical 
attention (10).  
 
Fractures of the distal radius and ulnar are commonly seen in middle aged and elderly 
women and falling on the outstretched hand is the commonest cause (2). Frozen 
shoulder and algodystrophy are known complications of forearm fractures (11).     
 
Osteoporosis; definition and diagnosis  
 
Osteoporosis is defined as “a disease characterized by low bone mass and 
microarchitectural deterioration of bone tissue, leading to enhanced bone fragility 
and a consequent increase in fracture risk” (2). 
 
Although the diagnosis of osteoporosis can be made in a patient presenting with a 
fragility fracture, bone mineral density (BMD) measured by Dual Energy X-ray 
Absorptiometry (DXA) is used to diagnose osteoporosis, particularly in patients who 
have not yet suffered a fracture. Furthermore, BMD has other clinical applications. It 
determines fracture risk in a given patient and also helps in assessing the effectiveness 
of therapy (2).  
4
  
Prevalence of postmenopausal osteoporosis  
 
In 1994, the WHO made guidelines to diagnose osteoporosis (table). These 
BMD deviates from the reference mean value of the sex-matched young adult 
population. It is calculated using the mean BMD and standard deviation of the young 
reference population using the following formula.  
 
T score = Patient’ s BMD – Mean BMD of the Young Normal population    
                                    SD of the Young Normal population 
 
Table: The WHO diagnostic categories based on T Scores  
WHO category  T Score  
Greater than -1.00 
Between -1.00 and -2.50 
Less than -2.50 
Less than -2.50 and history of a fragility 
fracture  
Normal 
Osteopenia 
Osteoporosis  
Severe (or established) 
osteoporosis  
 
The WHO working group in 1994 decided to take T score of -2.5 to define 
osteoporosis since it identified nearly 30% of women over 50 years as having the 
disease and this approximated to the proportion of population having lifetime fracture 
risk (2). Subsequent studies, however, showed a wide variation in the prevalence of 
in the prevalence of osteoporosis between USA and UK women older than 50 years 
(18). Among Thai postmenopausal women, osteoporosis prevalence varies between 
women of more than five years since menopause and women of less than five years 
since menopause (10% vs 5.7% in the spine) (19). It also varies according to the site 
selected to define the disease. Among Chinese women between 20-89 years, the 
prevalence of osteoporosis varies from 15% to 28% between hip and lumbar spine 
(15).  
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osteoporosis (2). T score indicates the number of standard deviations the patient’s 
guidelines, based on T score, provide different cut-off values for osteopenia and 
postmenopausal osteoporosis (12-18). Holt et al demonstrated a substantial difference 
  
Prevalence of postmenopausal osteoporosis among Sri Lankans is not known.  Apart 
from the limited availability of central-type DXA and financial constrains, the low 
priority given for the disease may have contributed to the lack of studies. Lack of 
prevalence data hinders the disease being recognized a health priority. Furthermore, 
preventive measures of osteoporosis could be implemented better if they are backed 
by country-specific epidemiological data.   
 
We, therefore, designed a study to estimate the prevalence of osteoporosis among 
postmenopausal women in Sri Lanka. While the entire study sample underwent 
phalangeal BMD estimation, a randomly selected subgroup had BMDs in spine and 
hip estimated using a central-type DXA machine. The approximate estimate of the 
disease prevalence was estimated by extrapolating the results of the subgroup analysis 
 
Age-related trends in BMD  
 
Bone is a living tissue and undergoes modeling and remodeling during different 
phases of skeletal growth. Accordingly, BMD which partly incorporates bone mass 
also shows age-related changes. During childhood BMD rapidly increases to reach a 
peak value (peak bone mass; PBM) around 20-30 years. BMD shows a rapid decline 
in old age, especially in women during the postmenopausal period(2).  
 
The age at which individuals reach their peak BMD is not uniform and varies 
according to ethnicity. Looker et al, found that individuals reach the peak BMD in the 
proximal femur between 20-30 years of age in all three major ethnic groups in the 
USA; non-hispanic whites, non-hispanic black and Mexican-Americans (12). 
However, studies in other populations have shown a delay in reaching the PBM. 
According to Ghannam et al, Saudi women reached peak spine BMD around 35 years 
but earlier at proximal femur (13). In Greek women, peak spinal BMD was observed 
between 30-35 years while maximum femoral neck BMD was seen between 25-30 
years (14). Similar to the USA findings, Chinese women reached the maximum BMD 
in the proximal femur between 20-24 years, but peak BMD in the forearm bones was 
delayed until 40-44 years (15). Although the exact reasons for delay in reaching the 
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to the entire study sample and was the subject of the study in Chapter 2.1.       
 PBM in certain populations and in certain skeletal sites are not known, variations in 
genetic, social, and nutritional factors in different populations may play a role. Nearly 
70% of BMD variation is genetically determined and non-genetic factors such as 
smoking, alcohol consumption and health-related factors contribute to the remaining 
variation (16). As these factors; genetic and non-genetic, differ in diverse ethnic 
groups, the behavior of BMD can be expected to vary in different populations.  
      
Age-related trends in BMD among Asians, especially those in South Asia, are not 
well known. It is important to know the age in which PBM is achieved in a particular 
population, so that measures that promote bone health can be maximized during this 
period to help gaining a higher PBM. Lack of data in these countries may partly be 
due to the limited availability of central-type DXA and financial constrains. Central-
type DXA, due to its dimensions and weight, has practical limitations when applying 
to community-based studies. Peripheral-type DXA which are portable and more user-
friendly can be an option for community-based studies in these countries. Although 
these devices limit BMD assessment to peripheral skeletal sites, their ability to predict 
fractures has been documented in community-based studies (17). Using a peripheral-
type DXA, we studied the age-related changes in phalangeal BMD in a group of men 
and women selected from seven provinces in Sri Lanka and this was the subject area 
      
 
DXA is the current gold standard for measuring BMD. Owing to the easy operability 
and low radiation risk, DXA is the technology recommended for routine patient 
evaluation (20). Basically, DXA machines are of two types; central and peripheral. 
Both types use two photoelectric beams; low and high energy, which get 
preferentially attenuated by different body tissues. The low energy beam is attenuated 
by both soft and bone tissues while the high energy beam is attenuated only by the 
bone tissue. The degree of attenuation of the two beams is used to calculate the energy 
absorbed by the hydroxyapatite crystals in bone tissue and this enables the system to 
calculate the BMD in the pathway of the x-ray beam. While peripheral devices are 
designed to measure BMD in a solitary site in the appendicular skeleton, central-type 
7
of the study described in Chapter 2.2.  
Dual Energy X-ray Absorptiometry  
 DXA are capable of measuring multiple sites in the axial and appendicular skeleton 
(21).      
 
DXA scanners use either a narrow cylindrical x-ray beam, known as pencil-beam, 
like opening in collimator to generate a fan shaped x-ray beam which sweeps over the 
region of interest. In comparison to pencil-beam, fan-beam technology is faster, hence 
has a shorter scanning time (21).  
 
Accuracy and Precision of DXA 
 
In measuring BMD, DXA maintains a high degree of precision and accuracy(20). 
Measurement precision and accuracy are two critical issues in any technology used in 
the biomedical field and DXA manufacturers have taken all steps to achieve a high 
degree of accuracy. Precision becomes a key issue when replicate BMD 
measurements are taken to study BMD trends over a period of time. Precision error 
determines the degree of BMD change that is required to define a “real change” when 
replicate BMD measurements of the same patient in the same site are obtained. At 
95% confidence level, BMD difference in excess of 2.77 times the precision error 
(2.77 x precision error) is considered to be a real and statistically significant BMD 
change and it is referred to as the Least Significant Change (22). As 2.77 remains 
constant for this confidence level, the Least Significant Change is proportionate to the 
precision error of the machine.  
 
should be estimated for a DXA scanner when it is operated by a particular operator 
(23). Precision error can be of short-term which is applicable to repeated scans 
performed within days or weeks or long-term which applies when repeated 
measurements are taken with a longer time gap, measured in years.      
 
Many factors related to machine, operator or patient determine DXA precision (24). 
Age (25) and amount of ascites (26) have been shown to influence short-term BMD 
reproducibility. Maggio et al found BMD precision error to be greater in elderly, 
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which moves in a rectilinear fashion to acquire bone image or a fan-beam, a slit-
Precision of DXA varies across operators and machine types. Hence, precision error 
  
regardless of sex, as compared to young individuals (25). Operator-related factors are 
known to contribute to both long and short-term precision errors. Differences in 
patient positioning and defining the regions of interest (ROI), both of which are 
heavily operator dependent, could contribute to these variations (21).  
 
Patient positioning and precision of DXA 
 
Correct patient positioning is vital when performing DXA. Although DXA 
manufacturers follow similar principles, there are disparities in their recommendations 
positioning during DXA and particular attention should be paid especially when 
replicate BMD measurements are taken (27). Although errors in positioning are 
known to affect precision, the degree of BMD variation or the degree of 
misclassification attributable to a particular incorrect positioning is not well known.  
 
We, therefore, decided to examine the effect of variations in leg positioning on the 
measurement of BMD in different sites. First, the impact of hip flexion on the 
measurement of spine BMD was tested in two studies and is described in Chapters 3.1 
and 3.2. While the first study (3.1) addressed the effect of a lesser degree of hip 
flexion on the precision, the second study (3.2) questioned whether same 
measurement accuracy can be maintained if legs were kept flat while estimating the 
spine BMD. Furthermore, we quantified the effect of minor variations in leg rotation 
 
All Norland DXA machines use a pencil-type x-ray beam to acquire DXA images and 
approximately 3-4 min is taken to complete a scan. As patients are required to keep 
their legs-up during spine BMD estimation in Norland machines, patients with 
degenerative diseases affecting lower limbs would find it difficult to stay positioned 
during the procedure. Although these patients are able to maintain a lesser degree of 
hip flexion without compromising their comfort, the acceptability of such a change is 
not certain. If a lesser degree of hip flexion does not alter BMD values substantially, 
patients who are uncomfortable with conventional 90 degree hip flexion can be 
allowed to have their spine scanned with a lesser degree of hip flexion, the idea 
motivated us for the study described in Chapter 3.1.  
9
regarding patient positioning. Technicians should be aware of the importence of patient  
on the precision of hip BMD measurements and is described in the Chapter 3.3.  
 Norland and Hologic manufacturers use a leg block to flex hip and knee joints by 90 
degrees when measuring spine BMD. It is expected that this procedure would reduce 
the lumbar lordosis allowing separation of intervertebral spaces for clear demarcation 
of individual vertebrae(21). However, there is no uniform agreement to date between 
DXA manufacturers. The real effect of using a leg block to position legs is not certain 
and this made the basis for our study described in Chapter 3.2. In contrast to the study 
the precision of spine BMD estimations, the analysis included in Chapter 3.2 
examines whether the same accuracy can be achieved with legs flexed or legs 
completely flat on the bed. A previous study using a Hologic scanner showed that 
there is no real difference in spine BMD when measured with legs-up or legs-flat 
(28). Yet, more data are required to examine the difference in spine BMD measured in 
these two positions. It will be easier for operators if all DXA manufacturers are 
uniform in their recommendations regarding leg positioning. Furthermore, it will be 
positioning does not make a difference in BMD values.   
 
When BMDs of the proximal femur are measured, the legs need to be rotated 
brings the femoral neck perpendicular to the x-ray beam, thus, preventing overlapping 
of the bone image(21) . However, the same degree of rotation should be achieved in 
subsequent scans for accurate interpretation of BMD trends. The effect of malrotation 
of femoral neck on BMD estimations has not been well studied. Previous studies on 
hip rotation have either used cadaveric specimens (29) or are few in numbers (30, 31). 
Very little is known about the effect of leg rotation on BMD interpretation in a 
clinical setting. As BMDs of the proximal femur are used to diagnose osteoporosis, 
estimate fracture probability and monitor treatment-related changes (23), more studies 
are needed to clarify the effect of leg rotation on BMD interpretation. We describe, in 
Chapter 3.3, the effect of leg rotation on BMD precision using a group of patients 
referred for clinical evaluation.  
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included in Chapter 3.1 which assessed the effect of the lesser degree of hip flexion on 
advantageous for patients to keep their legs-flat during the lumbar spine scan if 
internally to counteract the spontaneous ante-version of the femoral neck. Rotation 
 Hip geometry  
 
Independent of BMD, indices of hip geometry determine fracture risk (32). Hip 
geometry, estimated using BMD images, incorporates material properties (BMD) and 
measurements in the cross-section of the bone to illustrate structural properties of 
bone.  
 
Although there are many indices of bone structure, commonly used indices and their 
descriptions are given below (33).  
1) Hip axis length: the linear measurement from the middle of the inner surface 
of the acetabulum to the lateral border of the shaft of the femur drawn through 
2) Neck-shaft angle: the angle between the neck axis and the axis of the femoral 
3) Femoral neck length: the length of the femoral neck from the midpoint of the 
4) Femoral neck width: the subperiosteoal diameter of the femoral neck at its 
5) Dmax: the distance between bone edge and the centroid mass.   
6) Cross-sectional area(CSA): the cortical bone equivalent area of the cross-
section of the region of interest with all soft tissue voids eliminated.  
7) Cross-sectional moment of inertia (CSMI): a property of the cross-sectional 
area that represents the magnitude of the greatest bending rigidity.  
8) Section modulus(SM): an index of bending rigidity calculated by adjusting the 
CSMI for the distance between bone edge to the centroid (Dmax).  
9) Buckling ratio: an index of bone instability (estimated as Dmax/cortical 
thickness)      
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Indices of hip geometry  
a mid point in the femoral neck (line “a” in the picture).   
shaft (angle “•” in the picture).  
femoral head to the axis of the femoral shaft (line “b” in the picture).  
narrowest diameter. (line “c” in the picture). 
  
 
Picture; Some indices of hip geometry  
 
Indices of hip geometry 
Indices of hip geometry are estimated from BMD images using the analytical 
programs developed by Beck et al in 1990 (34) or Turner and Markwardt in 1994 
(35). The original program by Beck et al was based on Hologic BMD images while 
Turner and Markwardt used Lunar BMD images. These programs have followed the 
principles described by Martin and Burr (36) and assume the proximal femur as a one 
continuous cylindrical beam from the upper shaft to femoral neck. Furthermore, they 
assume that cortical envelop in a given area is circular and has equal thickness right 
round (34,35).  
 
Similar to BMD, the indices of hip geometry show age-related trends. Beck et al 
examining age trends in hip geometry in NHANES cohort, found a gradual decline in 
the cortical thickness, CSMI, SM and CSA of the femoral neck among 
postmenopausal women (34). Simultaneously, there was an expansion of the narrow 
neck diameter, attributed to the apposition of bone material under the periosteal 
surface (34). Hip geometry measures have shown a regional variation, especially 
among Europeans (37). 
 
geometry in other ethnic groups. In the study described in Chapter 4.2, we studied for 
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Most of the hip geometry studies available have used white populations of Northern 
European origin and do not allow one to make conclusions on behavior of hip 
 the first time the behavior of hip geometry indices in a group of women selected, 
randomly, from our university study area in Galle, Sri Lanka.    
  
Unlike BMD, the determinants of hip geometry remain largely unknown. Gender and 
racial differences of hip geometry have been observed (38) and they are believed, at 
least partly, to explain the geographical variation of hip fracture incidence reported 
earlier. Yan et al (2004), comparing a group of native Chinese with a comparable 
group of Europeans, found significantly lower BMD, BMC and bone area of the 
femoral neck (P<0.01) among Chinese men and women (39). After adjusting for bone 
area, weight and height, there was no significant ethnic difference in BMC in either 
gender. CSMI and SM, however, were significantly lower, while HAL, femoral neck 
women compared to European counterparts (39).   
 
Similar to BMD, indices of hip geometry are genetically determined (40). Cooper et 
spine (r=0.32) and femoral neck (r=0.26), raising the possibility that adult BMC is 
programmed during early period of life. Apart from BMD and BMC, bone size of 10-
year old children is related to their weight and height at 1 year (41). Currently, it is 
not well known whether indices of hip geometry are also programmed during early 
 
Body composition  
 
Associations between BMD, lean mass and fat mass have been demonstrated, 
determinant of BMD in postmenopausal women (44,45). Such associations between 
BMD and other body compartments have potential clinical implications. Positive 
association between lean mass and BMD could reflect the coexistence of both low 
BMD and low lean mass in a given patient. Such a patient will have an increased risk 
13
length and femoral neck diameter were significantly lesser in Chinese men and 
al, demonstrated that weight at 1 year is significantly associated with BMC of lumbar 
life. If this is true it will help the understanding of the mechanisms of hip fracture. In 
Chapter 4.3, we describe the associations between the indices of hip geometry in old 
age and anthropometric measurements at the age of 1 year.      
in pre-menopausal women than fat mass (42,43), while the latter is the major 
previously (42-45). In these studies, lean mass is more strongly associated with BMD 
  
of fracture due to the combination of low BMD and low BMI, as both are recognized 
independent risk factors of fractures (2). If fat mass and BMD have inverse 
associations, patients with osteoporosis are likely to have a higher fat mass which 
increases their cardiovascular risk (46) but at the same time provides some degree of 
 
Furthermore, previous studies have shown an association between BMD and serum 
showed both positive (49, 50) and inverse correlations (47, 48) with serum lipid 
levels. If an inverse correlation between BMD and atherogenic lipids are established, 
clinicians would be required to assess the cardiovascular risk of patients with low 
risk. Some drugs are known to have effects on both bone and lipid metabolic 
pathways. SERMs such as raloxifene while improving BMD reduced serum lipid 
levels (51). Similarly, statins while lowering serum lipids, improved BMD(52). These 
studies suggest the possibility of a common metabolic pathway or interconnections 
between the lipid and bone metabolism.  
 
Most of the studies examining body composition and lipids abnormalities have been 
done in Caucasian populations and studies from Asia are limited. Non-communicable 
disease prevalence among Asians is a major concern today. Prevalence estimates of 
osteoporosis, cardiovascular diseases, hypertension and diabetes show a wide 
geographical variation (53, 54). Compared to other regions, Asians have a higher 
prevalence of osteoporosis (2) and non-communicable diseases including diabetes and 
dyslipidemia (55). According to future predictions, the incidence of osteoporosis-
related fractures and cardiovascular diseases would increase, exponentially, in Asian 
countries (1). Despite these predictions, the understanding of the underlying 
mechanism of the high occurrence of non-communicable diseases in the Asian region 
is incomplete and lack of data largely contributes to this. Therefore, we decided to 
explore the association between osteoporosis and cardiovascular diseases among Sri 
Lankan women. In Chapters 5.1 and 5.2, we describe the association of BMD with 
other body compartments and serum lipid, respectively. In general, there is a paucity 
of information regarding body composition and lipid abnormalities in South Asian 
populations.       
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lipid levels (47,48-50). Yet, results of these studies are conflicting since BMD 
BMD and make a holistic approach in treating them to reduce the overall mortality 
protection against hip fractures, through an effect independent of BMD.  
  
Determinants of BMD 
 
There are many determinants of BMD. Nearly 70% BMD variation is explained by 
genetic factors (16). Further, body mass index in adult life (56) and weight in infancy 
(57) are determinant of bone mass in adulthood. Environmental factors such as 
calcium intake (58), physical activity (58), parity (59) and social habits such as 
smoking (60) and alcohol consumption (61) are associated with BMD. New 
associations of BMD are being recognized and they are being used in clinical settings 
to screen people for low BMD and also to determine their fracture risk (62, 63).  
 
Patients with chronic respiratory diseases tend to have low BMD and higher fracture 
risk with some studies showing an association between BMD and measures of 
respiratory function(64, 65). This association, however, could be explained by many 
confounders including smoking, corticosteroid use and poor physical growth. This 
could be clarified by demonstrating an association, independent of confounders, 
analyzed a group of community-dwelling men and women. In addition to their BMD 
and FEV1 measurements, confounders such as BMI, smoking habits and 
corticosteroid use were estimated. This allowed us to study the direct and independent 
relationship between BMD and respiratory function FEV1 and its gender difference.   
 
In summary, many areas in relation to BMD assessment and DXA technology which 
need further clarifications are addressed in this thesis. These include the effect of 
patient positioning on the estimation of both spine and hip BMDs which would be a 
great interest to technicians and clinicians interpreting DXA scans. In addition to 
estimating the prevalence of osteoporosis among postmenopausal women in Sri 
Lanka, this thesis assesses the factors that are associated with BMD of subjects in an 
Asian population. These include effect of age, interaction with other body 
compartments and serum lipids. The association between spine BMD and respiratory 
function FEV1 is also addressed using a UK study sample. Furthermore, the 
association between body measurements in postnatal period and hip geometry indices 
are explored to test the hypothesis that hip structure indices have undergone 
programming in early life.  
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especially among healthy subjects. In the studies described in Chapters 5.3 and 5.4, we 
 Outcome of these analyses would help to clarify many issues. In general, it would 
estimate the error attributable to flaws in patient positioning, answer questions 
whether hip geometry is programmed in early life and whether BMD has an 
independent association with cardiovascular and respiratory function. Specific to Sri 
Lanka, it would show the age in which peak bone mass is achieved and the prevalence 
of postmenopausal osteoporosis, information needed to plan health promotional 
activities in the country and to convince authorities about the gravity of the problem.  
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Abstract
Objective: This study was designed to estimate the prevalence of osteoporosis among postmenopausal women
selected from seven provinces in Sri Lanka.
Method: The study was a community-based cross-sectional survey of a group of 1642 community-dwelling
postmenopausal women in seven provinces, except the North and East, in Sri Lanka. Phalangeal bone mineral
density (BMD) was measured in all subjects using an AccuDEXA. In a subgroup of 150 women BMDs in the
spine from L2–L4 and proximal femur were measured using a Norland Eclipse central DXA machine. In this
subgroup, the diagnosis of osteoporosis was made according to the WHO criteria based on T-scores of the
spine or femoral neck. The sensitivity, specificity, positive predictive value and negative predictive value of
different phalangeal BMD levels were examined and the prevalence of osteoporosis was calculated using the
most acceptable cut-off value.
Results: A sharp decline in phalangeal BMD (0.006 g/cm2/year) was seen during the postmenopausal period.
Phalangeal T-score of −2.00, which had sensitivity, specificity, positive predictive value and negative predictive
value of 78%, 85%, 91% and 68% respectively, was selected as the most suitable value to predict osteoporosis:
357 women had phalangeal T-scores either equal to or lower than −2.00. When the positive predictive value
and negative predictive value of this cut-off value were applied, 736 women (44.9%) in our sample were likely
to have osteoporosis. 
Conclusions: Osteoporosis is a prevalent disease among postmenopausal women in Sri Lanka. Similar
prevalence figures have been reported from other Asian countries. 
Key words: epidemiology, osteoporosis.
INTRODUCTION
Osteoporosis is the major metabolic bone disease seen
in the world and it has affected 75 million people in
Europe, USA and Japan.1 Previous studies have indic-
ated that one-third of women and one-fifth of men over
the age of 50 years will experience an osteoporosis-
related fracture during their lifetime.2,3 The incidence
of hip fracture is predicted to increase by 310% in
men and 240% in women during the next 25 years
and nearly half of these fractures will occur in Asian
countries.4 In Asia, the incidence of hip fracture has
already shown an upward trend. In China, between
1988 and 1992, the incidence of hip fracture increased
by 34% in women and 33% in men.5 Similar trends
have been observed in Singapore and Hong Kong.6,7
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Despite the upward trend seen in osteoporosis-
related fractures, the awareness of the disease remains
low, especially among Asians. The prevalence of osteo-
porosis among Asians, particularly those who are in
South Asian countries, is not well known. The preval-
ence of osteoporosis in Sri Lanka remains unknown as
there are no large community-based studies. The cur-
rent study was carried out to estimate the prevalence of
osteoporosis in a sample of women recruited from
seven provinces in the country.
MATERIALS AND METHODS
The Community Osteoporosis Survey in Sri Lanka was
initiated in October 2004 and 9719 subjects, over the
age of 20 years, were recruited from all provinces except
the north and east which were not included due to
security reasons. From each province, a minimum of
two separate areas, one rural and one urban, were
selected. These areas were identified based on the type
of local administration, adhering to the method used
by the Department of Census and Statistics during the
2001 population census.8 In each scanning centre, post-
ers were displayed and public announcement systems
were used 2–3 days ahead, to inform the public about
the nature and the purpose of the study. On the day of
scanning, volunteers were recruited after an initial
interview. They all filled a brief health-related question-
naire and signed a consent form. Weight was measured
while wearing light clothes and without footware. We
intended to include 500 women (including 200 post-
menopausal women) and 250 men from each pro-
vince, to a total of 5250 subjects. Women were not
randomized at the time of recruitment and scanning
was continued until this number was met. In many
provinces the number was exceeded as we had to
include all subjects gathered on that particular day.
Bone mineral density (BMD) of the middle phalanx
of the middle finger in the non-dominant hand
(PBMD) was measured by dual energy X-ray absorp-
tiometry (DXA) using an AccuDEXA scanner (Schick
Technologists Inc., New York, USA). All scans were
done by two trained technicians and the calibration of
the machine was performed on each scanning day to
ensure the accuracy of readings. Automatically saved
data were transferred to the Center for Metabolic Bone
Diseases in Galle at the end of each month to be
included in a central database.
A subgroup of 150 women was selected randomly
from 380 postmenopausal women who were recruited
from the southern province. These women underwent
a second DXA scan using Norland Eclipse XR (Norland
Corp., Fort Atkinson, WI, USA) scanner. BMDs of the
lumbar spine from L2 to L4 in the anteroposterior
projection (SBMD), femoral neck (FNBMD) and
trochanteric region (TRBMD) were measured. In vitro
calibration of the Norland machine was done on each
scanning day using the calibration phantoms provided
by the manufacturer.
Statistics
Of 9719 subjects in the main study sample, data of
all healthy postmenopausal women (n = 1642) were
included in this analysis. Data of women with his-
tory of epilepsy, inflammatory arthritis, endocrine dis-
eases, chronic bronchial asthma, malabsorption, chronic
renal or liver diseases, vasculitis and other chronic
inflammatory diseases were excluded from the analysis.
Similarly data of women who had taken medications
such as corticosteroids, anticonvulsants, heparin, vit-
amin D, hormone replacement therapy, antiresorptive
drugs and pharmacological doses of calcium were
excluded (total number of exclusions = 186) Descript-
ive data of the study sample are given either as mean
(SD) or numbers (%) unless stated otherwise. Subjects
were categorized to 5-year age groups according to the
time since menopause (Group 1 < 5, Group 2 = 5–9,
Group 3 = 10–14, Group 4 = 15–19, Group 5 = 20–24,
and Group 6 ≥ 25 years). Mean PBMD values of each
group were estimated and compared using ANOVA. Per-
centage PBMD loss was calculated taking the mean
PBMD of Group 1 (within 5 years of menopause) as
the reference value:
Percentage PBMD loss = (PBMD of the 
subject – 0.485)/0.485 × 100 (1)
Percentage PBMD loss appeared to have a skewed
distribution, hence, median (IQR) values were estimated
and compared using Kruskal–Wallis test. Linear regres-
sion model was fitted with PBMD as the dependent
variable and age as the independent variable to deter-
mine the annual BMD loss. t-scores of PBMD, SBMD
and FNBMD were calculated using the Asian reference
data provided by the manufacturers of the two machines.
Women were diagnosed as having osteoporosis if they
had t-scores less than –2.5 in the spine, femoral neck
or both sites.9 The sensitivity, specificity, positive pre-
dictive value (PPV) and negative predictive value (NPV)
of different t-scores of PBMD were calculated. Receiver
operating characteristic (ROC) curves were constructed
for different t-scores of PBMD to select a suitable cut-
off value. Two-tailed P = 0.05 was taken as the level of
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statistical significance. SPSS for Windows (version 10)
was used for all calculations. Ethical approval for the
study was obtained from the Ethical Review Committee
of the Faculty of Medicine, University of Ruhuna, Galle,
Sri Lanka.
RESULTS
Mean age of 1642 postmenopausal women in the sam-
ple was 56.5 years (SD 6.8) while mean weight and age
at menopause were 55.8 kg (SD 9.97) and 47.2 years
(SD 3.13), respectively. Median (IQR) number of chil-
dren was 3 (2–4). Seventeen (1%) women had smoked
previously and 23 women (1.4%) had consumed alco-
hol occasionally. Twenty-two (1.4%) women had taken
hormone replacement therapy for a period more than
6 months. At the time of recruitment to the study, 1150
(70%) women were living for more than 5 years in
urban administrative areas while the rest were living in
rural administrative areas.
BMD results
A sharp decline in PBMD was seen in the postmeno-
pausal period. When compared with the second group,
the percentage BMD loss doubled in the third group
indicating a rapid initial loss (Table 1). The percentage
BMD loss in different age groups was highly signific-
ant (P < 0.001), when assessed by Kruskal–Wallis test.
Although BMD declined progressively, the rate of bone
loss was less rapid in old age. According to the linear
regression model, the annual BMD loss was 0.006 g/cm2
(standard error [SE] 0.0003, P < 0.001).
Specificity and sensitivity of PBMD in 
detecting osteoporosis
Sixty-three women in the subgroup of 150 postmeno-
pausal women had t-scores less than –2.50 in the spine
and a further two women in the femoral neck; hence,
65 women qualified for the diagnosis of osteoporosis.
When different t-score thresholds of PBMD were tested
for their ability to predict osteoporosis, t-score of –1.00
showed the highest sensitivity (89%) but lower speci-
ficity (45%). When t-score –2.5 was considered, the
specificity improved to 90%, while sensitivity dropped
to 62%. Trade-off between the sensitivity and specificity
was evident when we used different t-score thresholds
(Table 2).
Prevalence of low bone mass among women
A PBMD t-score of –2.00 was used to define ‘low BMD’
among postmenopausal women in the main study as
we considered this to be the most appropriate cut-off
point which detected osteoporosis with an acceptable
level of sensitivity and specificity. ROC curves con-
structed for different t-scores justified the selection of
–2.00 as the most appropriate cut-off value. Areas
under the curve (SE and P-value) for t-scores of –1.00,
–1.50, –2.00 and –2.50 were 0.67 (SE 0.08, P = 0.034),
Table 1 Absolute and percentage PBMD loss in 1642 postmenopausal women according to the time since menopause
Group 1 
(n = 472)
Group 2 
(n = 525)
Group 3 
(n = 314)
Group 4 
(n = 155)
Group 5 
(n = 99)
Group 6 
(n = 75)
Time since MP† Less than 5 years 5–9 years 10–14 years 15–19 years 20–24 years 25 or more years
Age (years) 50.8 (2.8) 54.0 (2.7) 58.3 (3.1) 63.4 (3.2) 67.6 (4.2) 72.9 (5.0)
BMD (g/cm2) 0.485 (0.071) 0.457 (0.070) 0.428 (0.071) 0.408 (0.074) 0.385 (0.065) 0.342 (0.059)
% BMD loss‡ 0 5.77 (–4.6–15.3) 11.3 (2.0–21.9) 16.7 (5.7–25.4) 21.8 (10.3–29.7) 31.5 (20.2–38.4)
†MP = menopause. PBMD = bone mineral density of the middle phalanx of the middle finger in the non-dominant hand.
‡Percentage bone loss given as median (IQR).
Table 2 Specificity and sensitivity of different PBMD t-scores in detecting osteoporosis in the subgroup of 150 postmenopausal 
women selected randomly from the southern province
Phalangeal t-score Sensitivity Specificity Positive predictive value Negative predictive value
–2.50 0.62 0.90 0.92 0.56
–2.00 0.78 0.85 0.91 0.68
–1.50 0.81 0.70 0.83 0.67
–1.00 0.89 0.45 0.75 0.69
PBMD = bone mineral density of the middle phalanx of the middle finger in the non-dominant hand.
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0.75 (SE 0.07, P = 0.002) 0.81 (SE 0.06, P < 0.001) and
0.76 (SE 0.07, P = 0.001), respectively.
Among 1640 postmenopausal women, 357 were
found to have PBMD t-scores either equal or less than
–2.00. Since the PPV at this cut-off point was 0.91, 325
women out of the positive 357 were likely to have osteo-
porosis. With NPV of 0.68, a further 411 out of the
remaining 1283 women who tested negative, were also
likely to have osteoporosis. Hence, 736 women were
likely to have osteoporosis and this estimated the pre-
valence of postmenopausal osteoporosis in our sample
to be 44.9%.
DISCUSSION
Progressive reduction of BMD among postmenopausal
women is a well-known phenomenon10 and this was
seen in this study population. The rate of loss was rapid
soon after menopause but slowed down later as age
progressed. Judging by the regression analysis, one
would expect PBMD to decline by nearly 0.060 g/cm2
after 10 years (12% reduction when compared with the
mean BMD at menopause).
Rapid reduction of BMD in postmenopausal age is
attributed to the reduced level of gonadal hormones.
Since estrogen deficiency has its maximum effect on
trabecular bone, the rapid initial reduction of BMD is
believed to be related to the rapid resorption of trabecu-
lar bone mass. As trabecular bone mass gradually
becomes smaller, the rate of bone loss becomes slower
in old age.
Although PBMD can predict fractures,11 it cannot be
used to diagnose osteoporosis, as the WHO guidelines
are based on BMD measured at spine, proximal femur
or mid-radius sites.9 In order to help clinicians, the sens-
itivity and specificity of different PBMD cut-off points
in detecting osteoporosis has been defined. At a t-score
of –2.50, sensitivity and specificity values in a previous
study were 39% and 96%, respectively,12 while the cor-
responding values in our study were 62% and 90%.
This discrepancy could be due to many reasons such as
differences in osteoporosis prevalence or the degree of
physical activities, in different samples selected for
calculations.
Limitations of AccuDEXA in screening for osteopor-
osis was evident as none of the PBMD t-scores exam-
ined, had acceptable sensitivity and specificity. PBMD
t-score of –2.00 was considered to be the most useful
cut-off point to diagnose osteoporosis as it had reason-
able sensitivity and specificity. When using this cut-off
value, clinicians need to know that only 91% of patients
who have an abnormal report are likely to have
osteoporosis and the balance is unlikely to have the
disease. Further, 32% of patients who record a normal
report are also likely to have osteoporosis.
We estimated that nearly 45% of postmenopausal
women in our sample were likely to have osteoporosis
and similar estimations have been observed in other
countries. In previous studies the prevalence of osteo-
porosis varied widely depending on the type of tech-
nology, measurement sites and the cut-off values used
for the diagnosis. In 1997, the working group of WHO
selected a t-score cut off-value of –2.5 to diagnose osteo-
porosis, somewhat arbitrarily, as it identified 30% of
postmenopausal women as having osteoporosis and it
captured most patients with osteporotic fractures.9 A
subsequent study in Denmark reported 50% prevalence
of osteoporosis among women older than 50 years.13
Among postmenopausal Thai women, the prevalence
of osteoporosis increased from 39% at 60–64 years to
57.7% at 70–74 years.14 Among Japanese women aged
between 50 and 79 years, the prevalence of osteopor-
osis was found to be 35% in the spine and 12% in the
hip.15 In the same population the prevalence of osteo-
porosis in the distal radius was 56.8%. In 2006, Jang
et al. reported 30.6% prevalence of osteoporosis among
postmenopausal women aged 45–64 years, 52.5%
among women aged 65–64 years and 68.7% in women
above 75 years. These figures were based on lumbar
spine BMD, measured in 365 postmenopausal women
selected from one area in China.16
This study has a number of limitations. People were
made aware of the study 3–4 days before the scanning
day and only women who volunteered to the study
were recruited. Hence, selection bias would have
occurred. Women who volunteered would have been a
health-conscious subgroup with a low prevalence of
osteoporosis and this would have led to underestima-
tion of osteoporosis. Also, this would make the study
sample not representative of the general population.
This was visible in the age distribution where the
number of women over the age of 70 was relatively
fewer when compared with the other age groups. This
too, would have underestimated the prevalence of osteo-
porosis, as only women who had reasonable mobility
were able to attend scan sessions held in various loca-
tions and women with marked osteoporosis or frac-
tures were not able to take part in the survey.
The north and east provinces were not included in
the data collection due to security reasons. We do not
see the non-inclusion of these two provinces as a major
drawback in the study as Tamil and Moor ethnic groups
APLAR Journal of Rheumatology 2007; 10: 234–238
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were included from other provinces. Comparison of
BMD between peripheral and central sites was done in
a small subgroup of randomized women from the
southern province. A larger sample, selected from all
seven provinces would have given more valid results
when calculating sensitivity and specificity figures. Fur-
ther, two technicians were involved in collecting data.
Although they were trained together and followed the
same protocol in scanning, interobserver variation in
BMD measurements would have occurred.
In summery, this study involving healthy postmeno-
pausal women in Sri Lanka, indicated that 45% of post-
menopausal women in our society are likely to have
osteoporosis. Although this is relatively high, similar
values have been reported from other Asian countries.
This information will be useful for health educators in
the country when planning preventive measures in
osteoporosis. Future studies may use this information
to plan their studies. However, this estimation is not
based on direct measurements of key skeletal sites such
as spine, proximal femur or mid-radius, but calculated
using peripheral BMD which tends to overestimate the
prevalence of osteoporosis. Hence the actual prevalence
of osteoporosis may be different from this estimated
value.
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AbstractRe
*A
Depar
Bone
E-maiTo establish normative reference values and to study the age-related trends in phalangeal bone mineral density
(BMD), 4504 male and 5215 female volunteers aged 20 yr or more were recruited from 7 provinces from October
2004 to October 2005. Subjects suffering from diseases and those who were taking medications, which could affect
BMD were excluded from the analysis (n5 530). Phalangeal BMD was measured in the nondominant hand using an
AccuDXA. Men and women were categorized to age groups of 20e29 (1087 men and 1079 women), 30e39 (1122
men and 1146 women), 40e49 (1148 men and 1455 women), 50e59 (810 men and 1111 women), 60e69 (250 men
and 335 women), and 70 yr or more (87 men and 94 women). Mean BMDs (SD) of men in above categories were
0.595 (0.057), 0.603 (0.061), 0.591 (0.066), 0.576 (0.069), 0.558 (0.077), and 0.522 (0.079) g/cm2, respectively. The
corresponding BMDs (SD) in women were 0.495 (0.057), 0.506 (0.062), 0.502 (0.064), 0.462 (0.072), 0.406 (0.072),
and 0.340 (0.055) g/cm2, respectively. Peak BMD was seen in 30e39-age category in both sexes. Women after 50 yr
lost BMD at a rate of 0.006 (standard error 0.0003) g/cm2/yr, whereas the corresponding value in men was 0.002
(standard error 0.0001) g/cm2/yr. These data provide normative reference data for the calculation of T-score and
Z-score for phalangeal BMD in Sri Lankan men and women aged more than 20 yr.
Key Words: AccuDXA; osteoporosis; phalangeal bone mineral density; reference data; Sri Lanka.Introduction
Osteoporosis has become a major noncommunicable dis-
ease and increased incidence of hip fractures is expected, par-
ticularly in Asian countries, in future (1). Bone mineral
density (BMD) is a major determinant of fractures in old
age (2) and it is widely used in identifying high-risk patients.
Factors such as genetic composition, social habits, nutrition,
physical activities, and gonadal hormones have varying
effects on the bone mass (3). As these factors vary in different
communities, variations in peak bone mass and the rate of
bone loss can be expected in different populations.ceived 08/14/08; Revised 09/29/08; Accepted 09/29/08.
ddress correspondence to: Sarath Lekamwasam, MD, FRCP,
tment of Medicine, Faculty of Medicine, Center for Metabolic
Diseases, Karapitiya, Galle, Southern 80000, Sri Lanka.
l: sarathlk@sltnet.lkRestricted availability of central-type DXA machines
limits the early detection and treatment of subjects with
high fracture risk in developing countries. Clinical risk factors
of fractures such as previous fractures and maternal history of
fractures are being used by clinicians to detect high-risk sub-
jects. Several peripheral-type DXA machines including Ac-
cuDXA, have been introduced to Sri Lanka recently. Using
2 energy beams, low and high, AccuDXA measures BMD
and bone mineral content (BMC) of the middle phalanx of
the middle finger of the nondominant hand, site, which is
rich in cortical bone. This portable device has the advantage
of easy using in community settings and scan time of
1e2 min. Ohtsuka et al in 2002 found a significant associa-
tion between phalangeal BMD (PBMD) and incident verte-
bral fracture (4), whereas Mulder et al found a significant
correlation between PBMD and BMDs in central sites (5).
However, the lack of reference data on local population and
limited knowledge on clinical applications of these devices
Table 1
Descriptive Data of 4504 Men and 5215 Women Included
in the Final Analysis
Measurement Men (n5 4504) Women (n5 5215)
Mean (SD) age: yr 42.1 (12.6) 40.6 (12.7)
Mean (SD) body
weight: kg
62.3 (19.5) 54.4 (10.6)
Mean* (SD) age at
menopause: yr
NA 47.2 (3.1)
Smoking**
Ever 1150 (43.8%) 4 (0.18%)
Never 1473 (56.2%) 2174 (99.8%)
Alcohol**
Ever 1767 (67.4%) 4 (0.18%)
Never 856 (32.6%) 2174 (99.8%)
*n5 1642 postmenopausal women.
**n5 2623 men and 2178 women.
  Lekamwasam et al. 29has created an uncertainty among clinicians. Although,
PBMD is not used to diagnose osteoporosis (6) or to monitor
the therapeutic efficacy of antiresorptive drugs (7), its ability
to predict fractures has been proven in epidemiological
studies (8). Despite limitations in clinical applications, these
peripheral devices will remain available for clinicians, as cen-
tral DXA facility is available only in few major cities in Sri
Lanka.
Country-specific normative data provide more accurate
estimation of the prevalence of osteoporosis and osteopenia
(9). Although some countries have developed local reference
data, this is a daunting task for countries with limited re-
sources. In Sri Lanka, no large community-based studies
have been done to establish normative reference BMD values
and this survey was carried out to study the age-related trends
in BMD in a sample of men and women selected from 7 out
of 9 provinces in Sri Lanka.
Methods
The Community Osteoporosis Survey in Sri Lanka re-
cruited men and women above 20 yr of age from October
2004 to October 2005; 9719 subjects were included from
all provinces except the 2 provinces in North and East, which
were not included due to security reasons. A minimum of 2
different residential areas, which represented rural and urban
populations, were selected randomly from each province.
These areas were identified based on the type of local admin-
istration, adhering to the method used by the Department of
Census and Statistics during 2001 census (10). Public was in-
formed about the purpose and the nature of the study using
public announcing systems 2e3 d prior to the scheduled visit.
After explaining the purpose of the study and the procedure
involved, subjects were recruited from volunteers who gath-
ered in these scanning centers. All consenting subjects filled
a brief questionnaire on health-related information. Weight
was checked while wearing light cloths and without foot
wear. PBMD and phalangeal BMC (PBMC) of the middle fin-
ger of the nondominant hand were measured using AccuDXA
(Schick technologists, USA). Two trained technicians filled
the questionnaire and performed all scans, while calibration
of the machine was performed on each scanning day to ensure
the accuracy of BMD measurements. The precision error
Coefficient of Variation (CV%) of BMD estimations was cal-
culated by measuring 30 women, aged between 20 and 60 yr,
twice on the same day with repositioning between the 2
measurements and was found to be 0.98%.
Statistics
Descriptive data of the study sample are given as mean
(SD) or numbers (%) unless stated otherwise. Subjects were
categorized to 10-yr age categories; 20e29, 30e39, 40e49,
50e59, and 60e69 yr. Subjects aged 70 yr or above were
grouped to 1 category as the number of participants was lim-
ited. Mean PBMD and PBMC in different age categories were
estimated and compared using ANOVA with BonferroniJournal of Clinical Densitometry: Assessment of Skeletal Healthcorrection in post hoc analysis. The association between the
PBMD and age was examined using linear regression model
with BMD as the dependent and age as the independent vari-
ables, initially unadjusted and then adjusted for body weight.
Similarly, regression model was fitted as PBMD as the depen-
dent and years since menopause as the independent variables.
Correlations between PBMD, current weight (in both men
and women), and years since menopause (in postmenopausal
women) were examined using Pearson correlation (r). p
(2-Tailed) less than 0.05 was taken as the level of statistical
significance. SPSS for Windows (version 10) was used for
all calculations. Ethical approval for the study was given by
the Ethical Review Committee of the Faculty of Medicine,
Galle.
Results
Data of subjects with history of epilepsy, inflammatory ar-
thritis, endocrine diseases, recurrent wheezing, malabsorp-
tion, chronic renal or liver diseases, vasculitis, and other
chronic inflammatory diseases were excluded from the analy-
sis. Similarly, data of subjects who had taken medications
such as corticosteroids, anticonvulsants, heparin, vitamin D,
hormone replacement therapy, antiresorptive drugs, and phar-
macological doses of calcium were excluded (total number of
exclusions5 530). Subjects with previous fracture were not
excluded from the analysis. After exclusions, 5215 women
and 4504 men were eligible for the study and description of
these subjects are given in Table 1. Mean (SD) age of women
and men were 40.6 (12.7) and 42.1 (12.6) yr, respectively;
1642 (31.5%) women were postmenopausal. The number of
children born to married women ranged from 1 to 14 with
median (inter quartile range) of 2 (1e4).
BMD showed a positive correlation with current body
weight, both in men and women (r5 0.17 and 0.27 in men
and women, respectively, p! 0.001). In postmenopausalVolume -, 2008
Table 2
Mean (SD) Phalangeal BMD and BMC of 4504 Men in
Different Age Categories
Age Group
(yr)
Number of
Subjects
*BMD (SD)
(g/cm2)
*BMC (SD)
(g)
20e29 1087 0.595 (0.057) 2.15 (0.341)
30e39 1122 0.603 (0.061) 2.21 (0.356)
40e49 1148 0.591 (0.066) 2.17 (0.385)
50e59 810 0.576 (0.069) 2.13 (0.387)
60e69 250 0.558 (0.077) 2.07 (0.412)
70 and above 87 0.522 (0.079) 1.90 (0.400)
Abbr: BMD, bone mineral density; BMC, bone mineral content.
*p! 0.001 for differences in both mean phalangeal BMD and
BMC between different age groups (assessed by ANOVA post hoc
test with Bonferroni correction).
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Fig. 1. Age-related changes of phalangeal bone mineral
density (BMD) in 4504 men and 5215 women included in
the analysis. PBMD5 phalangeal BMD in g/cm2.
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p! 0.001) with years since menopause.
Phalangeal BMD, BMC, and Age
When compared with the women in the same age cate-
gories, men always had a higher PBMD. The highest
PBMD and PBMC were seen in 30e39-yr age category in
both sexes (Tables 2 and 3). However, men and women in
20e29-yr age category had achieved 98% of the maximum
PBMD and the difference of PBMD between 20 and 29 and
30 and 39 age groups was only 2%. Furthermore, no substan-
tial change in PBMD occurred from 30 to 50 yr and PBMD
started declining after 50 yr of age. The decline was more
rapid in women than in men (Fig. 1).
Although women older than 50 yr, lost BMD at a rate of
0.006 g/cm2 each year (standard error, 0.0001; p! 0.001),
men above 50 yr, lost BMD at a lesser rate (0.002 g/cm2 an-
nually; standard error, 0.0001; p! 0.001), and the rate ofTable 3
Mean (SD) Phalangeal BMD and BMC of 5215 Women in
Different Age Categories
Age Group
(yr)
Number of
Subjects
*BMD (SD)
(g/cm2)
*BMC (SD)
(g)
20e29 1074 0.495 (0.057) 1.48 (0.279)
30e39 1146 0.506 (0.062) 1.55 (0.308)
40e49 1455 0.502 (0.064) 1.55 (0.308)
50e59 1111 0.462 (0.072) 1.44 (0.325)
60e69 335 0.406 (0.072) 1.27 (0.325)
70 and above 94 0.340 (0.055) 1.04 (0.251)
Abbr: BMD, bone mineral density; BMC, bone mineral content.
*p! 0.001 for differences in both mean phalangeal BMD and
BMC between different age groups (assessed by ANOVA post hoc
test with Bonferroni correction).
Journal of Clinical Densitometry: Assessment of Skeletal HealthBMD loss between the 2 genders was significant
( p! 0.001). Inclusion of weight in the model did not change
these values materially.
Among postmenopausal women, PBMD declined by
0.005 g/cm2 (standard error 0.0002, p! 0.001) for each
year since menopause and inclusion of body weight in the
model did not affect the results significantly.
Discussion
Our results will provide normative PBMD and PBMC
reference data for the calculation of T-score and Z-score for
PBMD, measured by AccuDXA in Sri Lankan men and
women older than 20 yr. Peak PBMD was seen between 30
and 39 yr in both sexes and compared to women, men had
19% higher peak bone mass (603 vs 506 g/cm2). Compared
to women, men maintained a higher BMD, while the magni-
tude of the difference was greater in old age. After the age of
50 yr, the annual bone loss was much higher in women than
in men.
Mean BMDs of women in age categories of 40e49,
50e59, 60e69, and 70 yr or above were, respectively,
0.9%, 8.6%, 19.7%, and 32.8% below when compared with
the peak bone mass of women in the age category of
30e39 yr. Corresponding figures for men were 1.9%, 4.5%
7.5%, and 13.4% in age categories 40e49, 50e59, 60e69,
and 70 yr or above, respectively. The annual bone loss in
women was 0.006 gm/cm2, whereas that in men was only
0.002 g/cm2. This indicates that for each decade after 50 yr,
women would lose about 11.9% of their BMD, whereas
men would lose only 3.4%.
We were unable to find similar epidemiological studies,
which used either AccuDXA or measured PBMD using other
device to compare our data. Hence, studies selected for com-
parisons have measured BMDs in other sites by different de-
vices. In a previous study, a gradual decline of hip BMD was
seen in both men and women of all 3 major ethnic groups in
the United States (11). Furthermore, in a study involving
Turkish women, bone loss amounting to 14.1e32.7% at dif-
ferent skeletal sites was seen in women older than 70 yr
when compared with young Turkish women (12). Similarly,Volume -, 2008
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and 70 yr in the femoral neck and spine, respectively. Corre-
sponding figures for men were 29% and 19.5%, lower than
those of women (13). Bone loss ranging from 29% to
34.3% has been recoded in the forearm bones in old Chinese
women (14). Further Chinese women in Hong Kong lost 10%
of their bone mass in each decade from 50 to 79 yr and this
compares well with our data. Although no significant bone
loss was seen in Hong Kong Chinese men from 40 to 70 yr,
we recorded a lesser but still significant, 3.4% bone loss in
each decade in men (14).
The age in which peak bone mass is achieved has shown
a wide variation according to the study population and the re-
gion of interest included in the BMD assessment. In our study,
although, the highest BMD was seen in men and women be-
tween 30 and 39 yr, subjects in 20e29-age category had gained
98% of their maximum BMD. When the study sample was fur-
ther divided to 5-yr age categories, the peakPBMDwas seen be-
tween 30 and 34 yr in both sexes. In the United States, men and
women in all 3 major ethnic groups reached the peak hip BMD
between20 and30 yr (11).However, delays in reaching the peak
bone mass in populations outside the United States have been
reported. Saudi women reached peak spine BMD around
35 yr but earlier at proximal femur (15). Similarly in Greek
women, spinal BMD reached its peak between 30 and 35 yr,
whereas at femoral neck the peak BMD was seen between 25
and 30 yr (13). In Chinese, although peak BMD in proximal fe-
mur was seen between 20 and 24 yr, the peak BMD in the fore-
arm bones was delayed until 40e44 yr (16). Although the exact
reasons for delay in reaching the peak bonemass in certain pop-
ulations is not known, variations in genetic, social, and nutri-
tional states in different populations may play a role.
It is important to develop country-specific reference data for
the accurate estimation of T-score and Z-score. Although
NHANES data are used widely in the United States, the validity
of such data outside United States has been questioned (9). This
becomes an important issue when diagnosing osteoporosis as
the prevalence of osteoporosis varies according to the reference
data used to calculate T-scores. In Turkish women the preva-
lence of low BMD in hip, defined as T-score less than 1.0,
changed from 60.8% to 14.6% when local reference values
were used instead of the NHANES data. Similarly in hip, the
prevalence of low BMD changed from 60.8% to 14.6% (17).
Awidevariation in the prevalence of osteoporosiswaswitnessed
among Austrians when local reference data were used (18).
There were several limitations in our study. BMD measure-
ment in this study was limited to 1 single area in the appendic-
ular skeleton. Hencewe have no insight as to howBMD in other
sites, particularly in clinically relevant central sites such as
spine or proximal femur would vary in different age groups.
Furthermore, only the scanning centers were selected randomly
but not the subjects. This would have led to selection bias. The
North and the East provinces were not included in the study due
to security reasons. However, we have 8.5% Tamils and 7.8%
Moors included from other provinces and these percentages
are roughly equal to the proportions of these ethnic groups
seen in the population (10). The brief interview did not allowJournal of Clinical Densitometry: Assessment of Skeletal Healthus to go to the details of their medical history and medications
and there was a possibility of including subjects suffering from
diseases or taking medications, which could affect bone metab-
olism. The large sample size, however, would have neutralized
some of the bias that occurred at the time of recruitment.
In conclusion, our study provides reference database for
the calculation of T-score and Z-score for the PBMD mea-
sured by AccuDXA in Sri Lankan men and women aged older
than 20 yr. Men and women in the study sample gained 98%
of their maximum BMD between 20 and 29 yr and this
remained relatively unchanged until 50 yr.
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Effect of Hip Flexion on the Measurement of Spinal Bone 
Mineral Density in the Norland Eclipse XR 
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Abstract
It is recommended that the hip joints be flexed to 90° during dual-energy X-ray absorptiometry scanning of the
lumbar spine in the anteroposterior projection; however, some patients are unable to maintain this position because of
the presence of degenerative changes in lower limb joints. This study examines the effect of a lesser degree of hip
flexion on the lumbar spine bone mineral density (BMD) measurement and its interpretation. Fifty women were
scanned on the Norland Eclipse XR, initially in the standard position with the hips flexed to 90° and then in the
adjusted position after allowing for some degree of hip extension to keep them comfortable (hip flexion of 60°–70°).
Higher bone mineral content (BMC), surface area, and BMD values were seen in the standard position compared to
the adjusted position, but none of the differences was statistically significant. There were strong correlations for BMC,
surface area, and BMD measured in the two positions. In the standard position, 26 women were found to have osteo-
porosis and 18 had osteopenia. In the adjusted position, osteoporosis was noted in 27 women, and 18 had osteopenia.
Four women showed a reduction, whereas 12 women showed an increase in BMD in excess of the least significant
change at the 95% confidence level, defined as 2.77 times the precision error (0.008 g/cm2 × 2.77 = 0.120 g/cm2). Our
study demonstrates that a lesser degree of hip flexion in women who find it difficult to maintain the recommended 90°
hip flexion during the lumbar spine BMD measurement would not affect the patient classification based on T-scores
recommended by the World Health Organization; however, variation in hip flexion can be a major confounding fac-
tor when interpreting a change in BMD over time.
Key Words: Osteoporosis; bone density; lumbar spine; hip flexion; patient positioning.
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Introduction
Bone mineral density (BMD) is the yardstick for the clini-
cal diagnosis of osteoporosis in those who have not yet sus-
tained a fragility fracture. BMD of both the lumbar spine and
hip are often obtained when evaluating patients for bone mass
because they are better predictors of fractures at their own sites
(1). Further, relatively good measurement precision observed
at these sites makes them suitable sites for monitoring BMD
trends (2). Spine and hip fractures are of clinical importance,
as they are often associated with significant morbidity and
mortality, costly to manage, and associated with increased risk
of fractures at other sites (3). The lumbar spine, where trabec-
ular bone contributes to 60% of bone composition, might have
an added advantage over other skeletal sites in the monitoring
of patients with osteoporosis. As a result of the high surface-
to-volume ratio in trabecular bone, the spine is a main site that
demonstrates bone mineral decline following primary gonadal
failure (4), during corticosteroid therapy (5), and in chronic
inflammatory diseases (6). Furthermore, the BMD response
following antiresorptive or anabolic therapy is greater in the
lumbar spine than in the hip (7). The additional advantage of
the spine over other sites for BMD measurement can, however,
be lost in the presence of degenerative skeletal conditions (8). 
Correct positioning of the patient during the measurement
of lumbar spine BMD is vital to generate precise values.
Patients are kept in the middle of the scanning area in the
supine position with upper limbs on either side. To minimize
Journal of Clinical Densitometry, vol. 8, no. 2, 183–186, 2005
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the curvature of lumbar spine, which, in turn, allows for the
maximum separation of lumbar vertebrae in the scan image,
leg blocks provided by the manufacturers are used to maintain
hip flexion at 90°. We encountered several practical problems
in positioning patients for lumbar spine BMD scanning in rou-
tine clinical practice, which prompted us to perform this study.
The recommended flexion of the hips to 90° was not achiev-
able in some patients because of the presence of degenerative
changes either in the hip or spine. Although adequate flexion
was achieved in some patients, they were not comfortable in
this position and were unable to maintain it during the entire
period of scanning.
Studies examining the effect of hip flexion on the measure-
ment of lumbar spine BMD are limited (9). This study was
done to assess the differences in lumbar spine BMD when
measured with a lesser degree of hip flexion in a group of
women who were uncomfortable in the recommended position
during the measurement of spinal BMD.
Materials and Methods
A group of 50 perimenopausal women, selected from
patients referred to the Center for Metabolic Bone Diseases in
Galle in southern Sri Lanka for the assessment of BMD was
included in the study. They were positioned on the scanner
table adhering to the Norland’s guidelines and using the leg
block provided by the manufacturer. The first dual-enrgy X-ray
absorptiometry (DXA) scan of the lumber spine from L2 to L4 in
the anteroposterior projection was done using the Norland
Eclipse XR machine (Norland Corp, Ford Atkinson, USA)
with the hip joints flexed to 90° as recommended by the man-
ufacturer (standard position). A second scan was done in
women who said they were “feeling uncomfortable” during
the initial scanning, after allowing some degree of hip exten-
sion from the initial position to make them more comfortable
(adjusted position). The widest side of the leg block was used
in all women. No change in the side of the leg block or other
parts of the patient’s body was allowed between the two scans.
The degree of hip extension from the position of the first scan
was measured (to the nearest 5°) using two thin rules: (1) per-
pendicular to the scan table and (2) along the shaft of the
femur from the greater trochanter to the tibial tuberosity. Bone
mineral content (BMC), surface area, and BMD of vertebrae
L2, L3, and L4, individually and then collectively were taken
for analysis.
Statistical Analysis
Bone mineral density, BMC, and the surface area between
the standard and adjusted positions were compared using the
Student’s paired t-test. Correlations of measurements in the
standard and adjusted positions were examined using the
Pearson correlation coefficient. T-Scores were calculated for
spine BMD (L2 to L4) using the Asian reference data provided
by the manufacturer and they were categorized as osteo-
porotic, osteopenic, or normal based on the World Health
Organization’s (WHO) criteria (10). This was done in both the
standard and adjusted positions and the degree of discrepancy     
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was examined. The precision error for spine BMD (0.008 g/cm2)
was estimated by scanning 30 perimenopausal women twice,
and the least significant change (LSC) in spine BMD at the
95% confidence level was taken as 0.020 g/cm2 (defined as
2.77 times the precision error) (11). The number of women
who showed BMD change in excess of 0.020 g/cm2 from the
initial scan was estimated. Statistical significance was defined
as two-tailed p < 0.05 for all estimations. All analyses were
done using the SPSS (version 10) for Windows. Each sub-
ject signed a consent form for the second scan, and ethical
approval for the study was obtained from the local ethics
committee.
Results 
The mean (SD) age of 50 women who participated in the
study was 56.5 (5.5) yr and 40 of them were postmenopausal.
In all of subjects, the initial scan was done in the standard posi-
tion with the hip flexed to 90°. The second scan was done after
allowing some degree of hip extension from the initial posi-
tion. In 19 subjects, we had to extend the hip by 20° (i.e., hip
flexion of 70°); in another 19 subjects, we had to extend the
hip by 25° (i.e., hip flexion of 65°); and in the rest, we had to
extend the hip by 30° (i.e., hip flexion of 60°).
The means and standard deviations for BMC, BMD, and
surface area of vertebrae from L2 to L4 individually and col-
lectively in both the standard and adjusted positions and their
differences are given in Table 1.
In general, higher BMC, surface area, and BMD values were
seen in the standard position compared to the adjusted position,
but none of the differences was statistically different from zero
at the 5% significance level. There were strong correlations for
BMC, surface area, and BMD measured in the two positions.
Table 2 shows the differences in BMD between the two
positions expressed as a percentage of the initial value. The
greatest variation was seen when the hip joint was flexed by
65°. At 70° and 60° of hip flexion, the variation was less. In the
standard position, 26 women were found to have osteoporosis
whereas osteopenia was detected in 18 subjects. In the adjusted
position, osteoporosis was noted in all who had osteoporosis in
the standard position and in one additional woman (total of 27).
Eighteen women in the adjusted position had osteopenia in the
spine. When examined for the absolute BMD change, four
women (8%) showed a decline, whereas 12 (24%) had an
increase in BMD beyond the defined level for the LSC.
Discussion
Lumbar spine BMD is useful for clinicians in many ways.
Apart from estimating the future fracture risk in post-
menopausal women (1), lumbar spine BMD is also used to
monitor effects of aging (4), prolonged corticosteroid use (5),
chronic inflammatory conditions (6), and response to medical
therapies (7). The usefulness of lumbar spine BMD, however,
diminishes with age (12) because, degenerative changes in the
lumbar spine and calcification of the abdominal aorta could
cause falsely elevated values (8).
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The prevalence of both osteoporosis and osteoarthritis in
weight-bearing joints in the lower limbs increases with advanc-
ing age and its not unusual for some patients referred for DXA
to have reduced mobility in the hip and knee joints, which
could make proper positioning of these patients on the scanning
table difficult. Attempts to flex the hip joints to 90° as recom-
mended by the manufacturer can cause great discomfort for
these patients. This study demonstrates the effect of a lesser
degree of hip flexion on the measurement of spinal BMD using
the Norland Eclipse XR and its clinical interpretation.
When the diagnosis of either osteoporosis or osteopenia is
of interest, a change of hip flexion to the degree that we
allowed in our study would not cause any significant impact in
the prevalence of these two conditions. In a clinical setting, if
a patient is unable to keep the hips flexed to 90° during the
estimation of spinal BMD, a slight extension of the hips from
the recommended position can be allowed, to keep the patient
comfortable without causing a significant impact on the WHO
classification of the patient.
When compared to the standard position, the mean BMC,
surface area, and BMD values in the adjusted position were
relatively higher, except for the surface area of the L2 vertebra.
Although these differences were not statistically significant,
their clinical relevance was clearly evident. When the position
was adjusted the, BMD change ranged from –4.8 to 10.8%,
with a mean of 0.9%. Both mean BMC and the surface area
increased when the position was adjusted, but the BMC to a
greater extent (–15.4 to 18.6%) than the surface area (–12.8 to
10.7%). This could explain the higher BMD observed in the
adjusted position. This pattern was similar when vertebrae
were considered both individually and collectively.
When the spine BMD (L2 to L4) in the second scan was
considered, 23 women (46%) had a reduction, and the rest
showed an increase from the initial value. In 16 women, the
change in BMD was in excess of the LSC. Thus, in follow-up
studies, if attention is not paid to the degree of hip flexion, a
difference of hip flexion by about 25° would cause either false
elevation or reduction of BMD in about 32% of subjects to a
value that could be interpreted as a biologically significant true
change. If the initial scan was obtained with a lesser degree of
hip flexion, then this must be recorded for future reference and
the same degree of hip flexion should be achieved in subse-
quent scans. This will minimize the false change in BMD
because of the variation in hip positioning. 
This study has several limitations. The applicability of our
results to DXA scanners other than Norland remains unknown.
Unlike Hologic and Lunar, Norland does not include L1 in
spinal BMD estimations and we have analyzed only L2 to L4
in this study. Similar studies should be performed using
Hologic and Lunar central DXA to determine if the principles
are broadly applicable. Finally, the degree of hip flexion was
measured to the nearest 5° and some patients may have been
categorized to the wrong group.
Conclusion
In summary, this study illustrates the effect of hip flexion
on the spinal BMD analysis and interpretation. As there should
Table 1
Mean (SD) BMC, Surface Area, and BMD in the Standard and Adjusted Positions, Their Correlations, and Their Differences
Site Standard position Adjusted position ra Mean differenceb 95% CI for difference p-Value
BMC (g)
L2 8.17 (2.19) 8.15 (2.27) 0.96 0.020 (–0.165, 0.206) 0.83
L3 9.33 (2.52) 9.15 (2.50) 0.96 0.179 (–0.028, 0.386) 0.09
L4 9.85 (2.50) 9.69 (2.47) 0.94 0.157 (–0.095, 0.409) 0.22
L2–L4 27.35 (6.97) 27.00 (7.05) 0.97 0.355 (–0.143, 0.853) 0.16
Surface area (cm2)
L2 11.20 (0.91) 11.22 (0.90) 0.83 –0.017 (–0.170, 0.135) 0.82
L3 12.24 (1.01) 12.13 (0.92) 0.81 0.120 (–0.053, 0.294) 0.17
L4 13.00 (1.20) 12.86 (1.10) 0.74 0.142 (–0.096, 0.380) 0.26
L2–L4 36.44 (2.64) 36.21 (2.49) 0.86 0.225 (–0.165, 0.615) 0.25
BMD (g/cm2)
L2 0.728 (0.178) 0.724 (0.184) 0.99 0.005 (–0.005, 0.014) 0.33
L3 0.759 (0.182) 0.752 (0.187) 0.99 0.006 (–0.002, 0.014) 0.11
L4 0.756 (0.171) 0.752 (0.175) 0.98 0.004 (–0.005, 0.013) 0.40
L2–L4 0.748 (0.174) 0.743 (0.178) 0.99 0.006 (–0.001, 0.013) 0.08
aPearson correlation coefficient between standard and adjusted positions (p < 0.0001 for all correlations).
bMean of the paired differences (standard–adjusted).
Table 2
Percentage Change of BMD at Different Hip Flexions
Minimum Maximum Mean SD
Entire group (n = 50) –4.80 10.85 0.90 3.52
At 70° (n = 19) –2.94 7.11 0.61 2.40
At 65° (n = 19) –4.83 10.85 1.95 4.49
At 60° (n = 12) –2.63 8.31 –0.31 3.01
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be a uniform method in positioning patients for spine scans,
keeping the thighs perpendicular to the scan table, with the
hips flexed to 90°, should be considered the standard method
when using Norland central DXA. Leg blocks provided by the
manufacturers are helpful to achieve and maintain this position
throughout the study. If this is not achievable, a lesser degree
of hip flexion can be allowed without altering the diagnosis
based on the WHO criteria. The degree of hip flexion achieved
should be documented in the patient’s notes and the same
degree of hip positioning should be maintained in repeat scans.
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Abstract
Although it is generally recommended that patients keep their hips flexed by 90 during the measurement of
spinal bone mineral density (BMD), there is no uniform agreement among the manufacturers of dual-energy X-ray
absorptiometry (DXA) scanners regarding the positioning of legs while scanning the spine. We measured spinal BMD
in 54 postmenopausal women, from L1 to L4 in posterior-anterior projection, using a Hologic Discovery scanner,
first with their legs elevated as recommended by the manufacturer and then with their legs flat on the scanning table.
Differences of bone mineral content (BMC), area of the region of interest (ROI), BMD, and T-score of the total spine
between the 2 scans were compared. The mean (SD) age of the women was 54.3 yr (15 yr). Between the 2 scans,
BMC, area of the ROI, BMD, and T-scores showed high correlations (r5 0.98, 0.94, 0.99, and 0.99, respectively).
BMC and the area of the ROI changed significantly between the 2 scans, but the changes of BMD and T-scores were
not significant. The percentage changes of BMC and the area of the ROI were similar (2.6% and 2.4%, respectively),
whereas T-scores showed no change and change of BMD was only 0.6%. The absolute difference in BMD between
the 2 scans was only 0.005 ( p5 0.09). When spinal BMD was measured with their legs elevated, 31 women were
found to have osteoporosis and further 13 were found to have osteopenia. When spinal BMD was measured with
their legs flat, 32 women were found to have osteoporosis and further 12 were found to have osteopenia. In conclu-
sion, no clinically or statistically significant difference in the total spinal BMD was found when the BMD in a group
of women was measured on a Hologic Discovery DXA scanner with their legs positioned flat.
Key Words: Bone mineral density; leg positioning; precision error.Introduction
The lumbar spine is one of the key sites used in the clinical
evaluation of patients with osteoporosis. Initial bone loss fol-
lowing menopause (1) and the maximum therapeutic effects
of current therapies of osteoporosis are mainly seen in the
lumbar spine (2). The clinical applicability of spinal bone
mineral density (BMD) diminishes in old age due to the oc-
currence of degenerative changes in and around the lumbar
spine (3).
Received 11/06/06; Revised 01/05/07; Accepted 01/22/07.
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80000, Sri Lanka. E-mail: sarathlk@sltnet.lkGenerally, the patients’ hip joints are flexed by 90 to keep
their thighs perpendicular to the scanning table while estimat-
ing spinal BMD. This reduces the lumbar curvature, allows
separation of individual vertebrae, and prevents overlap of
bone tissue. However, there is no uniform agreement between
the manufacturers of dual-energy X-ray absorptiometry
(DXA) scanners regarding the positioning of legs during
scanning of spine, and different leg positions are recommen-
ded by different DXA scanner manufacturers. Whereas the
manufacturers of the Hologic and Norland scanners recom-
mend flexion of hips by 90 while scanning for spinal
BMD, the Lunar scanner manufacturer does not recommend
such positioning. This study was done to estimate the differ-
ence between spinal BMD measured with hip flexion and that
measured without hip flexion, using a Hologic DXA scanner.
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Mean (SD) of BMC, Area of the ROI, and BMD Measured With Patients’ Legs Up and Patients’ Legs Down
and Their Correlations and Mean Differences
Measurement Legs-up position Legs-down position Correlation (r) Mean difference (95% CI) pa
BMC (g) 35.66 (9.90) 34.86 (10.04) 0.98* 0.79 (0.19 to 1.40) 0.011
Area of the ROI (cm2) 47.26 (5.47) 45.99 (5.62) 0.94* 1.27 (0.73 to 1.80) !0.001
BMD (g/cm2) 0.746 (0.164) 0.750 (0.168) 0.99* 0.005 (0.010 to 0.001) 0.09
T-score 2.74 (1.49) 2.70 (1.53) 0.99* 0.03 (0.09 to 0.01) 0.153
Abbr: BMC, bone mineral content; BMD, bone mineral density; CI, confidence interval; ROI, region of interest.
ap contrasts between the 2 DXA measurements taken with patients’ legs up and patients’ legs down.
*p! 0.001 (Pearson correlations for 2 measurements taken with patients’ legs up and patients’ legs down).Method
A group of postmenopausal women referred to the Center
for Metabolic Bone Diseases in the Faculty of Medicine,
Galle, Sri Lanka, was selected for the study. Fifty-four con-
senting women had their lumbar spine scanned from L1 to
L4 in the posterior-anterior projection, using a Hologic Dis-
covery W (Hologic Inc.) scanner. First, the scan was done
with their hips flexed, using the leg positioning cushion pro-
vided by the manufacturer (legs-up position). Patients were
then positioned for routine hip scans using the hip positioning
aid provided by the manufacturer, and a second scan of the
spine, from L1 to L4 in the posterior-anterior projection,
was done while their legs were flat on the bed (legs-down po-
sition). Patients were not moved from the scanning table, and
only their legs were adjusted between the 2 scans. All scans
were done by the same technician who analyzed each scan in-
dividually. Ethical approval for the study was obtained by the
Ethics Review Committee of the Faculty of Medicine, Galle,
and each participant signed a consent form.
Statistics
Data are given as mean (SD) values unless stated other-
wise. Only BMC, area of the region of interest (ROI),
BMD, and T-scores of the total spine from L1 to L4 were con-
sidered for the analysis. Differences in spinal BMC, area of
the ROI, BMD, and T-scores between the 2 scans were com-
pared using the paired Student’s t-test. Correlations of BMC,
area, BMD, and T-scores between the 2 scans were examined
Table 2
Change of BMC, Area, and BMD Between the 2 Scans
Measurement Median (%) IQR (%)
BMC 2.5 0.2 to 5.1
Area 2.6 1.2 to 4.7
BMD 0.48 2.3 to 0.9
T-score 0 3.2 to 6.5
BMC, bone mineral content; BMD, bone mineral density; IQR,
inter quartile range.Journal of Clinical Densitometryusing linear regression. The women were classified into oste-
oporosis, osteopenia, or normal groups depending on the
WHO cutoff values based on T-scores (4). The agreement
of the classification in the 2 positions was compared using
kappa statistics. The agreement of BMD, BMC, and area of
the ROI, measured in the 2 positions was examined using
the Bland-Altman plot. Precision error of spinal BMD was es-
timated for the leg-up position by scanning 30 perimeno-
pausal women twice, with repositioning between the 2
scans, and was found to be 0.008 g/cm2 (least significant dif-
ference5 0.020 g/cm2). Thirty-four perimenopausal women
were scanned twice on separate occasions in leg-down posi-
tion with repositioning between the 2 scans to estimate the
precision error of spinal BMD estimations in leg-down posi-
tion, which was found to be 0.009 g/cm2 (least significant dif-
ference5 0.022 g/cm2).
Results
The mean (SD) age of the women was 54.3 yr (15 yr).
High correlations were seen in BMC, area of the ROI,
BMD, and T-scores measured in legs-up and legs-down posi-
tions. Differences in BMC and the area of the ROI between
legs-up and legs-down positions were statistically significant,
whereas BMD and T-score differences were not significant
(Table 1). The percentage change of BMC, area of the ROI,
BMD, and T-score showed a skewed distribution; hence, me-
dian and inter quartile range (IQR) values were estimated.
Percentage changes of BMC and the area of the ROI were al-
most similar (2.5% and 2.6%, respectively), whereas no
change in T-score and a marginal change in BMD were
seen (Table 2).
In regression analysis, BMD measured in the 2 positions
showed a very high correlation (r5 0.99) (Fig. 1). The
Bland-Altman plot drawn to examine the agreement of
BMD measured in the 2 positions showed that most of the ob-
servations (96%) were within 2 SDs around the mean value of
difference between the 2 measurements (i.e., BMD leg
up BMD leg down), indicating good agreement of paired
measurements (mean50.004 and SD5 0.02 g/cm2)
(Fig. 2). However, more scatter was seen in plots drawn for
BMC (mean5 0.799 and SD5 2.21 g) and area of the ROIVolume 10, 2007
Lekamwasam et al. 40(mean5 1.27 and SD5 1.96 cm2), indicating less agreement
in those measurements (Figs. 3 and 4). When spinal BMD
was measured in the legs-up position, 31 women were found
to have osteoporosis and further 13 were found to have osteo-
penia. With spinal BMD measured in the legs-down position,
32 women were found to have osteoporosis and further 12
women were found to have osteopenia (kappa5 0.84).
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Fig. 2. Bland-Altman plot for bone mineral density (BMD)
measurements taken with patients in legs-up (LU) and legs-
down (LD) positions.Journal of Clinical DensitometryDiscussion
The results of our study showed no significant difference in
the total spinal BMD or T-score measured with hip flexion
and that measured without hip flexion. When patients’ legs
were kept flat, the area of the ROI and BMC, both reduced
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Fig. 3. Bland-Altman plot for bone mineral content (BMC)
measurements taken with patients in legs-up (LU) and legs-
down (LD) positions.
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measurements taken with patients in legs-up (LU) and legs-
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Spinal BMD Differences With and Without Leg Elevation 41almost to the same extent, and thus, BMD and T-score did not
change significantly. BMD and T-score differences remained
the same after adjusting for the height of the women, the per-
centage change in BMC, or the area of the ROI. The change
of mean BMD was only 3% when expressed as a percentage
of SD of BMD measurements. Change of BMD had only a mi-
nor effect on the T-score, resulting in misclassification of one
patient with osteopenia as having osteoporosis.
Flexion of legs at the hip joints reduces the lumbar curvature,
causing separation of intervertebral spaces. When legs are kept
flat, the spinewould resume its normal lumbar curvature, result-
ing in a reduction in the ROI. However, the Hologic analysis
software had no difficulty in locating the intervertebral spaces
to place horizontal lines to demarcate individual vertebrae
and the operator did not have to do this manually.
There is no uniform agreement among manufacturers of
DXA scanners on how the legs should be positioned while es-
timating spinal BMD. The manufacturers of the Hologic and
Norland scanners recommend flexion of hips by 90 to keep
the thighs perpendicular to the surface of the scanning table.
As the current reference data used in most of the systems have
been obtained by adhering to this positioning, it is logical to
position patients in a similar manner, if those reference data
are to be used in patient evaluation.
If BMD of the spine can be measured while the patient is
positioned for a hip scan, it will save time and can be less
troublesome to the patient. This can be done only if DXA ma-
chines have the same accuracy for measuring BMD with or
without hip flexion. Further, the high precision we observed
in leg-down position would support the adoption of such prac-
tice. A previous study using a Lunar Prodigy or Bravo scanner
showed results comparable to those of our study (5). In this
study involving a group of postmenopausal women, the corre-
lation of BMDs measured with or without leg elevation was
similar to the value we observed in our study. Further, in
the regression analysis, the slope and intercept values ob-
served were highly comparable to our figures. This study
based on Lunar, however, showed a statistically significant
and higher difference in BMDs between the 2 positions.
The difference in BMDs observed in this study was much
higher (0.014 g/cm2) than the corresponding figure observed
in our study (0.005 g/cm2).
Yang and Jeon, using a Hologic QDR 4500 scanner, dem-
onstrated comparable results (6). Spinal BMDs with and with-
out leg elevation showed a correlation of 0.99, whereas there
was no significant difference between the mean BMDs esti-
mated in the 2 positions (0.907 vs 0.922 g/cm2). Further, there
was only a 0.13 SD difference in the mean T-scores between
the 2 positions.This study has a few limitations. We used the same ref-
erence data to calculate T-scores in both positions. These
reference data have been developed using standard proto-
cols, and their applicability for BMD estimated in a differ-
ent way is questionable. T-scores obtained in the legs-down
position would have been different if we had used refer-
ence data developed by scanning subjects with their legs
flat. To the best of our knowledge, such reference data
do not exist.
Our data would add to the existing body of evidence that
the total spinal BMD can be measured while the patient is po-
sitioned for a hip scan, without compromising the diagnostic
stratification. The high precision and accuracy we observed in
this study, in estimating spinal BMD while patients’ legs were
positioned flat, would support this. The same cannot be said
about the BMC and the area of the ROI as there were signif-
icant differences in these 2 measures when estimated in the 2
positions. However, BMD is used more often by clinicians
and researchers in their decision making, and BMC or area
of the ROI is only seldom used.
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Introduction
Osteoporosis is defined as “a systemic skeletal
disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with
a consequent increase in bone fragility and suscepti-
bility to fracture” (1). The diagnosis of osteoporosis
is made when bone mineral density (BMD) esti-
mated by dual-energy X-ray absorptiometry (DXA)
is lower than 2.5 SD of the young normal reference
population (2). Further, BMD can quantify the future
fracture risk in an individual and is also used to mon-
itor skeletal response to therapeutic interventions
(2). Although BMDs of both lumbar spine and prox-
imal femur are considered when the diagnosis of
osteoporosis is made, the latter is preferred as is it
the best site to predict risk of future hip fracture (3)
and is less affected than lumbar spine by age-related
degenerative changes and other artifacts (4).
The precision and accuracy of DXA are the key
issues when interpreting BMD measurements in
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clinical practice. The annual BMD loss in most post-
menopausal women varies from 0.5% to 2%, and the
increase in BMD following currently available
antiresorptive drugs is only around 1–6% in 3 yr (5).
Hence the precision of DXA should be sufficiently
low to detect these modest BMD changes seen when
monitoring patients.
For accurate estimation of BMD, the axis of the
femoral neck should be maintained parallel to the
couch and perpendicular to the X-ray beam while
scanning, and DXA manufacturers provide different
types of positioning aids to achieve this objective.
When cadaveric specimens were used, the minimum
BMD in the femoral neck was recorded when the
femoral neck was parallel to the couch and gradual
increase in BMD occurred when the femur was
rotated either internally or externally (6). In another
study, anteversion of femur by 19.3° from the neu-
tral position was associated with a significant 2.8%
increase in femoral neck BMD (7). Girard et al. also
found a significant change in femoral neck BMD
when the leg was rotated 10–15° from its original
position (8).
Most of these studies have used cadaveric speci-
mens and devices for accurate estimation of the
degree of neck rotation (6–8), which is largely
unknown when scanning patients in a clinical setup.
Only limited data are available about the effect of leg
rotation on hip BMD in living subjects (9). This study
examines the effect of leg rotation by 10° either inter-
nally or externally on hip BMD in a group of 50
female volunteers recruited from the community.
Materials and Methods
This study was done on 50 female volunteers,
who were participating in a large community-based
osteoporosis study conducted in Southern Sri Lanka.
A pretested questionnaire was used to gather infor-
mation on current and previous diseases and med-
ications. This was followed by a detailed physical
examination. Subjects with history or clinical evi-
dence of diseases that can affect bone metabolism
were excluded from the study. Women who had
taken drugs that affect bone metabolism were also
excluded from the study.
All subjects had their left hip scanned using a
Norland Eclipse XR (Norland Corp., Fort Atkinson,
USA) scanner. Norland provides a leg separator
block to be kept between the patient’s heels and a
femoral rotating fixture to rotate the leg at the upper
thigh level using two Velcro straps. Subjects were
first scanned in the routine position (the customary
position) using these positioning aids and adhering
strictly to the instructions given in the operator’s
guide. The scan picture obtained in the customary
position was accepted regardless of the degree of hip
rotation and analyzed to obtain BMD, bone mineral
content (BMC), and surface area of the regions of
interest (ROI). In order to minimize the variation in
the positioning of ROI in the proximal femur, the
operator identified the center of the femoral neck the
same way in all scans. The degree of leg rotation in
the customary position was noted on a scaled arc
using the inner border of the foot as the guide. Two
further scans were done following rotation of the leg
internally by 10° (the internal rotation) and then
externally by 10° (the external rotation) from the
customary position. In all three positions, the leg
was supported manually to maintain the adjusted
position during scanning.
Ethical approval for the study was obtained from
the local ethics regulatory authority.
Statistical Analysis
Descriptive data of the cohort, BMC, BMD, and
surface area values are expressed as mean and stan-
dard deviations. Paired t-test was used to compare the
BMD, BMC, and surface area values obtained after
rotations to the customary position. Percentages of
patients with osteoporosis in three positions were
determined and compared using Wilcoxon’s Signed
Ranks Test. Diagnosis of osteoporosis was made
when T-score was found to be below –2.5 (using the
Asian reference dataset provided by the manufac-
turer) either in the femoral neck or in the trochanter.
The difference in BMD after rotation was calculated
and expressed as an absolute BMD change. A signif-
icant change in BMD was defined as a change in
excess of 2.77 times of the precision error at each site
(10) (i.e., either increase or decrease of femoral neck
BMD by 0.030 g/cm2, trochanteric BMD by 0.033
g/cm2, and Ward’s area BMD by 0.096 g/cm2). The
precisian errors of the machine estimated earlier were
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0.011, 0.012, and 0.035 g/cm2 for the femoral neck,
trochanter, and Ward’s area, respectively.
Results
Mean age of the 50 women in the study was 54.9
(SD = 11.1) yr. Mean weight and height of the sub-
jects were 50 (SD = 10.2) kg and 1.49 (SD = 0.06) m,
respectively. The positions of the leg measured as an
angle from the surface of the couch to the inner bor-
der of the foot were 70.4 (SD = 5.4), 60.4 (SD = 5.4),
and 80.4 (SD = 5.3) degrees in the customary posi-
tion, after external and internal rotations, respectively.
Table 1 shows the mean BMD, BMC, and sur-
face area values in the femoral neck and trochanter
in the customary position, after internal and exter-
nal rotations. Since the surface area of the Ward’s
triangle remains constant (1 cm2) in all three posi-
tions, both BMD and BMC have the same values
and are given together.
Table 2 shows the differences in mean BMD,
BMC, and surface area values in hip regions follow-
ing rotations. The external rotation increased BMD in
all three sites, while reduction of BMD was seen after
the internal rotation. Significant differences were
observed in the femoral neck and trochanteric area
Leg Rotation and Hip BMD
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Table 1
BMD, BMC, and Surface Area Values in Hip Regions in Three Different Positions
Description Mean (range) SD
Femoral neck BMD
In customary position (g/cm2) 0.713 (0.429–0.977) 0.123
After internal rotation (g/cm2) 0.704 (0.427–0.963) 0.120
After external rotation (g/cm2) 0.717 (0.418–0.962) 0.128
Femoral neck BMC
In customary position (g) 3.068 (1.583–4.630) 0.650
After internal rotation (g) 3.001 (1.428–4.486) 0.628
After external rotation (g) 3.145 (1.481–4.087) 0.666
Femoral neck area
In customary position (cm2) 4.32 (2.82–5.26) 0.55
After internal rotation (cm2) 4.28 (2.80–5.24) 0.55
After external rotation (cm2) 4.49 (2.81–7.28) 0.76
Trochanteric BMD
In customary position (g/cm2) 0.583 (0.336–0.754) 0.099
After internal rotation (g/cm2) 0.578 (0.353–0.751) 0.097
After external rotation (g/cm2) 0.586 (0.361–0.767) 0.099
Trochanteric BMC
In customary position (g) 5.676 (3.111–7.948) 1.238
After internal rotation (g) 5.800 (3.225–8.213) 1.210
After external rotation (g) 5.438 (2.397–7.745) 1.311
Trochanteric area
In customary position (cm2) 9.63 (5.58–11.69) 1.30
After internal rotation (cm2) 9.94 (6.19–12.23) 1.15
After external rotation (cm2) 9.17 (5.59–11.72) 1.44
Ward’s area BMD and BMCa
In customary position (g/cm2 or g) 0.518 (0.230–0.830) 0.131
After internal rotation (g/cm2 or g) 0.512 (0.244–0.761) 0.124
After external rotation (g/cm2 or g) 0.554 (0.255–0.860) 0.138
a In Ward’s triangle the surface area is 1 cm2 and it remains constant in all positions. Hence
BMD and BMC have similar values.
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after the internal rotation and also in Ward’s area after
the external rotation.
The external rotation increased BMC in the
femoral neck and Ward’s area significantly. The
internal rotation reduced BMC in these two sites and
only the difference in the femoral neck was statisti-
cally significant. In the trochanter, BMC decreased
after the external rotation and increased after the
internal rotation, and both differences were statisti-
cally significant.
In the femoral neck, surface area increased after
the external rotation and decreased after the internal
rotation. In the trochanter, changes in the surface
area following rotations were in opposite directions
to those observed in the femoral neck. In the
trochanter, surface area decreased after the external
rotation and increased after the internal rotation.
Nine subjects (18%) were found to have osteo-
porosis when the hip was scanned in the customary
position, and this number remained same after the
external rotation. Only seven subjects (14%) were
noted to have osteoporosis after the internal rotation.
These differences were not statistically significant.
A significant change in femoral neck BMD was
found in six (12%) subjects after the internal rota-
tion and in four subjects (8%) after the external rota-
tion. The number of subjects with a significant
change in trochanteric and Ward’s area BMD after
the internal rotation were one (2%) and two (4%),
respectively. After the external rotation, the number
of women with a significant BMD change in the
trochanteric and Ward’s area were two (4%) and
four (8%), respectively.
Discussion
This study once again highlights the importance
of proper positioning of the hip during DXA scan-
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Table 2
Differences in Mean BMD, BMC, and Surface Area 
in Three Regions After Internal and External Rotations
Comparison Mean difference SD p-Value
Femoral neck BMD
Customary–external rotation 0.005 g/cm2 0.021 0.119
Customary–internal rotation –0.009 g/cm2 0.015 <0.001
Femoral neck BMC
Customary–external rotation 0.077 g 0.155 0.001
Customary–internal rotation –0.067 g 0.109 <0.001
Femoral neck area
Customary–external rotation 0.169 cm2 0.467 0.012
Customary–internal rotation –0.044 cm2 0.105 0.003
Trochanteric BMD
Customary–external rotation 0.003 g/cm2 0.021 0.309
Customary–internal rotation –0.005 g/cm2 0.013 0.008
Trochanteric BMC
Customary–external rotation –0.238 g 0.408 <0.001
Customary–internal rotation 0.124 g 0.267 0.002
Trochanteric area
Customary–external rotation –0.465 cm2 0.760 <0.001
Customary–internal rotation 0.304 cm2 0.406 <0.001
Ward’s area BMD and BMCa
Customary–external rotation 0.036 g/cm2 0.048 <0.001
Customary–internal rotation –0.006 g/cm2 0.043 0.320
a In Ward’s triangle the surface area is 1 cm2 and it remains constant in all positions.
Hence BMD and BMC have similar values.
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ning. According to our results, the effect of malposi-
tioning of the hip during DXA scanning would be
more relevant in longitudinal patient monitoring than
in cross-sectional BMD analysis.
Previous studies demonstrated an increase in the
femoral neck BMD with either internal or external
rotation (6). However, in our study, mean BMDs in
all three hip regions increased after the external rota-
tion and decreased after the internal rotation.
Previous studies examining the effect of leg rotation
on BMD have used cadaveric specimens and devices
such as CT images for accurate positioning of the
femoral neck while scanning (6–8). Although manu-
facturers provide positioning aids to maintain the
axis of the femoral neck perpendicular to the X-ray
beam while scanning, whether this can be achieved
in all subjects is questionable. It is unlikely that all
subjects had their femoral neck positioned in the
ideal way when they were scanned first in the cus-
tomary position in our study. Increase in BMDs fol-
lowing rotation would have occurred in subjects who
had correct positioning of the femoral neck initially,
whereas in others, who had rotated femoral neck to
begin with, decrease of BMD would have occurred
when the neck assumed the correct position after
rotation. Change in BMD in different directions
could be partly due to variation in acquiring the ideal
position in the initial scanning.
When measured repeatedly, change in areal
BMD at a particular site can be a result of several
reasons. Differences in BMC, surface area in the
ROI, or both can change the areal BMD. When
measuring BMD in the proximal femur, Norland
systems maintain a constant surface area (1 cm2)
for Ward’s triangle but not for the other two sites.
In our analysis, BMD and BMC changes in Ward’s
area were similar in both direction and magnitude,
indicating that change in BMD in this site was due
purely to change in BMC. The same cannot be said
about the other two sites, where the surface areas
of the ROIs were not kept constant on repeated
measurements. In the femoral neck, although the
changes in both BMC and surface area were in the
same direction, they were of different magnitudes.
With the external rotation, femoral neck BMC
increased by an average of 2.6% (p = 0.001) while
surface area increased by 3.8% (p = 0.012), and the
resultant change in BMD was only marginal
(p = 0.119). With the internal rotation, femoral
neck BMC and surface area decreased by 2.1%
(p < 0.001) and 1.0% (p = 0.003), respectively, and
these disproportionate changes finally contributed
to a significant decline in femoral neck BMD
(p < 0.001) with the internal rotation.
After the external rotation, trochanteric BMC and
the surface area declined by 4.2% (p < 0.001) and
4.8% (p < 0.001), respectively, and no appreciable
change in BMD occurred at this site (p = 0.309).
However, with the internal rotation, trochanteric
BMC increased by 2.7% (p = 0.002) while the sur-
face area increased by 3.5% (p < 0.001), resulting in
a significant decline in BMD (p = 0.008).
The BMD changes after the internal and external
rotations showed normal distributions in all three
areas. Therefore the real magnitude of the BMD
change with rotation is not reflected in the mean dif-
ferences. A significant change in the femoral neck
BMD was seen in 12% of subjects after the internal
rotation and in 8% after the external rotation. This
indicates that internal rotation of the leg by merely
10° between the first and the second scan can bring
about significant BMD changes in 12% of subjects.
This degree of variation in patient positioning is pos-
sible in a clinical setup with high patient turnover
and can be a potential confounding factor when ser-
ial measurements are taken to monitor BMD trends
with or without interventions. Although not large,
the greatest effect of this technical error was seen in
the femoral neck, which is a key site in monitoring
treatment efficacy (2). Effect of leg rotation was less
pronounced in the trochanteric and Ward’s area in
our study. Less change in the trochanteric area fol-
lowing leg rotation was noted in previous studies
too, and this appears to be a better site to monitor
serial BMD changes (6,7).
The significant change of BMD in our study was
defined as an increase or decrease of BMD greater
than 2.77 times the precision error of the particular
site. This was based on the least significant change
(LSC), which shows the magnitude of the BMD
change required to indicate a real biological differ-
ence at a particular skeletal site provided the preci-
sion error of the site and the level of statistical
confidence required are known (10). If one scan was
done at the baseline and repeated during follow-up,
a change of BMD of more than 2.77 times precision
Leg Rotation and Hip BMD
Journal of Clinical Densitometry Volume 6, 2003
46
error would mean a real change at 95% confidence
level for a site that has a precision error of 1.0.
Although the proportion of subjects who showed a
BMD change of this magnitude in our study was rel-
atively small, this should be remembered when inter-
preting serial scan results of individual patients.
According to the results of our study, the preva-
lence of osteoporosis based on the T-scores of the
femoral neck and trochanter was not significantly
different in three different positions. BMD in Ward’s
area is generally not considered in making the diag-
nosis of osteoporosis (2), and this was not included
when the prevalence of osteoporosis was deter-
mined. Our data suggest that leg rotation by this
degree has no major effect on the prevalence of
osteoporosis when cross-sectional BMD measure-
ments are analyzed.
In summery, correct positioning of the hip dur-
ing DXA scanning is vital. Rotation of the hip is a
potential confounding factor when serial BMD
measurements are taken in a single subject, either
to monitor response to treatment or to determine
the rate of bone loss over a period of time. Attempts
must be made to adhere to the manufacturer’s hip
positioning protocol, which can minimize the vari-
ation between repeated scans. When serial BMD
measurements are taken, attempts must be made to
acquire similar hip positioning and to define ROIs
in similar way in all scans. Part of the lesser
trochanter, which is a posterior structure, becomes
visible when the hip is rotated, and this can be used
to judge adequate rotation of the hip prior to scan-
ning. Further, previous scan images can be recalled
and compared with the current scan image to mini-
mize variations in hip rotation and defining regions
of interests.
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Age-related trends in hip geometry in Sri Lankan women: 
a cross-sectional study
Abstract Indices of hip geometry are known to be predic-
tive of hip fractures while sex and ethnic differences in hip 
geometry have been previously demonstrated. Age-related 
trends in hip geometry among Asians, however, have not 
been studied suffi ciently. A total of 280 healthy, perimeno-
pausal women, aged between 32 and 97 years, were selected 
from the Community Study Area of the Faculty of Medi-
cine, Galle, Sri Lanka. Hip DXA images were analyzed 
further to calculate the hip axis length, neck-shaft angle, 
and femoral neck width at the narrowest point of the 
femoral neck. Standard formulae were used to calculate 
cross-sectional area, cross-sectional moment of inertia, and 
section modulus in the femoral neck region. Mean (SD) 
age, weight, height, femoral neck bone mineral density 
(BMD), hip axis length, neck-shaft angle, neck width, cross-
sectional area, and cross-sectional moment of inertia of the 
study sample were 56.8 (13.0) years, 47.8 (10.1) kg, 1.48 
(0.06) m, 0.704 (0.147) g/cm2, 90.6 (5.6) mm, 123.2 (5.7)°, 
2.99 (0.24) cm, 2.00 (0.42) cm2, and 1.62 (0.47) cm4, respec-
tively. Height and weight of subjects had positive correla-
tions with most of the indices of hip geometry. Femoral 
neck BMD, cross-sectional area and section modulus 
showed a rapid reduction during the postmenopausal 
period. With advancing age, there was a marginal but 
statistically nonsignifi cant expansion of the neck width, 
increase in the hip axis length, and narrowing of the neck-
shaft angle. In conclusion, this study demonstrated a gradual 
loss of BMD in postmenopausal age, accompanied by thin-
ning of the cortical shell and deterioration of the resistance 
to bending in the femoral neck of this group of healthy 
women. The clinical relevance of the marginal changes seen 
in other indices such as neck-shaft angle, hip axis length, 
and neck width is not known.
Key words postmenopausal osteoporosis · hip structure · 
Sri Lanka
Introduction
Although bone mineral density (BMD) is widely used in 
assessing the future risk of hip fracture [1–3], there is a wide 
overlap of BMD between subjects with and without hip 
fractures [4,5]. Previous studies have shown certain indices 
of hip geometry, such as hip axis length, to be predictive of 
hip fractures [6–8]. Further, indices of hip geometry when 
considered in combination with age and body proportions 
improved the sensitivity of BMD in predicting hip fractures 
[9,10].
Indices of hip geometry vary in different communities, 
and these variations may partly explain the geographical 
and ethnic differences in the hip fracture incidence [11,12]. 
When compared with white women, black women had 
higher BMD, cross-sectional area, mean cortical thickness, 
and section modulus both at the femoral neck and the prox-
imal shaft of the femur [13], and these differences may 
explain the difference in the hip fracture incidence observed 
in these two populations.
Compared with Europeans, Asians have a low incidence 
of hip fracture, and what factors protect Asians from hip 
fracture are not entirely clear. The relatively low incidence 
of femoral fractures among Asians may have several expla-
nations. The differences in genetic composition, environ-
mental infl uences, physical activity, and state of nutrition 
may have a role to play in determining fracture occurrence. 
Further, Asians in their postmenopausal age may have 
more favorable structural adaptations in long bones than 
white women, and hence retain bone integrity in old age 
[12,14]. Studies on age-related changes in hip geometry 
among Asians are limited. This study was done to assess the 
age-related trends in geometry of the femoral neck in a 
group of randomly selected, community-dwelling women in 
Southern Sri Lanka.
Received: January 26, 2007 / Accepted: April 10, 2007
49
Materials and methods
Study population
Female volunteers numbering 370, above 20 years of age, 
were selected using the latest voter registers from the 
Community Study Area of the Faculty of Medicine, Galle. 
Houses were selected randomly using a table, and all women 
over the age of 20 years in the selected households were 
contacted through the Family Health Worker of the 
area. Consenting women were invited to the Center for 
Metabolic Bone Diseases, in the Faculty of Medicine, where 
present and past health was assessed using a predesigned 
questionnaire and a complete physical examination was 
done. Pregnant women and those with a history of diseases 
such as infl ammatory arthritis, infl ammatory bowel disease, 
chronic asthma, hyperthyroidism, Cushing syndrome, type 
I diabetes, and hyperparathyroidism were excluded from 
the study. Women who had taken drugs such as oral corti-
costeroids, thyroxin, vitamin D preparations, pharmaco-
logical doses of calcium, and thiazide diuretics were also 
excluded. Weight of the subjects was measured after empty-
ing the urinary bladder and while wearing light garments, 
and height was measured without footwear. Ethical approval 
for the study was obtained from the local Ethical Review 
Committee of the Faculty of Medicine, Galle, and all 
participants signed a informed consent form before 
participation.
Bone densitometry
Bone mineral density (BMD) of the nondominant proximal 
femur was measured using a Norland Eclipse XR (Norland, 
Ft. Atkinson, WI, USA) densitometer, adhering to the rec-
ommendations of the manufacturer. Hip scan images with 
clearly visible femoral neck and devoid of artifacts were 
selected for extraction of structural properties.
Extraction of bone mass and structural properties
Hip axis length (HAL) was defi ned as the distance from the 
center of the pelvic acetabulum to the outer edge of the 
femoral shaft just below the greater trochanter and mea-
sured manually by drawing a line between those two points 
through the center of the femoral neck using the “ruler 
function” in the Norland software. The built-in Norland 
software measures the angle between the femoral neck axis 
and the line orthogonal to the femoral shaft and the neck 
shaft angle (NSA) was obtained by adding 90° to this value. 
Femoral neck width (FNW) was estimated by drawing a line 
between two subperiosteal surfaces of the femoral neck at 
its narrowest point which was determined visually by the 
observer.
Cross-sectional area of the femoral neck (CSA) was cal-
culated as:
CSA = (femoral neck BMD × femorla neck width)/pm
In this formula, pm is the effective density of bone mineral 
in fully mineralized bone tissue (1.05/cm2) [15,16].
The cross-sectional moment of inertia (CSMI – cm4) was 
calculated using the following formula [15]:
CSMI = π/4[(FNW/2)4 − p(ED/2)4]
ED is the estimated endosteal diameter and p is the tra-
becular porosity.
ED FNW/2) f (CSA/2 c= −2 [( )]π
where fc is the assumed proportion of cortical mass in the 
femoral neck, taken as 0.6, and p is the cortical porosity, 
which is calculated by following formula [15]:
P = 1 − [{(1 − fc) · CSA} ÷ π(ED/2)
2]
Section modulus was calculated by correcting the CSMI for 
the neck width:
Section modulus = CSMI/NW
The coeffi cient of variation (CV) of the manually mea-
sured HAL and FNW were estimated by measuring them 
twice in 20 scan images, blinded to the results of the fi rst 
analysis, and with a 2-week interval between analyses. CV% 
(calculated as SD/mean*100) for HAL and FNW were 
0.8% and 1.2%, respectively.
Statistics
Mean (SD) BMD of the femoral neck and other indices of 
hip geometry were estimated for different age groups unad-
justed and then adjusted for body weight using ANOVA. 
A linear regression model was fi tted to examine the effect 
of age (as independent variable) on femoral neck BMD and 
indices of hip geometry (as dependent variables).
Results
Fifty-four women who have taken drugs, or gave a history 
of diseases that can affect their bone health, were excluded 
from the study. Thirty-six scan images were unsuitable for 
the structure analysis because of poor clarity or hazy bone 
margins. Age of the women in the study ranged from 32 to 
97 years, with a mean of 56.8 (SD, 13) years (Table 1). 
Average FNW was nearly 3 cm, whereas the average HAL 
and NSA were 9.1 cm and 123°, respectively.
Once adjusted for age, height and weight had positive 
and signifi cant correlations with most of the indices. 
However, weight had no signifi cant correlations with either 
NW or the NSA (Table 2).
There was a sharp decline in femoral neck BMD as age 
progressed. Both CSA and the Section modulus, also 
showed changes parallel to BMD trends, indicating the 
deterioration of the structural properties of the femoral 
neck as BMD is lost leading to gradually thinning cortical 
shell (Fig. 1). Although there was a expansion of the neck 
width, the degree of expansion was not statistically signifi -
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cant. Unadjusted NSA showed a gradual narrowing with 
aging, while adjusted HAL showed a mild degree of length-
ening (Table 3).
Discussion
Results of our study showed a sharp decline in femoral neck 
BMD, CSA, and section modulus after 50 years. After 
adjusting for body measurements, there was a gradual but 
nonsignifi cant expansion of the femoral neck width with 
advancing age. When women in the third decade were taken 
as the reference group, women in the fi fth decade had 8.6% 
reduction in BMD, and it was further reduced by 20% in 
the sixth decade. Although reduction of hip BMD during 
postmenopausal age is a universal occurrence, more rapid 
reduction was seen among our subjects. The reason for this 
rapid BMD decline was not clear. These women, selected 
from our community study area, had a rural and semiurban 
background and their living conditions, current and past, 
would have partly contributed to this rapid BMD decline. 
CSA, which measures the area of the cortical bone in the 
neck region, showed parallel changes with neck BMD, indi-
cating gradual thinning of the cortical envelope with aging. 
These changes were accompanied by the gradual reduction 
of section modulus, indicating gradual reduction in resis-
tance to bending.
Our data showed a progressive lengthening of the hip 
axis length and narrowing of the neck shaft angle as age 
advanced. Whether this was a real biological change or 
secondary to degenerative changes in the hip joint was not 
clear. In previous studies, however, longer neck length and 
wider neck shaft angle were associated with increased frac-
ture risk [6,8].
Age-related BMD loss is a universal phenomenon. This 
loss eventually reduces the mechanical properties of the 
bone tissue, making the bone vulnerable to structural break-
down. Expansion of the neck would partly compensate the 
gradual reduction of mechanical strength by widening the 
outer diameter of the long bone, which prevents easy buck-
ling under stress [16]. With rapid bone turnover during 
postmenopausal age, resorption of bone in the endosteal 
surface leads to the thinning of the cortical envelope and 
expansion of the medullary cavity, weakening the bone 
structure [17]. Gradual apposition of bone in the periosteal 
surface would increase the diameter of the long bones, and 
this would partly compensate the mechanical failure [17]. 
Table 2. Age-adjusted (partial) correlations between weight, height, BMD, and the indices of 
hip geometry
BMD NW CSA Height Weight NSA
HAL 0.04
P = 0.47
0.41
P < 0.001
0.23
P < 0.001
0.55
P < 0.001
0.27
P < 0.001
0.04
P = 0.47
BMD — −0.14
P = 0.017
0.89
P < 0.001
0.20
P = 0.001
0.57
P < 0.001
−0.17
P = 0.004
NW — — 0.32
P < 0.001
0.39
P < 0.001
0.05
P = 0.32
0.25
P < 0.001
CSA — — — 0.36
P < 0.001
0.57
P < 0.001
−0.06
P = 0.32
Height — — — — 0.33
P < 0.001
0.20
P = 0.001
Weight — — — — — 0.008
P = 0.89
HAL, hip axis length; NW, neck width; CSA, cross-sectional area; NSA, neck shaft angle; BMD, 
femoral neck bone mineral density
Table 1. Descriptive data of 280 women whose hip structure was 
analyzed
Measurement Mean SD
Age (years) 56.8 13.0
Weight (kg) 47.8 10.1
Height (m) 1.48 0.06
Femoral neck bone mineral density 
 (BMD, g/cm2)
0.704 0.147
Hip axis length (mm) 90.6 5.6
Neck shaft angle (degrees) 123.2 5.7
Neck width (cm) 2.99 0.24
Cross-sectional area (cm2) 2.00 0.42
Cross-sectional moment of inertia (cm4) 1.62 0.47
-30
-25
-20
-15
-10
-5
0
5
10
30-39 40-49 50-59 60-69 >70
BMD NW CSA
Fig. 1. Percentage changes in bone mineral density (BMD), neck width 
(NW), and strength-related indices in different age groups. CSA, cross-
sectional area of the femoral neck
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These compensatory mechanisms can only be partly effec-
tive, and bone strength fi nally deteriorates, as indicated by 
falling section modulus [18]. Further, the widening of the 
femoral neck associated with aging has shown gender dif-
ferences in that men showed more favorable changes than 
women [15]. These differences in hip geometry are believed 
to explain, partly, the gender differences observed in hip 
fracture incidence [15,17].
Compared with Caucasian women, Asian women are 
shown to have different hip structural properties, partly 
because of differences in height and weight measurements 
[14]. Firm conclusions, however, cannot be made as hip 
structure data in Asian populations are limited. In a study 
by Wang et al., Chinese women in young adulthood were 
observed to have 0.85 SD narrower femoral neck, 0.79 SD 
shorter femoral neck axis length, and 0.47 SD thinner cortex 
when compared with Caucasian women of the same age 
group [19].
Results comparable to ours have been noted in previous 
cross-sectional studies examining the age-related trends in 
the indices of hip geometry. In the National Health and 
Nutrition Examination Survey (NHANES) study, a gradual 
expansion of the femoral neck width was seen while BMD 
and cross-sectional area of the femoral neck continued to 
decline [16]. There was a gradual decline in strength-related 
indices such as the cross-sectional moment of inertia and 
section modulus whereas expansion of the neck partly offset 
the decline [16]. Similar trends were observed in our study, 
too.
Our study has several limitations. CSA calculated in our 
study represented the area of the cortical bone within the 
femoral neck envelope. This value was calculated assuming 
that the femoral neck is a circular structure and the cortical 
shell has an even thickness in the entire rim. Further, the 
hip axis length was measured from the inner surface of the 
acetabulum through a midline up to a point in the outer 
margin of the femoral shaft. This value is different from the 
femoral neck length measured in other methods, which 
exclude the hip joint, and therefore is not affected by 
changes in the hip joint. The neck width was measured 
between the two periosteal surfaces in the narrowest part 
of the neck, determined visually by the investigator. All 
measurements were done by the same investigator, and 
they showed an acceptable measurement precision. This 
study has a cross-sectional design, which has its own limita-
tions when studying age-related changes. Also, the sample 
size was relatively small.
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Infant Growth Influences Proximal Femoral Geometry in Adulthood
M Kassim Javaid,1 Sarath Lekamwasam,2 Judith Clark,1 Elaine M Dennison,1 Holly E Syddall,1 Nigel Loveridge,2
Jonathan Reeve,2 Tom J Beck,3 Cyrus Cooper,1 and The Hertfordshire Cohort Study Group1
ABSTRACT: The relationship between early growth and adult femoral geometry has not been studied
previously. In 333 adults, we were able to show that infant weight predicts femoral width and cross-sectional
moment of inertia but not femoral neck length. These results support the hypothesis that growth in early life
leads to persisting differences in proximal femoral geometry.
Introduction: Both femoral geometry and bone mass have been shown independently to predict both hip
strength and fracture risk. Whereas growth during intrauterine and early postnatal life has been shown to
influence adult bone mass, the relationship between growth in early life and adult femoral geometry has not
been described previously.
Materials and Methods: We studied the relationship between growth during early life, adult hip geometry, and
proximal femur bone mass in a sample of 333 men and women (60–75 years of age), for whom birth weight
and weight at 1 year of age were recorded. Hip geometry was derived using Hip Structure Analysis software
from proximal femur DXA scans (Hologic QDR 1000).
Results: There were significant (p < 0.002) relationships between weight at age 1 year and measures of femoral
width as well as intertrochanteric (IT) cross-sectional moment of inertia (CSMI), but not with femoral neck
length. The relationships with measures of femoral width but not CSMI remained after adjusting for adult
body weight and were independent of proximal femoral BMC.
Conclusions: These results support the hypothesis that different patterns of growth in utero and during the first
year of life lead to persisting differences in proximal femoral geometry, thereby mediating in part the effects
of early growth on risk of hip fracture in adulthood.
J Bone Miner Res 2006;21:508–512. Published online on December 26, 2005; doi: 10.1359/JBMR.051214
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INTRODUCTION
OSTEOPOROSIS IS A MAJOR cause of morbidity and mor-tality through its association with fragility fractures.
Of the estimated £1.7 billion cost each year incurred by
patients with osteoporotic fractures in England and Wales,
80% are caused by hip fracture.(1) Whereas BMD is well
recognized as a risk factor for hip fracture,(2) the distribu-
tion of bone mineral within the proximal femur seems to be
an independent determinant of proximal femoral strength.
Among measures of femoral geometry, hip axis length(3)
and femoral width(4) have been shown to determine hip
fracture risk. These can be used to derive the cross-
sectional moment of inertia (CSMI), a biomechanical mea-
sure of the bending strength of bone.(5)
Among determinants of osteoporotic fracture, there is a
growing body of evidence to suggest that poor growth dur-
ing intrauterine and early postnatal life might be associated
with an increased likelihood of both low bone mass(6) and
fracture(7) in later adulthood. However, observed differ-
ences in bone mass attributable to poor intrauterine and
infant growth do not seem to account for the documented
increase in risk of hip fracture in late adulthood. We there-
fore used a British cohort, which included data on birth
weight, growth in infancy, and adult skeletal status (the
Hertfordshire Cohort Study), to test the hypothesis that
poor growth during early life influences femoral geometry
some seven decades later.
MATERIALS AND METHODS
We studied 333 healthy subjects (178 men and 155
women), 60–75 years of age, included in the skeletal com-
ponent of the Hertfordshire Cohort Study.(8) The subjects
were born and still reside in the county of Hertfordshire,
UK, and are known to be representative of elderly men and
women in the country, with regard to body build, cigarette
smoking, and other lifestyle determinants of bone mass.The authors state that they have no conflicts of interest.
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The birth weight and weight at 1 year of age of each indi-
vidual had been recorded in a ledger by a team of midwives
and health visitors who had attended each birth in Hert-
fordshire and had visited the child’s home at intervals dur-
ing the first year of life. After obtaining written permission
from each person’s general practitioner, we approached
each subject by letter asking whether they would be willing
to be contacted by one of our research nurses.
At interview, each subject completed a questionnaire in-
cluding information on previous medical history, current
medications, alcohol intake, cigarette smoking, physical ac-
tivity, and dietary calcium intake. In addition, measure-
ments were made of height (using a stadiometer) and
weight (using calibrated electronic scales). BMD was mea-
sured in each subject by DXA at the lumbar spine and
femoral neck, using a Hologic QDR 1000 instrument. Bone
area, BMC, and BMD were obtained directly from the
scans. Measurement precision, expressed as the CV, was
1.55% for lumbar spine BMD, 1.45% for total femur BMD,
and 1.83% for femoral neck BMD.
DXA scan images were first converted into bone mass
images using the automated Hip Structure Analysis (HAS)
program.(5) A single operator manually placed four cursers
to define the limits of the femoral neck. The software au-
tomatically demarcated the linear axes of the neck and shaft
as well as three cross-sectional analysis regions: the narrow-
est width of the femoral neck; the intertrochanteric region;
and the femoral shaft. For each of these regions, cross-
sectional measurements were derived from the distribution
of bone mass across the bone using the method described
by Martin and Burr.(9) Reproducibility of the technique in
this study was assessed in 50 replicate scans; the CV was
derived for the femoral neck length (5.1%), femoral width
(0.83%), and CSMI (1.7%).
Data were double entered and analyzed using STATA v
7.0. Variables with a skewed distribution were normalized
by an appropriate transformation where necessary. The re-
lationships between birth weight, weight at 1 year, and adult
proximal femoral geometry were explored using linear re-
gression. Partial correlation coefficients after adjustment
for body size were tested for statistical significance. Poten-
tial confounding variables, for example, smoking, were ex-
amined using multiple regression. Early growth was further
characterized by calculating sex-specific SD scores for birth
weight, weight at 1 year, and infant growth conditional on
birth weight.(10) This conditional infant growth SD score
was free of the artefactual effects of regression to the mean
and could be included in analyses simultaneously with birth
weight without multicolinearity problems. Use of a condi-
tional characterization of postnatal growth enabled the in-
dependent effects of growth in the first year of life on femo-
ral geometry to be separated from the effects of birth
weight.
RESULTS
Table 1 shows the anthropometric characteristics of the
333 subjects. Whereas men and women were of similar age
and current BMI, the men were significantly taller (p <
0.001) and heavier (p < 0.001) than the women; as infants,
males weighed significantly more than females at 1 year
(p < 0.001). At the proximal femur, men had greater BMD
than women (p < 0.001). Femoral geometry measurements
also differed by sex; men had significantly (p < 0.001)
greater femoral neck length and width than women. CSMI
at the narrow neck, intertrochanteric (IT), and femoral
shaft was also greater in the men (p < 0.001). In both men
and women, current height was significantly related to neck
length (men, r  0.28, p  0.0002; women, r  0.30, p 
0.0001), IT width (men, r  0.44, p < 0.0001; women, r 
0.51, p < 0.0001), and IT CSMI (men, r 0.46, p < 0.0001;
women, r  0.51, p < 0.0001). Current height was also
significantly (p < 0.001) associated with width and CSMI at
the narrow neck and femoral shaft sites.
Figure 1 and Table 2 show the relationship between
femoral geometry and birth weight, weight at 1 year, and
conditional infant growth in men and women. In both sexes,
a 1-kg increase in weight at 1 year was associated with an
increase in IT width by 0.11 cm (0.25 SD of IT width in men
and 0.33 SD in women). These relationships persisted even
after adjusting for lifestyle determinants of BMD (exercise,
dietary calcium intake, cigarette smoking, and alcohol con-
sumption), as well as current height and weight. Weight at
1 year also predicted IT CSMI in men and women and IT
cortical buckling ratio in men (Fig. 1). The association be-
tween infant weight and IT cortical buckling ratio in the
women was also positive but just failed to attain statistical
significance (r 0.14, p 0.08). Whereas the relationship
between IT CSMI and weight at 1 year did not remain
statistically significant after adjusting for adult weight and
height, weight at 1 year predicted IT cortical buckling ratio
even after adjustment for both current height (r  0.22,
p 0.008) and weight (r 0.26, p < 0.01). Similar positive
associations were found between weight at 1 year and
TABLE 1. DESCRIPTIVE CHARACTERISTICS AND PROXIMAL
FEMORAL BMD AND GEOMETRIC MEASUREMENTS OF 333
ADULTS FOR WHOM WEIGHT AT BIRTH AND 1 YEAR OF AGE
WERE RECORDED
Men
(n = 178)
Women
(n = 155) p
Age (years) 66 (3.2) 66 (2.8) 0.41
Height (m) 1.7 (0.07) 1.6 (0.06) <0.001
Weight (kg)* 78.8 (1.2) 67.9 (1.2) <0.001
BMI (kg/m2)* 26.5 (1.1) 26.5 (1.2) 0.88
Birth weight (kg) 3.6 (0.5) 3.5 (0.5) 0.02
Weight at 1 year (kg) 10.3 (1.2) 9.7 (1.1) <0.001
Proximal femoral
bone mass and
geometry
BMD (g/cm2) 0.81 (0.1) 0.71 (0.1) <0.001
Neck length (cm) 4.9 (0.6) 4.5 (0.5) <0.001
Neck width (cm) 3.7 (0.3) 3.2 (0.2) <0.001
Neck CSMI (mm4)* 3.5 (1.3) 1.9 (1.2) <0.001
IT width (cm) 6.2 (0.4) 5.5 (0.3) <0.001
IT CSMI (mm4)* 19.0 (1.3) 11.7 (1.3) <0.001
Values are means (SD).
p values contrast men and women.
* Geometric mean and SD.
CSMI, cross-sectional moment of inertia; IT, intertrochanteric.
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femoral width, CSMI, and buckling ratio at the narrow neck
and femoral shaft. Weaker associations were observed be-
tween birth weight and measures of femoral width (Table
2); adult CSMI was not, however, significantly associated
with birthweight (Table 2).
Weight at 1 year was also significantly (p < 0.01) associ-
ated with bone mass (BMC) at the proximal femur. We
therefore evaluated the independent relationship between
weight at 1 year, adult proximal femoral BMC, and proxi-
mal femoral geometry. The data relating each of these de-
terminants to proximal femoral cross-sectional moment of
inertia are shown in Fig. 2. Figure 2 shows that each third of
weight at 1 year and proximal femoral BMC were indepen-
dent predictors of adult proximal femoral CSMI (p < 0.001).
The relationships between femoral geometry and condi-
tional infant growth were strikingly similar to those be-
tween femoral geometry and weight at 1 year (Table 2),
showing that postnatal growth was related to IT width and
CSMI in men and women and buckling ratio in men, inde-
pendently of size at birth.
Eighteen men and 16 women had sustained fractures af-
ter age 45 years. Twenty-eight of these 34 fractures were at
the wrist, with the remainder at the shoulder, hip, and spine.
Measures of proximal femoral geometry did not show sig-
nificant associations with fracture history, but analyses of
relationships with hip fracture were not possible because of
limited statistical power.
DISCUSSION
The results of this study suggest that poor growth in in-
fancy is associated with disproportion of the proximal fe-
mur in later adult life and a possible corresponding reduc-
tion in the mechanical strength of this region. The selective
association between weight in infancy and reduced width of
FIG. 1. Relationship between infant weight
and femoral neck length, intertrochanteric
(IT) width, cross-sectional moment of inertia
(CSMI), and cortical buckling ratio.
TABLE 2. RELATIONSHIPS BETWEEN BIRTH WEIGHT, WEIGHT AT 1 YEAR, CONDITIONAL INFANT GROWTH, AND FEMORAL GEOMETRY
Birth weight Weight at 1 year Conditional infant growth
Men
Neck length (cm) −0.03 (p 0.68) 0.12 (p 0.10) 0.14 (p 0.05)
Neck width (cm) 0.15 (p 0.05) 0.23 (p 0.002) 0.19 (p 0.01)
Neck CSMI (mm4) 0.10 (p 0.17) 0.14 (p 0.07) 0.10 (p 0.16)
IT width (cm) 0.22 (p 0.003) 0.37 (p < 0.0001) 0.30 (p < 0.0001)
IT CSMI (mm4) 0.14 (p 0.06) 0.23 (p 0.002) 0.19 (p 0.01)
Buckling ratio 0.14 (p 0.06) 0.19 (p 0.01) 0.14 (p 0.06)
Women
Neck length (cm) 0.05 (p 0.50) 0.08 (p 0.31) 0.06 (p 0.44)
Neck width (cm) 0.18 (p 0.03) 0.27 (p 0.0007) 0.21 (p 0.009)
Neck CSMI (mm4) 0.19 (p 0.02) 0.26 (p 0.001) 0.19 (p 0.02)
IT width (cm) 0.19 (p 0.02) 0.40 (p < 0.0001) 0.34 (p < 0.0001)
IT CSMI (mm4) 0.19 (p 0.02) 0.28 (p 0.0004) 0.21 (p 0.007)
Buckling ratio 0.02 (p 0.85) 0.14 (p 0.08) 0.14 (p 0.08)
Values are Pearson r (p).
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the femoral neck, with relative preservation of femoral
neck length, may contribute to the previously observed re-
lationship between poor growth in utero and during in-
fancy, with the later risk of hip fracture.
Proximal femoral geometry is an independent determi-
nant of hip fracture risk.(3,11) Whereas hip axis length is
important in determining fracture risk, mechanical models
suggest that other measures of femoral geometry, such as
femoral width and cross-sectional moment of inertia, are
also important contributors to strength. Hip structure
analysis permits dissection between these various structural
components; previous cadaveric studies have suggested that
the mechanical characteristics of the proximal femur are
more closely assessed by these measures than by BMD
measurement alone.(5)
This study adds to the growing body of evidence for the
developmental origins of osteoporosis. Programming is the
term used to describe lasting changes in structure and func-
tion caused by environmental stimuli acting at critical peri-
ods during early development.(12) Several epidemiological
studies have shown an association between growth in in-
fancy and both adult bone mass(6) as well as hip fracture.(7)
Mother-offspring cohort studies have delineated maternal
environmental characteristics, such as nutrition, smoking,
and physical activity, which alter the trajectory of mineral
accrual in the fetal skeleton.(13) However, most studies to
date have evaluated the influence of these early environ-
mental characteristics on BMC rather than on femoral ge-
ometry. Our study suggests that an adverse intrauterine
environment might influence fracture risk not only through
reduced bone mass, but also by an alteration in proximal
femoral shape and structure. The underlying mechanism for
this specific effect of poor intrauterine and early postnatal
growth on femoral shape is not known. Poor growth in early
life may alter subperiosteal apposition at the proximal fe-
mur either during infancy or by altering the trajectory of
growth in subsequent years. The timing of this effect might
be determined in future studies by assessment of proximal
femoral geometry during childhood and adolescence.
Our study has several limitations. These include the use
of the DXA images for assessment of proximal femoral
geometry. Although these images were not designed for
this purpose, the hip structure analysis software has been
well validated and limitations in the system described pre-
viously.(14) The degree of anteversion of the femoral neck
would also alter estimation of neck length and neck shaft
angle; such bias would act conservatively in our study. Fur-
thermore, previous studies have shown that at least 15° of
anteversion is required before significantly modifying
proximal femoral measurements.(15) We found that the CV
for femoral neck length was higher than that for femoral
width and CSMI. This is because the former measurement
is determined as the distance between the center of the
femoral head and the intersection of the neck and shaft
axes. The latter is automated, but the former is strongly
dependent on the user correctly placing the circle on the
head. We were unable to measure muscle strength around
the hip joint in this study. Although adult grip strength, a
measure of muscle strength at a distant site that is moder-
ately well correlated with quadriceps strength, was signifi-
cantly associated with femoral neck width, the relationship
was no longer apparent after adjustment for adult height.
Finally, the Hertfordshire Cohort Study does not include
detailed information on gestational age at birth or maternal
lifestyle (e.g., cigarette smoking). During the period cov-
ered by the cohort, it is likely that almost all babies were
term births, and we were able to explore relationships be-
tween weight in infancy and proximal femoral geometry
among subsets in the lowest and highest 10ths of the sex-
specific birthweight distribution. These relationships were
constant in these two subsamples, suggesting that they act
across the population distribution of birth weight rather
than being subject to a threshold by gestation. Although
information on maternal smoking was not available, we
were also able to analyze the relationships between proxi-
mal femoral geometry and smoking during adult life among
women. No significant relationships were found between
any of the geometric parameters and smoking status in
adulthood.
In conclusion, the results of this study show that low
weight in infancy is associated with reduced femoral neck
width, but with relative preservation of femoral neck
length. This disproportion results in reduced CSMI and
might account for reduced proximal femoral strength sev-
eral decades later. The association seems independent of
that between poor early growth and adult bone mass; it may
explain, in part, the developmental origins of hip fracture.
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Abstract Associations between lean mass, fat mass, and
bone mass have been reported earlier; however, most of
those studies have been done in Caucasian populations, and
data from Asian countries, especially those in South Asia,
are limited. We examined the associations between lean
mass, fat mass, bone mineral density (BMD), and bone
mineral content (BMC), determined by dual-energy X-ray
absorptiometry technology, in a group of healthy, middle-
aged, premenopausal female volunteers. The mean (SD)
age of the women (n = 106) was 42.1 (6.1) years and the
mean (SD) body mass index was 24.3 (3.6) kg/m2. Total
body BMD, total body BMC, and BMD in total spine, total
hip, and femoral neck showed statistically significant par-
tial correlations (adjusted for age) with total fat mass
(r = 0.19–0.43, P \ 0.05) and lean body mass (r = 0.28–
0.54, P \ 0.05). Truncal fat mass correlated positively with
total body BMC and BMD at total hip and femoral neck
(r = 0.33–0.40, P \ 0.001). When a stepwise regression
model was fitted, lean mass remained the strongest pre-
dictor of total body BMD, total body BMC, and total spine
BMD (regression coefficients = 0.004–0.008 g/cm2 per
1-kg change in lean mass, P \ 0.001). Similarly, crude
BMD and BMC increased across the tertiles of lean mass
(P trend \ 0.05). We show that lean mass is the strongest
predictor of total body BMC and BMD at different sites,
although positive correlations with fat mass also exist.
Keywords Lean mass  Fat mass  Bone mineral density 
Premenopausal women  Sri Lanka
Introduction
Although there are various ways to estimate body com-
position, dual-energy X-ray absorptiometry (DXA) is
widely used in research and clinical settings [1]. DXA uses
two X-ray beams of different energies; high and low, which
are attenuated preferentially while passing through differ-
ent body compartments. The low-energy beam is
attenuated by the soft and bone tissues; the high-energy
beam is attenuated only by the bone tissue. The degree of
attenuation of the two beams is used to estimate bone
mineral content (BMC), bone mineral density (BMD), and
fat mass and lean mass. BMD and BMC, which are highly
correlated with bone mass [2], are used to determine the
fracture risk of an individual with low bone mass [3].
Previous studies have demonstrated significant associ-
ations between different body compartments, and some of
these associations were age specific [4–7]. In young and
premenopausal women, lean mass was the main predictor
of BMD [4, 5], whereas in old or postmenopausal women,
fat mass predicted BMD better than lean mass [6, 7].
These studies would help in understanding age-related
trends in body composition in different populations.
Increased fat mass and reduced bone mass have clear
clinical consequences, and this information would help in
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understating the comorbidity associated with osteoporosis
or hyperlipidemia.
Studies on body composition among South Asian
women are scarce, which may reflect the restricted avail-
ability of facilities of estimating body composition in these
countries. Women in South Asia can be expected to have
associations different from those already reported from
Western countries as South Asian women have a different
lifestyle, which is associated with a high level of physical
activity, marginal nutrition, multiparity, less smoking, and
low alcohol consumption. This study was conducted in
southern Sri Lanka using a group of healthy, middle-aged,
premenopausal volunteers to examine the associations
between lean mass, fat mass, and BMD, and also to
determine the strongest predictor of BMD at various sites.
Materials and methods
A group of healthy premenopausal female volunteers, aged
30 years or older and living in the neighborhood of the
Faculty of Medicine, Galle, Sri Lanka, was included in the
study. These volunteers responded to an open invitation
displayed in public places within 1 km distance from the
faculty. After a brief interview and physical examination,
women with history of diabetes, hypertension, chronic
renal or liver disease, hyperlipidemia, ischemic heart dis-
ease, endocrine diseases, or prolonged inflammatory
conditions were excluded from the study. Women using
bone-active medications such as systemic corticosteroids,
heparin, vitamin D, or pharmacological doses of calcium
were also excluded, and 113 women were selected for the
study.
All consenting women completed a health-related ques-
tionnaire and underwent a detailed physical examination
conducted at the Center for Lipid Disorders in the Faculty
of Medicine, Galle, during which body measurements
such as weight, height, and hip and waist circumference
were recorded. All measurements were taken by the same
technician, adhering to the standard protocols of defining
these measurements. Weight was measured while wearing
light clothes and after emptying the urinary bladder. Height
was measured using a stadiometer.
A total body DXA scan was performed for all subjects
using a Hologic Discovery scanner (Hologic, Bedford, MA,
USA). DXA scanning was also performed over the lumbar
spine and proximal femur of the nondominant side to
estimate BMD in the total spine from L1 to L4 in the
anteroposterior projection, total hip, and femoral neck
region. The coefficient of variation of BMD measurements
in the same machine has been published earlier [8].
Analytical software provided by the DXA manufacturer
was used to analyze body composition. All scans were
analyzed by the same technician, adhering to the guidelines
provided by the manufacturer, and total body bone mineral
density, total body bone mineral content, and lean body
mass were estimated. Furthermore, total fat mass and the
regional fat mass over the abdomen, truncal fat mass, were
measured using the same analytical software. Ethical
approval for the study was obtained from the local Ethics
Review Committee of the Faculty of Medicine, Galle, and
all participants signed a consent form at the beginning of
the study.
Statistics
Descriptive data of the sample are given as mean (SD)
values. Associations between lean body mass, fat mass,
BMC, and BMD were examined by partial correlations,
after controlling for age. The regression model was fitted
with BMD or BMC as the dependent variable and body
mass index (BMI), waist–hip ratio, age, lean body mass,
and total fat mass as independent variables; weaker vari-
ables were excluded in stepwise fashion to find the
strongest predictor of BMC or BMD at different sites.
Mean BMD across the tertiles of lean body mass, which
emerged as the strongest predictor of BMD in the regres-
sion model, were compared using analysis of variance
(ANOVA), initially unadjusted, and then adjusted for age
and BMI. Data were not adjusted for smoking habits or
alcohol consumption as only five women had consumed
alcohol in the past. No subjects in the study group reported
smoking. Two-tailed P \ 0.05 was taken as the level of
statistical significance. The SPSS version 10 for Windows
was used for all statistical analyzes.
Results
Fifteen women were excluded and 113 subjects were
recruited to the study. Seven DXA images were unsuitable
for body composition measurements, and data of 106
women were included in the final analysis. Age of the
women in the sample ranged from 30 to 54 years, with a
mean of 42.1 (SD 6.1) years. Mean (SD) BMI and waist–
hip ratio (WHR) were 24.3 (3.6) kg/m2 and 0.87 (0.06),
respectively (Table 1). When controlled for age, both lean
mass and total fat mass showed positive and significant
partial correlations with total body BMC and all BMD
measurements. Furthermore, truncal fat mass correlated
positively with total body BMC and BMD at total hip and
femoral neck (r varied from 0.33 to 0.40; P \ 0.001)
(Table 2).
In the regression analysis, lean body mass remained the
strongest predictor of total body BMC, total body BMD,
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and spine BMD. During this process, the model excluded
the weak predictors such as age, BMI, waist–hip ratio, and
total fat mass. However, BMD in the total hip and femoral
neck showed less strong associations with the lean body
mass, and in these sites BMI was the strongest determinant.
Independent of age, BMI, and total fat mass, a change of
lean body mass by 1 kg was associated with change in total
body BMD and spine BMD by 0.004 and 0.008 g/cm2,
respectively (SE 0.002; P \ 0.05). Regression coefficients
between lean body mass and BMD at proximal femur sites
were relatively smaller and nonsignificant (Table 3).
When mean total body BMC and BMD were compared
across the tertiles of lean body mass, the lowest BMD or
BMC were seen among women in the lowest tertile of lean
mass, whereas the highest BMC or BMD were seen among
women in the highest tertile. When these values were
corrected for age and BMI, except for the total body, total
hip, and lumbar spine BMD, the pattern remained the same
(Table 4).
Although fat mass showed significant partial correla-
tions with BMC and BMD (see Table 2), in the regression
analysis it did not predict BMC or BMD as strongly as lean
mass. The regression model excluded weaker associations
such as age, BMI, waist–hip ratio, and total fat mass in
stepwise fashion while identifying the lean mass as the
strongest predictor of BMD or BMC. In support of this
finding, age- and BMI-adjusted BMC or BMD in the ter-
tiles of the total fat mass were not significantly different
(data not shown).
Table 2 Age-adjusted partial correlations between bone mineral density (BMD), bone mineral content (BMC), lean body mass, and total fat
mass in 106 women included in the analysis
Total body
BMC
Total spine
BMD
Total hip
BMD
Femoral neck
BMD
Total fat
mass
Lean body
mass
Truncal fat
mass
Total body BMD 0.87
(P \ 0.001)
0.63
(P \ 0.001)
0.72
(P \ 0.001)
0.68
(P \ 0.001)
0.19
(P = 0.047)
0.28
(P = 0.004)
0.17
(0.080)
Total body BMC – 0.61
(P \ 0.001)
0.66
(P \ 0.001)
0.68
(P \ 0.001)
0.41
(P \ 0.001)
0.54
(P \ 0.001)
0.33
(\0.001)
Total spine BMD – – 0.49
(P \ 0.001)
0.52
(P \ 0.001)
0.21
(P = 0.032)
0.22
(P = 0.02)
0.17
(0.085)
Total hip BMD – – – 0.83
(P \ 0.001)
0.43
(P \ 0.001)
0.37
(P \ 0.001)
0.038
(\0.001)
Femoral neck BMD – – – – 0.43
(P \ 0.001)
0.40
(P \ 0.001)
0.40
(\0.001)
Total fat mass – – – – – 0.69
(P \ 0.001)
0.84
(\0.001)
Lean body mass 0.58
(\0.001)
Table 1 Descriptive data of 106 women who participated in the
study
Measurement Mean Standard deviation
Age (years) 42.1 6.1
BMI (kg/m2) 24.3 3.6
Waist–hip ratio 0.87 0.06
Total body BMD (g/cm2) 1.065 0.086
Total body BMC (g) 1782.6 226.9
Total fat mass (kg) 20.25 5.2
Lean body mass (kg) 36.11 5.4
Total spine BMD (g/cm2) 0.923 0.136
Total hip BMD (g/cm2) 0.922 0.099
Femoral neck BMD (g/cm2) 0.764 0.097
BMI body mass index, BMD bone mineral density
Table 3 Regression coefficients of lean mass with BMD or BMC
where lean mass was taken as the independent variable and BMD or
BMC was taken as the dependent variable
Regression
coefficientsa
Standard
error
P
valueb
Whole-body BMD 0.004 0.002 0.013
Whole-body BMC 22.88 3.89 \0.001
Total spine BMD 0.008 0.002 0.001
Total hip BMD 0.002 0.002 0.4
Femoral neck
BMD
0.004 0.002 0.056
a Data are adjusted for age, BMI, and truncal and total fat mass
b P values indicate statistical significance of regression coefficients
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Discussion
In the current study, we observed positive and significant
correlations between lean mass, fat mass, BMC, and BMD
measured at various sites. Lean mass emerged as the
strongest predictor of total body BMC, total body BMD,
and spine BMD. The categorical analysis showed a pattern
in which the highest BMC and BMD were seen among
women with higher lean mass and the lowest BMC and
BMD were seen among women with lower lean mass; all
these associations were independent of age and BMI.
Generally, BMI is considered a surrogate of the global
adiposity or total fat mass. However, both lean mass and
total BMC contribute to the weight of the person, which is
used in calculating BMI. Therefore, BMI partly reflects the
changes in lean mass and total BMC. In our study sample,
BMI was more representative of total fat mass (r = 0.89)
than either lean mass (r = 0.66) or total BMC (r = 0.66).
We believe that when results were adjusted for BMI, it
actually tested the effect of total fat mass on the analysis. In
support of this, we did not see a change in the results when
the categorical analysis was adjusted for the total fat mass.
A similar association between BMD and lean mass has
been demonstrated among young or premenopausal women
[4, 5], and it has been observed among healthy women
[4–7] as well as in women with rheumatoid arthritis [9].
In contrast, fat mass showed a stronger association with
BMD in postmenopausal or older women [6, 7].
Although current literature demonstrates an association
between lean mass and BMD or BMC, especially among
young women, the exact mechanism underlying this
association is not clear. The role of insulin-like growth
factors and circulating adiponectin has been discussed [10,
11]. Physical activity appears to be the most plausible link
between these measures. Physical activity has a positive
influence on both BMD and lean mass [12, 13]. Compared
to less physically active women, women who were more
active had a stronger association between lean mass and
BMD [14]. Less physical activity in old age may disrupt
this association, allowing the fat mass to be the main
predictor of bone density in postmenopausal women. If
physical activity is the underlying mechanism between lean
mass and bone density, the association can be expected
to be more prominent among males. However, studies
involving men are limited [15].
In our data collection, we had categorized our subjects
as ‘‘very active,’’ ‘‘moderately active,’’ or ‘‘less active’’
depending on their current physical activities. Most of the
women (80 subjects) were found to be in the ‘‘moderately
active’’ group, and the data did not change materially when
adjusted for their physical activity. This, we believe, is the
result of inadequacy of recording the physical activity of
our subjects.
Aromatization of estrogen precursors in the peripheral
adipose tissue and skin is the main source of estrogen in
postmenopausal women. The concentration of circulating
estrogens in postmenopausal women increases according to
body weight and age [16]. Common biallelic polymor-
phism of the aromatase gene was found to be associated
with significant differences in bone mass and fracture
occurrence [17]. Therefore, women with higher fat mass
are likely to have higher circulating estrogen levels and
Table 4 Crude and adjusted (age, BMI) mean (SD) BMC and BMDs in the tertiles of the lean body mass
The lower third of
lean mass (n = 35)
The middle third of
lean mass (n = 36)
The upper third of
lean mass (n = 35)
Pa
Age (years) 42.6 (1.03) 41.3 (1.02) 42.6 (1.03) 0.62
Lean mass (g) 31466 (601.7) 35484 (593.3) 41407 (601.7) \0.001
TBBMDb 1.024 (0.014) 1.082 (0.014) 1.088 (0.014) 0.002
TBBMDc 1.030 (0.018) 1.086 (0.016) 1.081 (0.018) 0.054
TBBMCb 1628.15 (33.33) 1812.77 (32.86) 1906.13 (33.33) \0.001
TBBMCc 1636.13 (42.63) 1823.48 (38.27) 1885.24 (42.65) 0.001
TSBMDb 0.876 (0.023) 0.943 (0.022) 0.950 (0.023) 0.04
TSBMDc 0.884 (0.023) 0.956 (0.021) 0.939 (0.023) 0.065
THBMDb 0.862 (0.015) 0.941 (0.015) 0.962 (0.015) \0.001
THBMDc 0.891 (0.018) 0.952 (0.016) 0.928 (0.018) 0.039
FNBMDb 0.701 (0.015) 0.784 (0.015) 0.805 (0.015) \0.001
FNBMDc 0.730 (0.018) 0.785 (0.016) 0.787 (0.018) 0.04
TBBMD total body BMD, TBBMC total body BMC, TSBMD total spine BMD, THBMD total hip BMD, FNBMD femoral neck BMD
a P contrasts mean differences between the three groups and estimation by analysis of variance (ANOVA)
b Crude values
c Age- and BMI-adjusted values expressed in g/cm2
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higher BMD. This mechanism may explain the association
between BMD and fat mass in postmenopausal women.
The role of vitamin D in the association between lean
mass and BMD should be examined. Although association
between serum vitamin D level and BMD or fracture
occurrence is well established [18], it is also known that
vitamin D polymorphism is associated with strength of
major skeletal muscles such as the quadriceps and ham-
strings in premenopausal women [19]. Hypovitaminosis D
leading to low BMD and low lean mass is a possible link
between these two measures. Vitamin D deficiency or
insufficiency is prevalent in many countries in Europe as
well as in Asia [18].
The link between lean body mass and BMD has several
clinical applications. When low BMD is associated with
low muscle mass, the risk of facture is relatively higher as
sarcopenia would increase the risk of falls. This associa-
tion has been shown in epidemiological studies where low
BMI appeared as a risk factor for fractures, and low BMI
in these patients may represent the combination of low
bone and muscle mass [20]. As BMD and lean mass are
positively related, interventions meant to improve muscle
mass would simultaneously improve BMD. The associa-
tion between physical activities and fractures has been
shown previously [21]. Various forms of forces, such as
torsion and traction, applied by muscles during physical
activities would facilitate the accumulation of bone
materials under the periosteum, leading to increased cor-
tical thickness. Bradney et al. [22] found more cortical
thickness and increased section modulus in the proximal
femur in growing subjects allocated to moderate exercise
program.
In our study, a change of 1 kg in lean mass was asso-
ciated with a change of 0.004–0.008 g/cm2 in BMD in
different sites. An increase of lean mass by 5 kg would
result in a 0.04 g/cm2 increase in total spine BMD, which
would represent a 4.3% difference when expressed as a
percentage of the mean total spine BMD of the sample.
Further, this would approximate to one-third of the SD of
lumbar spine BMD of the study sample. This degree of
BMD difference could be clinically important. In epide-
miological studies, a 1 SD decrease of lumbar spine BMD
doubled the risk of vertebral fractures [3]. In a previous
analysis, although a 10% loss of bone mass in the vertebrae
doubled the risk of vertebral fractures, a 10% loss of bone
mass in the hip increased the risk of hip fracture by 2.5-fold
[23]. Hence, the 4.3% change in spine BMD associated
with a 5-kg change in lean mass would be clinically
relevant.
The current study has a few limitations. Our sample size
was relatively small, and selection bias could have occur-
red at the time of recruitment. Most of the women belonged
to the working class, engaged in sedentary office work, and
would not represent the normal community. This factor
was evident in our results, as they mostly belonged to the
‘‘moderately physically active’’ category. We had no
detailed estimation of their current and past activities to
adjust our data for physical activities.
In summary, results of our study showed a positive
correlation between lean mass, fat mass, and bone mass in
these healthy, middle-aged, premenopausal female volun-
teers. Of all the measurements examined, lean mass was
the strongest predictor of BMD or BMC, and this associ-
ation was independent of age and BMI. Physical activity
and vitamin D status appear to be the most plausible
explanations of this association. This finding is clinically
relevant as women with low BMD would have an added
risk of fracture because of associated sarcopenia leading to
falls. Interventions such as physical activity may simulta-
neously modify both these risk factors.
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Abstract
We examined the association between bone mineral density (BMD) and cardiovascular risk in a group of premen-
opausal women selected from the Southern province of Sri Lanka. One hundred six previously healthy premeno-
pausal volunteers (aged 30e54 yr) were recruited by open invitations. Subjects with previous history of diabetes,
hypertension, epilepsy, chronic renal or liver disease, hyperlipidemia, ischemic heart disease, endocrine diseases,
or prolonged inflammatory conditions were excluded. Subjects who were taking medications that can affect bone
density, blood sugar, serum lipids, or blood pressure (BP) were also excluded. Women with the history of previous
fractures were not excluded. BMDs in the spine, hip, and total body (TB) were measured using a Hologic Discovery
scanner (Hologic Inc, Bedford, MA). BP, fasting glucose, and fasting lipids were also measured. Independent of
body mass index (BMI) and age, TB bone mineral content (BMC) and spine BMD showed inverse and significant
correlations with total cholesterol (TC), low density cholesterol, and the ratio between TC and high density lipopro-
tein cholesterol (r ranged from 0.24 to 0.27, p! 0.05 for all). The highest mean lipid levels were seen among the
women in the lowest third of spine BMD, whereas women in the upper third of spine BMD had the lowest lipid
levels. The number of women with metabolic syndrome in the 3 tirtiles of spine BMD was not significantly different.
Fasting glucose or BP had no association with either BMD or BMC. In conclusion, our data demonstrates an asso-
ciation, independent of age and BMI, between BMD and BMC or lipid levels among previously healthy, premen-
opausal women. This may explain the high cardiovascular risk seen in women with osteoporosis in old age.
Key Words: Blood pressure; fasting glucose; lipids; osteoporosis; Sri Lanka.
Introduction
Epidemiological studies have shown a high occurrence of
acutemyocardial infarctions among patients with osteoporosis,
suggesting a possible link between the 2major noncommunica-
ble diseases affecting women (1). An inverse association
between bone mineral density (BMD) and calcification of
aorta, which is a surrogate marker of cardiovascular disease,
has also been documented (2,3). Among postmenopausal
women, an association has been seen between BMD and serum
lipids, in which, women with low BMD had a lipid profile that
promotes atherosclerosis (4,5). This association, however, was
not consistently seen in other studies (6,7). In 1999, Cappuccio
et al, found an inverse association between femoral neck BMD
and diastolic blood pressure (DBP) among postmenopausal
women and this association was independent of age, body
measurements, and other confounders (8).
The clinical consequences of low BMD and high lipids are
well established. Although BMD shows a continuous associa-
tion with the risk of osteoporosis-related fractures in postmen-
opausal women (9), a similar relationship is observed between
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cardiovascular disease and elevated total cholesterol (TC) or
low density lipoprotein (LDL) cholesterol levels (10,11).
Most of the studies examining the association between
bone health and cardiovascular health have used postmeno-
pausal female populations who have a relatively higher risk
for both osteoporosis and cardiovascular diseases when com-
pared with premenopausal women. The association between
osteoporosis and cardiovascular diseases among premeno-
pausal women has not been well documented. Although
data from older women would help clinicians to recognize
the cardiovascular risk among women with osteoporosis,
and vice versa, data from younger patients would help to
identify the origin of this association. Furthermore, most of
the studies have been done in Caucasian populations and
data from South Asian populations are limited.
The current study was performed in a group of previously
healthy, middle-aged, premenopausal women selected from
the Southern province of Sri Lanka to study the association
between BMD and conventional cardiovascular risk factorsd
serum lipids, fasting blood sugar, and BP.
Materials and Methods
Previously healthy, premenopausal women, aged 30 or
more, were invited to participate in a research related to bone
and cardiovascular health conducted by the Center for Meta-
bolic Bone Diseases in Galle, Sri Lanka. Open invitations
were sent to the nearby institutions and they included a govern-
ment primary school, 2 hospitals, and a university. Posters were
also displayed in public places, such as bus stops and religious
places inviting middle-aged healthy female volunteers for
the study. All volunteers who responded to our invitation
(n5 163) had a brief interview and a physical examination
andwomenwith the history of diabetes, hypertension, epilepsy,
chronic renal or liver disease, hyperlipidemia, ischemic heart
disease, endocrine diseases, or prolonged inflammatory condi-
tions were excluded. Women who had taken drugs, such as
systemic corticosteroids, heparin, vitamin D, antiresoptives,
lipid-lowering therapy, hypoglycemic agents, antihyperten-
sives, hormonal contraceptives, or pharmacological doses of
calcium were also excluded (total number of exclusions5 46).
Although women younger than 30 yr (n5 4) were excluded
from the study, those who had previous traumatic fractures
(n5 8) were not excluded. Further, 7 subjects had no lipid
reports and finally 106 women were selected for the study.
All women included in the study signed an informed con-
sent form, filled a health-related questionnaire, and underwent
a detailed physical examination during which 2 mL of venous
whole blood was collected with a minimum of 12 h overnight
fasting. Weight was measured while wearing light cloths and
after emptying the urinary bladder. Height was measured
without footware using a stadiometer (Nagata, Tainan, Tai-
wan). All body measurements were taken by one technician,
adhering to the standard protocols of defining these measure-
ments. After 15 min of resting, systolic BP (SBP) and DBP
were measured, twice, with 15-min interval between the mea-
surements and average BPs were considered for the analysis.
Serum TC, high density lipoprotein (HDL), triglyceride
(TG), and plasma glucose concentrations were measured
using Humalyzer 2000 (Wiesbaden Human, Germany). Con-
centration of LDL was calculated using the Friedewald for-
mula. None of the subjects had TG level that would make
the application of this formula invalid.
All subjects had total body (TB) dual-energy X-ray
absorptiometry (DXA) performed using Hologic Discovery
scanner (Hologic Inc, Bedford, MA) to measure TBBMD
and TB bone mineral content (TBBMC). DXA was also per-
formed over the lumber spine and left proximal femur to mea-
sure total spine BMD (TSBMD) from L1 to L4 in the
anteroposterior projection, total hip BMD (THBMD), and
femoral neck BMD (FNBMD). All scans were performed
and analyzed by one technician. Precision errors of BMD
estimations in the same machine were checked by measuring
30 postmenopausal women, twice on the same day, with repo-
sitioning between scans and found to be 0.008, 0.001, and
0.002 g/cm2 for the TS, FN, and TH, respectively (12). Ethi-
cal approval for the study was obtained from the local Ethics
Review Committee of the Faculty of Medicine, Galle.
Statistical Analyses
Thecharacteristics of the 106women included in the analysis
are given as mean and standard deviation (SD) (Table 1). Corre-
lations between age, body mass index (BMI), BMDs, lipid
levels, BPs, and plasma glucose level were examined first and
Table 1
Descriptive Data of 106 Premenopausal Women Included
in the Analysis
Measure Mean (SD)
Age (yr) 42.0 (6.0)
Weight (kg) 57.6 (8.9)
Height (m) 1.54 (0.06)
BMI (kg/m2) 24.4 (3.6)
Waist circumference (cm) 84.9 (9.2)
Hip circumference (cm) 96.9 (7.5)
Waist hip ratio 0.87 (0.06)
TC (mg/dL) 201.7 (32.9)
LDL cholesterol (mg/dL) 129.2 (31.5)
HDL cholesterol (mg/dL) 44.7 (6.4)
TG (mg/dL) 137.9 (33.8)
TG/HDL ratio 4.5 (0.94)
TBBMD (g/cm2) 1.065 (0.086)
TBBMC (g) 1782.63 (226.9)
TSBMD (g/cm2) 0.923 (0.136)
THBMD (g/cm2) 0.922 (0.099)
FNBMD (g/cm2) 0.764 (0.097)
Abbr: SD, standard deviation; BMI, body mass index; TC, total
cholesterol; LDL, low density lipoprotein; HDL, high density lipo-
protein; TG, triglyceride; TBBMD, total body bone mineral density;
BMC, bone mineral content; TBBMC, total body bone mineral con-
tent; TSBMD, total spine bone mineral density; THBMD, total hip
bone mineral density; FNBMD, femoral neck bone mineral density.
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partial correlations between the TBBMC, BMDs, lipids, BPs,
and fasting glucose were examined after adjusting for age and
BMI. Using analysis of variance (ANOVA), mean levels of
lipids, blood sugar, and BPs in the thirds of the TSBMD were
estimated and compared, initially unadjusted and then adjusted
for age and BMI. Homogeneity of variance of the model was
checked using Levene test and interactions between BMD,
BMC, and indices of cardiovascular risk were also checked.
TSBMD was selected for the above analysis as it showed the
highest correlation with lipid levels. Women were diagnosed
to have metabolic syndrome if they had waist circumference
80 cm or more and 2 other abnormalitiesdHDL cholesterol
less than 50 mg/dL, TG more than 150 mg/dL, fasting glucose
more than 100 mg/dL, or BP greater than 130/85 mmHg. The
mean TBBMC, TBBMD, and regional BMDs in women with
andwithoutmetabolic syndromewere estimated and compared,
using unpaired Student’s t-test, initially unadjusted and then ad-
justed for age. Statistical PackageFor the Social Sciences (SPSS
Inc., Chicago) forWindows version 10was used for all analyses
and 2-tailed p less than 0.05 was taken as the level of statistical
significance.
Results
Age of the women ranged from 30 to 54 with mean (SD) of
42.0 (6.0) yr. None of the subjects had ever smoked, whereas
only 5 (4.7%) women had taken alcohol previously. Ninety-
three (87.7%) of them were married and the median (Inter-
quartile range) number of children was 2 (2,3). Eight
(7.5%) women had suffered traumatic fractures but none
had suffered fragility fractures.
Age showed no significant correlations with BMI, BMD, or
lipid levels, whereas BMI showed significant correlations with
spine and hip BMDs (r5 0.31e0.41, p! 0.05) but not with
lipids. When adjusted for age and BMI, the TC, LDL choles-
terol and the ratio between TC and HDL (TC/HDL) showed
negative correlations with the TBBMC and all BMD values.
Of these correlations, only the correlations seen with the
TBBMC and TSBMD were statistically significant. Although
not statistically significant, TG showed negative associations
with BMDs and TBBMC. HDL cholesterol showed positive
correlations with BMDs and TBBMC but these associations
too were not statistically significant (Table 2).
When adjusted for age and BMI, fasting glucose, DBP, and
SBP showed no statistically significant correlations with the
TBBMC or BMDs measured at various sites.
The highest mean TC, LDL cholesterol, and TC/HDL ratio
were seen among women in the lower third of TSBMD,
whereas the lowest mean lipid levels were seen among
women in the upper third of spinal BMD. These differences
were statistically significant and were independent of age
and BMI. Mean values of HDL cholesterol, TG, fasting
glucose, SBP, or DBP were not statistically different in the
tirtiles of the TSBMD (Tables 3 and 4).
Fifty-seven (53.8%) women in the study sample had waist
circumference either equal or greater than 80 cm and 47
(44.3%) of them had 2 other criteria of metabolic syndro-
medHDL less than 50 mg/dL, TG greater than 150 mg/dL,
fasting glucose greater than 100 mg/dL or BP more than
130/85, and they were diagnosed to have metabolic syn-
drome. Independent of age, women with metabolic syndrome
had lower BMC and BMD, but only the difference in the TH
Table 2
Age and BMI Adjusted Partial Correlations Between BMD, BMC, and Lipids
Variable TC LDL cholesterol TGs HDL cholesterol TC/HDL ratio
TBBMD 0.13 0.14 0.01 0.05 0.15
(0.31 to 0.06) (0.31 to 0.05) (0.20 to 0.18) (0.14 to 0.24) (0.33 to 0.04)
p5 0.25 p5 0.19 p5 0.95 p5 0.64 p5 0.19
TBBMC 0.25 0.25 0.12 0.08 0.26
(0.43 to 0.06) (0.43 to 0.06) (0.31 to 0.07) (0.11 to 0.27) (0.43 to 0.06)
p5 0.03 p5 0.03 p5 0.30 p5 0.49 p5 0.02
TSBMD 0.26 0.26 0.05 0.13 0.27
(0.43 to 0.06) (0.43 to 0.06) (0.24 to 0.14) (0.06 to 0.31) (0.44 to 0.08)
p5 0.03 p5 0.018 p5 0.64 p5 0.25 p5 0.02
THBMD 0.04 0.07 0.03 0.12 0.10
(0.23 to 0.15) (0.26 to 0.12) (0.16 to 0.22) (0.07 to 0.31) (0.29 to 0.09)
p5 0.74 p5 0.54 p5 0.78 p5 0.28 p5 0.34
FNBMD 0.18 0.21 0.06 0.14 0.23
(0.37 to 0.01) (0.39 to 0.02) (0.25 to 0.13) (0.05 to 0.32) (0.41 to 0.04)
p5 0.11 p5 0.06 p5 0.57 p5 0.21 p5 0.05
Abbr: BMI, body mass index; BMD, bone mineral density; BMC, bone mineral content; TC, total cholesterol; LDL, low density lipopro-
tein; TGs, triglycerides; HDL, high density lipoprotein; TBBMD, total body BMD; TBBMC, total body BMC; TSBMD, total spine BMD;
THBMD, total hip BMD; FNBMD, femoral neck BMD.
Given in cells are r, 95% confidence intervals (within brackets) and p values examined by partial correlation, adjusted for age and BMI.
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was statistically significant. Further, the percentages of
women with metabolic syndrome in the lower, middle, and
upper thirds of the TSBMD were 40.7%, 50%, and 38.5%,
respectively, and this difference was not statically significant
( p5 0.67).
Discussion
Osteoporosis-related fractures and cardiovascular diseases
are 2 major noncommunicable diseases seen among postmen-
opausal women. Moreover, there is substantial mortality, mor-
bidity, and loss of productivity associated with these diseases.
Early detection and treatment are the main measures adopted
by current health care systems to reduce the burden of these
2 diseases.
Results of the current study demonstrate an association
between measures of bone health and lipid levels among these
previously healthy, middle-aged, premenopausal females. In
this analysis, TC, LDL cholesterol and TC/HDL ratio
inversely and significantly correlated with the TBBMC and
TSBMD. In contrast to women with high TSBMD, women
with low TSBMD had high TC, LDL cholesterol, and TC/
HDL ratio. Furthermore, women with metabolic syndrome
had lower BMD and BMC, but only the difference observed
in the TH was significantly different. Although there was an
inverse correlation between TG and BMD among our sub-
jects, the association was not statistically significant and not
in keeping with previous reports (13). In general, results of
the current study indicate a coexistence of low bone mass
and dyslipidemia in these middle-aged women.
In previous studies, women with low bone mass had high
cardiovascular mortality (1), calcification of aorta (2,3) and
lipid abnormalities that would promote atherosclerosis (4,5).
In contrast, Adami et al and Brownbill et al, found a positive
association between BMD and lipids levels where women
with higher BMDhad elevated lipid levels (5,7). An association
between BMD and BP has been observed among postmeno-
pausal women. In one study, the group of women with low
BMDand highBP had high urinary calcium excretion, suggest-
ing a possiblemechanismof this association (8).Wedid not find
an association between BP and BMD or BMC and our results
are consistent with a large epidemiological study conducted
Table 3
Mean (SEM) Lipids, Fasting Blood Glucose, and BPs in the Thirds of the TSBMD of 106 Premenopausal Women
Variable
Lower third
of spinal BMD
Middle third
of spinal BMD
Upper third
of spinal BMD p Value*
TC
Crude 210.8 (6.0) 207.8 (6.2) 188.4 (6.3) 0.026
Age and BMI adjusted 210.9 (6.1) 208.1 (6.3) 187.9 (6.6) 0.029
LDL cholesterol
Crude 138.4 (5.8) 136.1 (6.0) 115.1 (6.1) 0.013
Age and BMI adjusted 138.8 (5.9) 135.6 (6.1) 115.3 (6.3) 0.021
HDL cholesterol
Crude 44.5 (1.2) 43.4 (1.2) 46.0 (1.2) 0.32
Age and BMI adjusted 44.2 (1.2) 43.6 (1.2) 46.2 (1.3) 0.33
TG
Crude 139.9 (6.5) 140.4 (6.7) 135.6 (6.8) 0.86
Age and BMI adjusted 140.9 (6.3) 143.3 (6.5) 131.4 (6.7) 0.42
TC/HDL
Crude 4.8 (0.18) 4.8 (0.18) 4.1 (0.19) 0.021
Age and BMI adjusted 4.8 (0.18) 4.8 (0.18) 4.1 (0.19) 0.017
Fasting glucose
Crude 83.5 (2.6) 84.8 (2.7) 83.1 (2.8) 0.90
Age and BMI adjusted 82.9 (2.7) 84.9 (2.8) 83.6 (2.9) 0.88
SBP
Crude 109.3 (2.0) 111.3 (2.0) 112.5 (2.1) 0.53
Age and BMI adjusted 109.1 (1.8) 112.7 (1.9) 111.3 (2.0) 0.39
DBP
Crude 72.3 (1.4) 71.9 (1.5) 75.0 (1.5) 0.29
Age and BMI adjusted 72.2 (1.3) 72.8 (1.4) 74.2 (1.4) 0.60
Abbr: SEM, the standard error of the mean; BPs, blood pressures; BMD, bone mineral density; TSBMD, total spine BMD; TC, total cho-
lesterol; BMI, body mass index; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride; SBP, systolic blood pressure;
DBP, diastolic blood pressure.
*p Value contrasts differences in mean values in 3 columns and calculated using post-hoc analysis of variance with Bonferroni correction.
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using 2738 nationally representing group of women where no
association between BMD and hypertension was found (14).
Similarly there was no significant association between blood
sugar and BMD or BMC among our women and this is keeping
with the data seen previously (15).
Coexistence of osteoporosis and dyslipidemia has not been
proven yet. Hence, current practice guidelines do not recom-
mend routine testing of lipids in women with osteoporosis. If
further studies confirm this coexistence, it can have several
clinical implications. Once a woman is detected to have one
abnormality, clinician will be required to search for the other
and then attempt to reverse both conditions. Non-pharmaco-
logical measures such as enhanced physical activity and limit-
ing the intake of alcohol can reverse dyslipidemia while
influencing BMD positively (16). Furthermore, cessation of
smoking would help both conditions. Therapy with selective
estrogen receptor modulators (17) or bisphosphonates (18)
in postmenopausal women led to reversal of dyslipidemia.
Therapy with statins in women with high lipids resulted in
increasing BMD (19). This indicates the existence of shared
metabolic pathway in bone and lipid metabolism.
The exact mechanism involving regulation of bone mass
and cardiovascular risk in humans is not known. Some obser-
vational studies have indicated that atherosclerosis could lead
to local bone loss. Finding of low BMD and aortic calcifica-
tion among women with intermittent claudication of legs
would support this hypothesis (2). Also obstructing atheromas
were found in the small and large arteries supplying the hip
region in women with osteoporotic hip fractures (20,21).
The role of lipids, especially in oxidized form, in the cau-
sation of atherosclerosis and mineralization of vascular wall
and bone tissue has been discussed. In 1999, a study involving
mice, showed that minimally-oxidized LDL (MM-LDL) is
capable of promoting adipogenic differentiation of marrow
stromal cells while inhibiting their osteoblastic differentiation
(22). Parhami et al in 1997 reported that MM-LDL and other
oxidized lipoproteins could promote mineralization of vascu-
lar cells while inhibiting mineralization of bone cells (23).
Brodeur et al (2008) demonstrated the influence of oxidized
LDL in reducing the viability of osteoblasts, mediated
through lysosomal membrane damage (24). Bagger et al
examining the role of lipids in the link between bone and car-
diovascular heath were unable to find a significant association
between lipids and bone health. In this observational study the
presence of apolipoprotein E 34 allele had significant impact
on lipid profile but not on BMD measurements (25). Osteo-
protegerin, receptor activator of nuclear factor kB (RANK),
and RANK-ligand, the well-established cytokinin network
in bone metabolism, has been linked to cardiovascular dis-
ease. Studies have established links between this pathway
and vascular calcification, advanced atherosclerosis, plaque
destabilization, and heart failure indicating its role in the
pathophysiology of cardiovascular disease (26).
The current study hasmany limitations.Women participated
in this study were volunteers who responded to our open invita-
tion. As they were not selected on random basis, selection bias
would have occurred. Thirty-five of them were used in seden-
tary type of jobs and others were mainly housewives. Although
these subjects would not be representative of the normal mid-
dle-aged female population of the country, we were able to
draw a sample, which had employment ratio roughly equal to
the normal population of the country. Small sample size prob-
ably contributed to inconclusive results in many analyses.
Although uniform patterns were seen in TG and HDL choles-
terol, the differenceswere not statistically significant, probably,
because of small sample size. It can be argued that BMD
decline associated with estrogen deficiency may have already
begun in perimenopausal women included in this study and
this may have contributed to the results. We examined the cor-
relations between age, BMI, BMDs, and lipids among women
older than 50 yr (n5 7) and then women older than 45 yr
(n5 35) and found no association between these variables.
Hence this is an unlikely possibility.
In summary this study, involving a selected group of pre-
menopausal healthy women, showed an inverse association,
independent of age and BMI, between BMD and BMC or TC,
Table 4
Mean (SEM) BMC and BMDValues Among Women With
and Without Metabolic Syndrome
Variable
With metabolic
syndrome
(n5 45)
Without
metabolic
syndrome
(n5 34)
p
Value*
TBBMD
Crude 1.061 (0.013) 1.080 (0.015) 0.33
Age and BMI
adjusted
1.061 (0.013) 1.078 (0.015) 0.39
TBBMC
Crude 1782 (33) 1823 (38) 0.41
Age and BMI
adjusted
1783 (33) 1820 (38) 0.47
TSBMD
Crude 0.931 (0.017) 0.950 (0.020) 0.90
Age and BMI
adjusted
0.931 (0.017) 0.935 (0.020) 0.87
THBMD
Crude 0.905 (0.014) 0.950 (0.016) 0.036
Age and BMI
adjusted
0.906 (0.014) 0.948 (0.016) 0.046
FNBMD
Crude 0.757 (0.013) 0.785 (0.015) 0.18
Age and BMI
adjusted
0.758 (0.013) 0.784 (0.015) 0.21
Abbr: SEM, the standard error of the mean; BMC, bone mineral
content; BMD, bone mineral density; TBBMD, total body BMD;
BMI, body mass index; TBBMC, total body BMC; TSBMD, total
spine BMD; THBMD, total hip BMD; FNBMD, femoral neck BMD.
*p Value contrasts differences in mean values in 2 columns
and calculated using Student’s t-test (unpaired) with Bonferroni
correction.
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LDL cholesterol, or TC/HDL ratio. Fasting sugar, TG, HDL
cholesterol, and BP were not found to have significant associa-
tions with BMD or BMC. Finding this association in premeno-
pausal age would support the idea that association between
lipids and bone health is established early in life, predisposing
them to long-term complications in old age. If further studies
generate similar associations, clinicians will be required to
adopt a holistic approach in evaluating patients with abnormal
lipids or low BMD to assess overall mortality and morbidity.
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Original Article
An Association Between Respiratory Function and Bone Mineral Density
in Women from the General Community: A Cross Sectional Study
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Abstract. Respiratory function has been associated with
bone mineral density (BMD) in patients with respiratory
diseases. We examined the relationship between bone
density measured at the hip and respiratory function in
women from the general community. A total of 4830
women aged 45–76 years were recruited from general
practice age – sex registers in Cambridge between 1991
and 1995. At baseline survey, data collection included
health questionnaires, measures of anthropometry,
respiratory function, as well as bone mineral density
BMD measured using dual energy X ray absorptiometry.
BMD at total hip, femoral neck and trochanter
significantly and positively correlated with FEV1. This
association was independent of age, weight, height,
smoking habit, history of respiratory diseases, corticos-
teroids and use of hormone replacement therapy. After
adjustment for these factors, an increase in FEV1 of 1 l/s
was associated with 0.026, 0.021 and 0.026g/cm2
increase in bone mineral density at total hip, femoral
neck and trochanter respectively. The association was
consistent and similar in magnitude among current
smokers and current non-smokers and across all age
groups. The magnitude of the association was compar-
able to that associated with an age difference of 6 years
or weight difference of 5 kg. Women in the bottom
compared to top quartile of respiratory function had
about double the risk of low bone density independent of
other factors. Respiratory function measured using FEV1
is positively and independently related to BMD in these
middle-aged and older women across the whole normal
distribution of these physiologic measures. This may
reflect underlying common determinants such as
physical activity. Even in healthy women, respiratory
function may be a marker for women at increased risk of
osteoporosis and associated fractures.
Keywords: Bone density; Community; Forced expira-
tory volume; Osteoporosis; Respiratory function;
Women
Introduction
Osteoporosis and fragility fractures not only have
considerable current medical and economic impact but
are projected to increase exponentially world wide[1,2].
Bone mineral density (BMD) and fragility fractures in
adults have been associated with numerous genetic,
nutritional and environmental factors [3,4]. These
include physical activity [5], alcohol intake [6], smoking
habit [7], milk consumption [8] and parity [9] as well as
early life factors such as weight and length at birth or at
one year [3,4]. Some of these factors may help to explain
the wide geographic variations and secular changes in
bone health and fracture occurrence [10].
In clinical studies in patients with respiratory diseases
such as cystic fibrosis and bronchial asthma, measures of
respiratory function have correlated with bone mineral
density [11,12]. In addition to compromised lung
function, patients with these conditions are exposed to
a variety of other factors that might impair their bone
health. For example, cystic fibrosis is associated with
pancreatic malabsorption and bronchial asthma is often
treated with long-term corticosteroids. Conversely, in
patients who have spinal osteoporotic fractures, reduced
Osteoporos Int (2002) 13:710–715
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pulmonary function is related to the severity of spinal
deformity [13] where, again, there are obvious reasons
for the association.
It is, therefore, not clear whether the observed
association between respiratory function and BMD is
simply restricted to patients with respiratory or other
diseases or whether it occurs across the whole normal
range of respiratory function.
In the current study we examined the relationship
between respiratory function and bone mineral density in
a population-based cross-sectional study of women
living in the community.
Methods
The Cambridge General Practice Health Study invited
women aged 45–76 years, resident in the community and
identified using general practice age-sex registers, to
participate in a health survey between 1991 and 1995.
About 50% of those mailed agreed to participate. All
those consenting completed a health and lifestyle
questionnaire, which included questions on past medical
history and social habits. They then attended for a health
examination at Addenbrooke’s Hospital, Cambridge.
At the health examination, height and weight was
measured in light clothing without shoes. Body mass
index (BMI) was calculated as weight in kilograms
divided by height in meters squared. Bone mineral
density was measured at the total hip, femoral neck and
trochanter by dual energy X-ray absorptiometry
(DEXA), using the Hologic QDR –1000 densitometer
(Hologic Inc., Waltham, MA, USA). The coefficient of
variation for hip BMD measurement was 1.6% for
femoral neck, 1.5% for trochanter and 3.0% for Ward’s
triangle [14]. In these analyses, results for total hip,
femoral neck and trochanteric area are presented.
Current smokers were defined as those who reported
‘Yes’ to the question ‘Do you smoke cigarettes now?’
Steroid users were defined as those who reported ‘Yes’
to the question ‘Have you ever taken steroid tablets or
injections for three months or more?’ Women taking
hormone replacement therapy (HRT) were defined as
those who reported ‘Yes’ to the question ‘Are you
currently receiving any hormone replacement therapy
(HRT)?’
Respiratory function was assessed by forced expira-
tory volume in 1 second, FEV1, which was measured
twice using a portable spirometer (Micromedical, UK)
[15]. The higher reading of the two measurements was
used in the analyses. Pulse rate was assessed as the
average of two readings after the participant had been
sitting resting for five minutes.
Statistical Analyses
Women were divided into quartiles according to
respiratory function. Descriptive data are expressed as
mean (SD) or percentages (number) in FEV1 quartiles.
Differences in BMD between FEV1 quartiles were
compared unadjusted and then adjusted for possible
covariates using analysis of variance (ANOVA). Since
FEV1 and BMD are related to weight and height in
different ways, we used weight and height independently
in the models rather than the BMI. However, using BMI
in place of height and weight in the analytical model did
not change the salient findings. A linear regression
model was fitted with BMD as the dependent variable
and FEV1 as independent variable with and without
other covariates in the model. This analysis was repeated
in women who had no previous history of respiratory
(chronic obstructive airways disease or asthma),
cardiovascular disease or cancer and had not taken
steroids or hormone replacement therapy.
We arbitrarily defined low bone density as women in
the bottom quintile of the bone density distribution
(bottom quintile threshold points for total hip were
5=0.771 g/cm2 (estimated T-score 71.70), neck
5=0.634 g/cm2 and trochanter 5=0.570 g/cm2). We
examined the prevalence of women with low bone
density by quartile of respiratory function in the whole
cohort and after excluding all women taking steroids,
HRT or current smokers. Data were analyzed using
SPSS software, version 10.0 for Windows. All sig-
nificance tests were two sided.
Results
Descriptive Data
The baseline characteristics for 4830 women aged 45–76
years according to quartile of FEV1 are shown in Table
1. Compared to the highest quartile of FEV1, women in
the lowest quartile were older, shorter and had lower
bone mineral density. They were more likely to have
taken steroids and report past history of respiratory
disease, cardiovascular disease or cancer. Women in the
lowest quartile were less likely to be current users of
HRT compared to those in the highest quartile.
Association between BMD and FEV1
Bone mineral density was continuously related with
FEV1, with mean bone mineral density increasing with
increasing quartile of FEV1 (Table 2). This association
was apparent in all three sites, and remained significant
after adjusting for age, weight, height, current smoking,
and past history of disease, HRT and steroid use.
Table 3 shows the relationship between BMD and
FEV1 as continuous variables using multiple regression
adjusted for age, weight, height, current smoking,
current HRT, steroid use, past history of respiratory
disease, cardiovascular disease or cancer.
We also analyzed the relationship in subgroups
stratified by age (45–54 years, n=2047; 55–64 years,
n=1588; and 65+ years, n=1195) adjusting for weight
and height and stratified by smoking status (623 current
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smokers and 4207 current non-smokers) adjusting for
age, weight and height. Finally we examined the
relationship between bone mineral density and FEV1 in
2692 women after excluding all women with a history of
respiratory diseases, cancer, cardiovascular disease and
steroid use, as well as women who were current HRT
users, adjusting for age, weight and height in the model.
A unit increase in FEV1 (1 l/s) was associated with an
increase of 0.065–0.075 g/cm2 (p50.001) in BMD
across three sites in the hip. After adjusting for age,
weight and height the magnitude of relationship was
reduced to between 0.023 and 0.03 g/cm2 though still
significant (p50.001). The relationship remained sig-
nificant after adjusting for other covariates including
smoking, medication use and existing diseases. The
gradients of the relationship between bone mineral
density and FEV1 were comparable not only across
different age groups but also between current smokers
and current non-smokers. Results were similar in women
with no past history of diseases and those not taking
steroids or HRT.
Table 4 shows the prevalence of women with low
bone density (bottom quintile of BMD distribution)
increased with decreasing quartile of respiratory func-
tion, with about three times the prevalence in the lowest
compared to the highest quartile. Findings were similar
Table 1. Characteristics of 4830 women aged 45–76 years according to FEV1 quartiles in the Cambridge General Practice Study
Quartile 1
(0.51–1.98 l/s)
n=1216
Quartile 2
(1.99–2.32 l/s)
n=1167
Quartile 3
(2.33–2.67 l/s)
n=1232
Quartile 4
(2.68–4.11 l/s)
n=1215
Unadjusted
p value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
FEV1 1.7 (0.28) 2.2 (0.10) 2.5 (0.10) 2.9 (0.23) 50.001
Age (years) 64.4 (7.2) 59.7 (7.6) 54.8 (7.1) 51.5 (5.8) 50.001
Height (cm) 157.9 (6.3) 159.9 (5.3) 161.8 (5.5) 161.5 (6.4) 50.001
Weight (kg) 65.8 (11.8) 66.8 (11.8) 66.7 (11.9) 66.9 (9.8) 50.056
BMI (kg/m2) 26.5 (4.5) 26.1 (4.4) 25.5 (4.3) 24.4 (3.3) 50.001
Pulse (beats/min) 75.2 (12.4) 75.1 (11.7) 74.7 (14.1) 75.1 (11.8) 50.713
Total hip BMD (g/cm2) 0.829 (0.136) 0.879 (0.139) 0.911 (0.133) 0.932 (0.123) 50.001
Femoral neck BMD (g/cm2) 0.686 (0.118) 0.728 (0.124) 0.763 (0.127) 0.791 (0.121) 50.001
Trochanter BMD (g/cm2) 0.616 (0.112) 0.656 (0.108) 0.681 (0.103) 0.703 (0.101) 50.001
Number (%) Number (%) Number (%) Number (%)
COAD/asthma 377 (31%) 250 (21.4%) 263 (21.3%) 208 (17.1%) 50.001
History of cancer 96 (7.9%) 75 (6.4%) 60 (4.9%) 50 (4.1%) 50.001
History of CVD 56 (4.6%) 27 (2.3%) 18 (1.5%) 2 (0.2%) 50.001
Current HRT 118 (9.7%) 210 (17.9%) 317 (25.7%) 317 (26.1%) 50.001
Ever taken steroid 80 (6.6%) 39 (3.3%) 47 (3.8%) 32 (2.6%) 50.001
Current smoking 119 (9.8%) 150 (12.9%) 156 (12.7%) 118 (9.7%) 50.001
FEV1,Forced expiratory volume; BMD, Bone mineral density; COAD, chronic obstructive airway disease; CVD, cardiovascular disease; HRT,
hormone replacement therapy.
Table 2. Crude and adjusted mean BMD values in FEV1 quartiles in 4830 women aged 45–76 years in the Cambridge General Practice Study
Quartile 1
(0.51–1.98 l/s)
n=1216
Quartile 2
(1.99–2.32 l/s)
n=1167
Quartile 3
(2.33–2.67 l/s)
n=1232
Quartile 4
(2.68–4.11 l/s)
n=1215
p value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Total hip BMD (g/cm2) *
**
***
0.829 (0.136)
0.865 (0.278)
0.854 (0.556)
0.879 (0.139)
0.888 (0.208)
0.873 (0.556)
0.911 (0.133)
0.896 (0.208)
0.879 (0.556)
0.932 (0.123)
0.904 (0.278)
0.887 (0.625)
50.001
50.001
50.001
Femoral neck BMD (g/cm2) *
**
***
0.686 (0.118)
0.726 (0.278)
0.721 (0.556)
0.728 (0.124)
0.739 (0.208)
0.731 (0.556)
0.763 (0.127)
0.746 (0.208)
0.737 (0.556)
0.791 (0.121)
0.757 (0.278)
0.748 (0.556)
50.001
50.001
50.001
TrochanterBMD (g/cm2) *
**
***
0.616 (0.112)
0.643 (0.208)
0.629 (0.486)
0.656 (0.108)
0.663 (0.208)
0.645 (0.486)
0.681 (0.103)
0.671 (0.208)
0.652 (0.486)
0.703 (0.101)
0.681 (0.208)
0.661 (0.486)
50.001
50.001
50.001
FEV1 = Forced expiratory volume, BMD=Bone mineral density
*Crude; **Adjusted for age, height and weight; ***Adjusted for age, height, weight, smoking, hormone replacement therapy and steroid use,
chronic obstructive airway disease, /asthma, cancer and cardiovascular disease.
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for 2361 women with no past history of diseases, not
taking steroids or HRT and were non-smokers. Table 4
also shows that women in the bottom compared to the
top quartile of respiratory function had about double the
risk of low bone density even after adjusting for
covariates age, weight, height, pulse rate, smoking,
medication use and past history of respiratory and
cardiovascular disease or cancer.
Discussion
We found a positive and continuous relationship
between FEV1 and bone mineral density at the hip
across the whole normal range of respiratory function in
women in the community. After adjusting for possible
confounding factors, the mean hip bone mineral density
in women in the highest FEV1 quartile was 3%–5%
Table 3. Relationship of FEV1 and BMD in multiple regression analysis: Regression coefficients
of BMD with FEV1 quartiles in the Cambridge General Practice Study
Coefficient
(per one 1 l/s)
SE p value
Entire group Total hip * 0.026 0.004 50.001
(n=4830) Femoral neck * 0.021 0.004 50.001
Trochanter * 0.026 0.004 50.001
Age 45–54 Total hip ** 0.034 0.006 50.001
(n= 2047) Femoral neck ** 0.031 0.007 50.001
Trochanter ** 0.033 0.006 50.001
Age 55–64 Total hip ** 0.039 0.007 50.001
(n=1588) Femoral neck ** 0.032 0.007 50.001
Trochanter ** 0.032 0.006 50.001
Age 65+ Total hip ** 0.039 0.008 50.001
(n=1195) Femoral neck ** 0.029 0.008 50.001
Trochanter ** 0.040 0.007 50.001
Current smokers Total hip *** 0.036 0.012 50.002
Femoral neck *** 0.031 0.011 50.004
(n=620) Trochanter *** 0.023 0.010 50.028
Current nonsmokers Total hip *** 0.029 0.005 50.001
Femoral neck *** 0.021 0.004 50.001
(n=4210) Trochanter *** 0.030 0.004 50.001
Excluding diseases Total hip *** 0.029 0.006 50.001
and drugs (n=2692) Femoral neck *** 0.023 0.006 50.001
Trochanter *** 0.031 0.005 50.001
FEV1 = Forced expiratory volume, BMD=Bone mineral density.
* FEV1 adjusted for age, height, weight, smoking, hormone replacement therapy, steroid use,
chronic obstructive airways disease/asthma, cancer and cardiovascular diseases.
** FEV1 adjusted for height and weight.
*** FEV1 adjusted for age, height and weight.
Table 4. Risk of low bone density according to respiratory function in 4830 women aged 45–76 years in the Cambridge General Practice Study
Prevalence of low bone densitya
n (%)
Adjustedb odds ratio
of low bone density
in FEV1 quartile 1
vs quartile 4 (95% CI)
p value
Quartile of FEV1 Quartile 1
(0.51–1.98 l/s)
n=1216
Quartile 2
(1.99–2.32 l/s)
n=1167
Quartile 3
(2.33–2.67 l/s)
n=1232
Quartile 4
(2.68–4.11 l/s)
n=1215
Total hip BMD 428 (35.2) 256 (21.9) 173 (14.0) 111 (9.1) 2.14 (1.57–2.92) 50.001
Femoral neck BMD 429 (35.3) 271 (23.2) 165 (13.4) 100 (8.2) 1.83 (1.34–2.51) 50.001
Trochanter BMD 434 (35.7) 253 (21.7) 170 (13.8) 104 (8.6) 2.22 (1.64–3.01) 50.001
FEV1=Forced expiratory volume; BMD, Bone mineral density.
aLow bone density = bottom quintile of bone density distribution.
bAdjusted for age, height, weight, pulse rate, smoking, hormone replacement therapy, steroid use, chronic obstructive airways disease/asthma,
cancer and cardiovascular diseases.
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higher than the mean BMD in women in the lowest
quartile (Table 2). In multiple regression analyses, a unit
change in FEV1 (1 l/s) was associated with about 0.030
g/cm2 change in total hip BMD independent of other
covariates. Despite the differences in composition of
bone in different skeletal sites, there was little variation
in the BMD FEV1 relationship at different sites. Within
this study group, the magnitude of this relationship was
comparable to a difference of 6 years in age or difference
of 5 kg in weight on total hip bone mineral density.
Random measurement errors in both FEV1 and bone
mineral density are likely to underestimate the magni-
tude of the relationship.
In our study population, both BMD and FEV1 were
positively related to weight and height. The age-adjusted
partial correlation coefficients between BMD and weight
at total hip, femoral neck and trochanter were r = 0.46,
0.37 and 0.36 (p50.001 for all), respectively. Partial
correlations between bone mineral density and height at
same sites were r = 0.09, 0.10 and 0.13, respectively
(p50.001 for all). FEV1 related more strongly to height
(r = 0.43, p50.001) than weight (r = 0.05, p50.001).
However, the correlation seen between BMD and FEV1
remained significant even after adjusting for the effect of
height and weight and the association appeared to be
independent of these two measurements.
FEV1, a commonly used lung function test in clinical
practice, is reduced in both obstructive and restrictive
lung diseases. Low BMD has been shown to occur in
both obstructive and restrictive lung diseases [11,12].
Although the exact etiology of this is unclear, in patients
with these respiratory diseases, chronic ill health, poor
nutrition or medication such as steroid use could affect
BMD. However, in the current cohort, the association
between BMD and FEV1 was apparent across the normal
range of respiratory function even after excluding
women with any history of respiratory disease.
The reason for this relationship is not clear. Cigarette
smoking habit might plausibly explain the association.
Smoking has a negative effect on bone metabolism [7]
and is also a major cause of chronic obstructive airway
disease resulting in impaired FEV1 [16]. However, a
similar correlation was observed in this cohort of women
in both current smokers and current non-smokers; 68%
of the latter group consisted of people who never smoked
during their life. Smoking is therefore unlikely to explain
this association.
Hypoxia has negative effects on bone mineralization
[17] but whether the association is mediated through the
degree of arterial oxygen saturation is unknown. Patients
with chronic airflow limitation tend to be symptomatic
by the time they develop chronic hypoxia and are not
likely to remain undiagnosed. Patients with interstitial
lung diseases tend to develop chronic hypoxia early and
they can remain asymptomatic and undiagnosed for a
variable period of time. Nevertheless, the low prevalence
of interstitial lung diseases in the community [18] is
unlikely to explain the above findings.
Low vitamin D levels have been documented among
patients with cystic fibrosis, in whom the FEV1 was
correlated with bone mineral density [11]. Poor nutrition,
limited sun exposure and pancreatic malabsorption can
all contribute to hypovitaminosis D in these patients.
Chronic hypovitaminosis D and resulting secondary
hyperparathyroidism is known to impair bone mineral-
ization [19]. Hypovitaminosis D is also known to be
associated with skeletal muscle weakness [20] although
the effect on respiratory muscles has not been
documented. Whether low vitamin D status might
contribute to the observed association remains to be
established.
Physical activity is known to have a positive influence
on bone mineral density [21]. FEV1 depends on the
strength of respiratory musculature and vital capacity,
both of which are likely to improve with physical
activity. Adjusting for self-reported physical activity did
not change the findings (results not shown), but it is
likely that we were unable to adjust adequately for
physical activity in the statistical analysis, since our
measurements of physical activity were crude. We used
pulse rate as a surrogate marker of physical fitness but its
inclusion in the regression model together with other
covariates did not change the magnitude of the observed
association.
The observed 3–5% difference in mean hip bone
mineral density between top and bottom FEV1 quartiles
seen in this study may be of clinical and public health
relevance. A difference in bone mineral density of
similar magnitude was found when women reporting
most frequent milk consumers were compared with least
frequent milk consumers [8] and tea drinkers were
compared with non-tea drinkers [22]. Tea drinking
appears to be associated with lower hip fracture rates
in both men and women in Europe [23,24]. Bone mineral
density change of similar magnitude occurs following
long-term HRT therapy, which has been shown to reduce
the incidence of vertebral fractures by nearly 50%.
Although BMD is a major known determinant of
future fracture risk of an individual, and pharmacologic
interventions such as the bisphosphonates have been
shown to reduce fracture risk, other factors which may
influence the absolute risk of fracture are taken into
consideration when making therapeutic decisions.
Women in the bottom quartile of distribution for
respiratory function had double the risk of low bone
density. It would be of interest to know if respiratory
function is an independent predictor of fracture risk.
Among the patients with low BMD, the subgroup with
poor respiratory function may form a special risk group
for future fractures. Both low BMD and low FEV1 have
been shown to predict mortality in men and women [25–
27].
The significant association between respiratory func-
tion and hip bone mineral density, found across all age
groups in women living in the general community has,
not to our knowledge, been previously reported. This
relationship was independent of age, weight, height,
smoking habit, medication use and clinical respiratory or
bone diseases. The exact mechanism of this association
is unclear but is likely to reflect some common
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etiological factor or factors such as physical activity or
nutritional status which need to be explored in future
studies. In the interim, poor respiratory function may be
a useful indicator of women at increased risk of
osteoporosis.
Acknowledgements. We thank the general practitioners, The Meta-
bolic Bone Unit, Addenbrooke’s Hospital, and participants in the
Cambridge General Practice Health Study which was supported by a
research grant from the Wellcome Trust. S.L is a recipient of the
Commonwealth Fellowship.
References
1. Ray NF, Chan JK, Thamer M, Melton LJ,III. Medical
expenditures for the treatment of osteoporotic fractures in the
United States in 1995: report from the National Osteoporosis
Foundation. J Bone Miner Res 1997;12:24–35.
2. Cooper C, Campion G, Melton LJ, III. Hip fractures in the
elderly: a world-wide projection. Osteoporos Int 1992;2:285–9.
3. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C.
Intrauterine programming of adult body composition. J Clin
Endocrinol Metab 2001;86:267–72.
4. Cooper C, Cawley M, Bhalla A, et al. Childhood growth, physical
activity, and peak bone mass in women. J Bone Miner Res
1995;10:940–7.
5. Bradney M, Pearce G, Naughton G, et al. Moderate exercise
during growth in prepubertal boys: changes in bone mass, size,
volumetric density, and bone strength: a controlled prospective
study. J Bone Miner Res 1998;13:1814–21.
6. Clark K, Sowers MR. Alcohol dependence, smoking status,
reproductive characteristics, and bone mineral density in
premenopausal women. Res Nurs Health 1996;19:399–408.
7. Daniell HW. Osteoporosis of the slender smoker. Vertebral
compression fractures and loss of metacarpal cortex in relation to
postmenopausal cigarette smoking and lack of obesity. Arch
Intern Med 1976;136:298–304.
8. Murphy S, Khaw KT, May H, Compston JE. Milk consumption
and bone mineral density in middle aged and elderly women.
BMJ 1994;308:939–41.
9. Murphy S, Khaw KT, May H, Compston JE. Parity and bone
mineral density in middle-aged women. Osteoporos Int
1994;4:162–6.
10. Melton LJ, III, O’Fallon WM, Riggs BL. Secular trends in the
incidence of hip fractures. Calcif Tissue Int 1987;41:57–64.
11. Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and
low bone mineral density in adults with cystic fibrosis: a cross-
sectional study. Osteoporos Int 2001;12:366–72.
12. Nishimura Y, Nakata H, Maeda H, Yokoyama M. [Bone mineral
content in patients with bronchial asthma]. Nihon Kyobu Shikkan
Gakkai Zasshi 1995;33:300–5.
13. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary
function in patients with spinal osteoporotic fractures. Osteoporos
Int 1998;8:261–7.
14. Laskey MA, Flaxman ME, Barber RW, et al. Comparative
performance in vitro and in vivo of Lunar DPX and Hologic
QDR-1000 dual energy X-ray absorptiometers. Br J Radiol
1991;64:1023–9.
15. Cox BD, Huppert FA, Whichelow MJ. The Health and Lifestyle
Survey: 7 years on. Dartmouth, 1993.
16. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med
2000;343:269–80.
17. Fujimoto H, Fujimoto K, Ueda A, Ohata M. Hypoxemia is a risk
factor for bone mass loss. J Bone Miner Metab 1999;17:211–6.
18. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The
epidemiology of interstitial lung diseases. Am J Respir Crit
Care Med 1994;150:967–72.
19. Lamberg-Allardt CJ,Outila TA, Karkkainen MU, Rita HJ, Valsta
LM. Vitamin D deficiency and bone health in healthy adults in
finland: could this be a concern in other parts of Europe? J Bone
Miner Res 2001;16:2066–73.
20. Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D
myopathy without biochemical signs of osteomalacic bone
involvement. Calcif Tissue Int 2000;66:419–24.
21. Welten DC, Kemper HC, Post GB, et al. Weight-bearing activity
during youth is a more important factor for peak bone mass than
calcium intake. J Bone Miner Res 1994;9:1089–96.
22. Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral
density in older women. Am J Clin Nutr 2000;71:1003–7.
23. Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J
et al. Risk factors for hip fracture in men from southern Europe:
the MEDOS study. Mediterranean Osteoporosis Study. Osteopor-
os.Int. 1999;9:45-54.
24. Johnell O, Gullberg B, et al. Risk factors for hip fracture in
European women: the MEDOS Study. Mediterranean Osteoporo-
sis Study. J Bone Miner Res 1995;10:1802–15.
25. Trivedi DP, Khaw KT. Bone mineral density at the hip predicts
mortality in elderly men. Osteoporos Int 2001;12:259–65.
26. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma
mortality in elderly women with low bone mineral density. Study
of Osteoporotic Fractures Research Group. Lancet 1991;338:355–
8.
27. Ryan G, Knuiman MW, Divitini ML, James A , Musk AW,
Bartholomew HC. Decline in lung function and mortality: the
Busselton Health Study. J Epidemiol Community Health
1999;53:230–4.
Association Between Respiratory Function and Bone Mineral Density in Women 77
ORIGINAL ARTICLE
An association between respiratory function and hip bone
mineral density in older men: a cross-sectional study
S. Lekamwasam Æ D. P. Trivedi Æ K. T. Khaw
Received: 22 October 2003 / Accepted: 4 May 2004 / Published online: 12 June 2004
 International Osteoporosis Foundation and National Osteoporosis Foundation 2004
Abstract The association between respiratory function
and bone mineral density (BMD) among women living
in the community has been reported previously. We
examined the association between forced expiratory
volume in 1 s (FEV1) and BMD measured at hip using
dual-energy X-ray absorptiometry in a group of 947 men
(aged 65 to 76 years) recruited from general practice
age-sex registers in Cambridge between 1991 and 1995.
A positive and significant correlation was seen between
FEV1 and BMD measured at total hip, femoral neck,
and trochanter. A unit change (1 l) in FEV1 was asso-
ciated with a change of BMD by 0.019, 0.017, and
0.026 g/cm2 in the total hip, femoral neck, and tochan-
teric region, respectively. These associations were inde-
pendent of possible confounding factors such as age,
height, weight, smoking habit, major disease prevalence,
and medications, which might affect bone metabolism.
In categorical analyses, the highest BMD was seen in the
highest FEV1 quartile, while the lowest BMD was seen
in the lowest FEV1 quartile. This pattern was seen in all
three skeletal sites and was independent of covariates
listed above. Compared with the bottom FEV1 quartile,
mean hip BMDs in the top quartile were 2–3.5% higher.
The exact mechanism of this association is not clear to
us. One plausible explanation is that respiratory func-
tion and bone health both reflect common but as yet
unknown determinants.
Keywords Bone density Æ Community Æ Forced
expiratory volume Æ Men Æ Osteoporosis Æ
Respiratory function
Introduction
The association between respiratory function and bone
mineral density among patients with chronic respiratory
diseases has been reported previously [1]. Further,
higher risk of osteoporosis among subjects with airflow
limitation has been demonstrated in a recent study [2].
We have previously reported a positive and continuous
association between forced expiratory volume in 1 s
(FEV1) and bone mineral density (BMD) of the proxi-
mal femur in women living in the general community in
the UK [3]. This association was independent of age,
height, weight, smoking habit, medication use, and
presence of chronic diseases, which can affect bone
metabolism. We wished to examine the association be-
tween respiratory function FEV1 and hip BMD in a
group of older men living in the community.
Methods
This study involved men who participated in the Cam-
bridge General Practice Health Study, which invited
men aged 65 or above, resident in the community, and
identified using general practice age and sex match reg-
isters between 1991 and 1995. Those who consented for
the health survey completed the health and lifestyle
questionnaire, which gathered information on their
current and past medical history. Height and weight
were measured in light clothing without shoes during the
physical examination by trained personnel at Adden-
brooke’s Hospital, Cambridge. History of cancer, heart
disease, stroke, and respiratory disease, were assessed
using self-completed questionnaires. The use of systemic
corticosteroids was recorded as ‘‘never’’ or ‘‘ever,’’ while
participants were categorized into three groups on their
smoking habits: ‘‘current smokers,’’ ‘‘past smokers,’’
and ‘‘never smoked.’’ BMD of the nondominant proxi-
mal femur was measured using the Hologic QDR 1000
densitometer (Hologic, Waltham, MA, USA). The
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coefficient of variance for hip BMD measurements in
our unit was 1.6% for the femoral neck, 1.5% for the
trochanter, and 3.0% for Ward’s triangle [4].
Forced expiratory volume in the 1st second (FEV1)
was measured twice using a portable spirometer
(Micromedical, UK) [5]. The higher reading of the two
measurements was used in the analysis.
Statistical analyses
Men were divided into quartiles according to FEV1, and
descriptive data of each quartile were given as mean
(SD) or percentages (number). Correlations between hip
BMD, age, weight, height, and FEV1 as continuous
variables were examined using Pearson correlation
coefficients. Mean BMDs at total hip, femoral neck, and
trochanter were compared using multivariate analysis of
variance, initially adjusted for age, height, and weight,
and then additionally for possible confounders such as
respiratory disease, cardiovascular disease, and smoking
habit. A linear regression model was fitted to examine
the relationship of FEV1 (independent variable) on
BMD (dependent variable) with and without covariates
in the model. Data were analyzed using SPSS software,
version 10 for Windows.
Results
Descriptive data
The descriptive data of 947 men aged 65 to 76 years
(mean 69.2 years, SD=2.8) are shown in Table 1.
Compared with men in the highest quartile of FEV1,
men in the lowest quartile were older, shorter, and
lighter, and had lower average BMDs in all hip regions.
The percentage of current smokers, corticosteroid users,
and men with history of cardiovascular disease and
respiratory disease were significantly higher in the lowest
FEV1 quartile when compared with the highest.
Association between FEV1 and BMD
Significant and positive correlations were observed be-
tween FEV1 and BMD measured in all three hip sites.
Age, weight, and height also showed significant corre-
lations with both BMD and FEV1 (Table 2).
Table 1 Descriptive data of 947 men aged 65–76 years, according to FEV1 quartiles in the Cambridge General Practice Study
Parameter Quartile 1 (n=234) Quartile 2 (n=234) Quartile 3 (n=240) Quartile 4 (n=236) p Value
Characteristics Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age, years 69.9 (2.8) 69.5 (2.8) 69.1 (2.7) 68.4 (2.5) <0.001
Height, cm 169.9 (6.5) 177.7 (6.2) 172.3 (6.4) 175.5 (6.1) <0.001
Weight, kg 76.2 (11.9) 77.3 (10.5) 78.5 (11.5) 79.4 (9.7) 0.009
BMI, kg/m2 26.3 (3.8) 26.5 (3.2) 26.4 (3.2) 25.7 (2.6) 0.008
FEV1, liter 1.79 (0.31) 2.45 (0.12) 2.83 (0.11) 3.37 (0.28) <0.001
Total hip BMD, g/cm2 0.935 (0.151) 0.959 (0.141) 0.963 (0.146) 0.982 (0.133) 0.004
Femoral neck BMD, g/cm2 0.759 (0.133) 0.778 (0.117) 0.782 (0.126) 0.803 (0.121) 0.003
Trochanter BMD, g/cm2 0.712 (0.124) 0.746 (0.123) 0.751 (0.131) 0.766 (0.119) <0.001
Percentage of men with Number (%) Number (%) Number (%) Number (%)
COAD/asthma 88 (37.6) 42 (17.7) 31 (12.9) 22 (9.3) <0.001
Cancer 14 (6.0) 11 (4.6) 12 (5.0) 14 (5.9) 0.890
Cardiovascular disease 43 (18.4) 37 (16.0) 24 (10.0) 28 (11.9) 0.035
Current smoking habit 41 (17.5) 27 (11.4) 13 (5.4) 9 (3.8) <0.001
Steroid use 20 (8.5) 5 (2.1) 12 (5.0) 4 (1.7) 0.001
Table 2 Correlations between
age, weight, height, hip BMD,
and FEV1. All variables were
entered as continuous measures
Weight Height Total hip
BMD
Femoral
neck BMD
Trochanteric
BMD
FEV1
Age )0.124 )0.087 )0.106 )0.105 )0.073 )0.198
<0.001 0.007 0.001 0.001 0.026 <0.001
Weight - 0.482 0.441 0.376 0.339 0.128
- <0.001 <0.001 <0.001 <0.001 <0.001
Height - - 0.208 0.192 0.233 0.301
- - <0.001 <0.001 <0.001 <0.001
Total hip BMD - - - 0.854 0.910 0.137
- - - <0.001 <0.001 <0.001
Femoral neck BMD - - - - 0.781 0.132
- - - - <0.001 <0.001
Trochanteric BMD - - - - - 0.167
- - - - - <0.001
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Mean (and SD) BMDs of total hip, femoral neck, and
trochanter in FEV1 quartiles are shown in Table 3. After
adjusting for possible confounding factors, the highest
BMDs were observed in the highest FEV1 quartile, while
the lowest BMDs were seen in the lowest FEV1 quartile,
and this pattern was seen in all three hip regions. Mean
BMDs generally showed an upward trend with increas-
ing FEV1.
Results of the regression analysis are shown in
Table 4. A significant and positive relationship, inde-
pendent of the effects of age, height, weight, smoking
habits, prevalent disease, or steroid medication was
observed between FEV1 and hip BMD. A unit change in
FEV1 (1 l) was associated with a statistically significant
0.031, 0.027, and 0.034 g/cm2 change in BMD in total
hip, femoral neck, and trochanter, respectively. Includ-
ing the potential confounding factors in the model
attenuated these associations but they still remained
significant. Excluding current smokers or steroid users in
the regression model did not materially alter the
regression slopes (data not shown).
Discussion
We previously reported a continuous and positive
association between FEV1 and hip BMD among com-
munity-living women who participated in the same
study. These women were recruited from the same
community and were assessed by the same team in the
same manner. The association seen in these women was
independent of age, body mass index, smoking habit,
and history of diseases or medications which might
influence bone metabolism [3]. The association was evi-
dent in young, middle, and older age groups almost to
the same extent. Although the exact mechanism of this
association was not clear, a common underlying deter-
minant, such as physical activity was a plausible expla-
nation.
In the current study, a positive correlation was seen
between respiratory function measured by FEV1 and hip
BMD measured at total hip, femoral neck, and tro-
chanter in men aged 65–76 years. The association was
independent of age, weight, height, smoking habits,
steroid use, and prevalent diseases, which might affect
bone metabolism. After adjusting for above potential
confounding factors, mean hip BMD of men in the
highest FEV1 quartile was approximately 2.0–3.5%
higher when compared with mean BMD in those in the
lowest quartile. This is somewhat less than what was
seen in women previously [3]. BMD in all three hip
regions showed a general upward trend from the lowest
to the highest FEV1. In contrast to women, the mean
differences in BMD in FEV1 quartiles were not statisti-
cally significant except in the trochanteric area. How-
ever, more sensitive regression analyses showed
statistically significant relationships.
In the regression analysis, the magnitude of the
association seen between respiratory function and BMD
in men was weaker than that seen in the subgroup
analysis of women over 65 years [3]. In older women
(n=1,195), a unit (1 l) change in FEV1 was associated
with a change in BMD of 0.039, 0.029, and 0.040 g/cm2
in total hip, femoral neck, and trochanter, respectively.
In the current study involving men of a similar age
group, corresponding figures were 0.019, 0.017, and
0.026 g/cm2. Nevertheless, while these differences were
small, and observed mean BMDs for men did not reach
osteoporosis or osteopenia thresholds in the lowest
quartiles, they may still be of interest in terms of
understanding the mechanisms involved in bone loss.
The differences we observed in the association be-
tween respiratory function and BMD between men and
women could partly be due to differences in sample sizes
and, hence, lack of power, although a real gender dif-
ference cannot be excluded. Gender differences were
observed in both BMD and hip geometry [6, 7]. Gender
differences in BMD were observed early in life, between
Table 3 Adjusted mean (SD) BMD values in FEV1 quartiles in men aged 65–76 years, in the Cambridge General Practice Study. Fem
neck BMD femoral neck BMD, Troch BMD trochanteric BMD
Quartile 1 Quartile 2 Quartile 3 Quartile 4 p Value
Total Hip BMDa 0.945 (0.012) 0.963 (0.012) 0.959 (0.012) 0.973 (0.012) 0.18
Total Hip BMDb 0.950 (0.012) 0.963 (0.012) 0.957 (0.012) 0.970 (0.012) 0.45
Fem neck BMDa 0.768 (0.012) 0.781 (0.012) 0.779 (0.012) 0.795 (0.012) 0.15
Fem neck BMDb 0.773 (0.012) 0.782 (0.012) 0.777 (0.012) 0.792 (0.012) 0.41
Troch BMDa 0.721 (0.012) 0.748 (0.012) 0.749 (0.012) 0.756 (0.012) 0.01
Troch BMDb 0.725 (0.012) 0.74 (0.012) 0.748 (0.012) 0.752 (0.012) 0.09
aAdjusted for age, weight, and height
bAdjusted for age, weight, height, respiratory diseases, cardiovascular diseases, smoking, and steroid use
Table 4 Regression coefficients of BMD with FEV1 in men aged
65–76 years, in the Cambridge General Practice Study
Coefficient
(per 1 l/s)
SE p Value
Total hip BMD, unadjusted 0.031 0.008 <0.001
Total hip BMD, adjusteda 0.019 0.007 0.006
Femoral neck BMD, unadjusted 0.027 0.007 <0.001
Femoral neck BMD, adjusteda 0.017 0.006 0.005
Trochanter BMD, unadjusted 0.034 0.008 <0.001
Trochanter BMD, adjusteda 0.026 0.006 <0.001
aAdjusted for age, weight, height, respiratory diseases, cardiovas-
cular diseases, smoking, and steroid use
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prepubertal men and women [8] and also in forearm
bones among Japanese [9]. If physical activity is the link
between BMD and respiratory function, the association
might be expected to be greater among men, who are
more physically active than women. Other possible
factors such as smoking, alcohol consumption, preva-
lence of diseases, and use of drugs which can affect bone
metabolism may also differ in men and women.
Although recruited from the same community, consid-
erable differences in the prevalence of current smokers
and in the number of patients with a history of cancers
and other relevant diseases were seen between men in the
current study and women in our previous study [3],
reflecting the well-recognized sex differences in health.
Our study has several limitations. Selection bias is
unlikely to explain the relationship unless nonresponders
differed from responders with respect to the relationship
between respiratory function and BMD. That is, that
nonresponders were more likely to have good respira-
tory function and low BMD or vice versa, which does
not seem plausible. There are measurement errors in
assessment of BMD and respiratory function, but ran-
dom measurement error would attenuate any relation-
ship. We did not quantify smoking and corticosteroid
use, and they were used as categorical variables in the
analysis. The effects of smoking and corticosteroids both
on BMD and lung functions are dose related, so we may
not have adjusted adequately for smoking and steroid
use. Nevertheless, regression analyses after excluding
steroid users and current smokers found similar rela-
tionships between respiratory function and BMD. We
did not include spine BMD in the analysis, since spine
BMD is influenced by the presence of degenerative
changes and vertebral fractures. Vertebral fractures
reduce lung function, and the extent of this problem
was not known to us in this study.
The association between respiratory function and
BMD seen in these studies need further exploration.
Whether respiratory function has a direct influence on
BMD or both measures reflect a common predisposing
factor is unknown. Elucidating the nature of the rela-
tionship may help in the understanding of the determi-
nants and prevention of bone loss in later life.
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General Discussion 
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Osteoporosis-related fractures create a substantial economic burden on current health- 
care systems [1] and many countries have adopted measures at different levels to 
lessen the burden. Despite the predictions that increased number of hip fractures 
would occur in Asia [2], South Asian countries are not considering osteoporosis a 
health priority[3]. Lack of epidemiological data in these countries has partly 
 
Prevalence of postmenopausal osteoporosis  
 
likely to develope osteoporosis [4]. This observation is based on phalangeal BMD 
measured in a community survey conducted in seven out of nine provinces of the 
country. This survey is the largest bone-related health survey conducted in Sri Lanka. 
Although we were unable to draw subjects from the North and East provinces which 
are largely inhabited by Tamils and Sri Lankan Moors, we were able to include these 
ethnic groups from other provinces, roughly to the same proportions they exist in the 
country’s population. In general, the participants of this survey were volunteers who 
gathered to the community screening centers and were not selected on a random basis. 
Since only the screening centers were randomized we cannot exclude the possibility 
this consideration needs to be contemplated in the interpretation of these figures.  
 
As our estimation is based on phalangeal BMD, it is likely that, the prevalence we 
observed could be materially different if a central site such as spine or hip was 
studied. Discordance of T scores as well as the prevalence of osteoporosis between 
skeletal sites is well documented. El Maghraoui et al reported discordance of WHO 
diagnostic category between spine and hip in every 4 in 10 patients[5]. Mulder et al 
showed that estimation of osteoporosis prevalence, based on a single skeletal site, can 
lead to a substantial variation. They observed the prevalence of osteoporosis to vary, 
widely, when BMDs were estimated in multiple sites including phalanx, forearm, 
spine and proximal femur [6]. Hence the prevalence figure we observed in our 
analysis could be different from the true disease prevalence. Further studies using 
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Discussion  
contributed to the low priority given to the disease, currently.   
Our study showed that nearly 45% of Sri Lankan women in postmenopausal age are 
of selection (health) bias that might have influenced the results, and most importantly 
  
is a daunting task in a country which has only three central-type densitometers for the 
entire population. Until such a study is conducted, our prevalence data can be used as 
population. 
 
makers about the high prevalence of osteoporosis in our society. It is also likely that 
our figure is somewhat closer to the true value as similar prevalence figures have been 
reported from neighboring countries. Cheng et al found 31% prevalence of 
osteoporosis, either in the spine or proximal femur, in Chinese women older than 50 
years [7]. Among postmenopausal Thai women, the prevalence of osteoporosis was 
39% between 60-64 years and 57.7% between 70-74 years [8-10]. Among Japanese 
women aged between 50 and 79 years, the prevalence of osteoporosis was 35% in the 
spine, 12% in the hip, and 56.8% in the forearm [11]. Among Chinese women, Jang et 
al reported 30.6% prevalence of osteoporosis between 45-64 years, 52.5% between 
65- 64 years and 68.7% above 75 years [12]. The prevalence we reported is 
comparable with above figures.   
 
Peak bone mass (PBM) 
 
We found the phalangeal BMD among our subjects to reach the peak value between 
showed a delay in achieving PBM when compared with central sites such as spine or 
proximal femur which most of the time, reached a peak between 20-30 years [14]. It 
is possible, therefore, the maximum BMDs of spine and proximal femur to occur 
earlier in our subjects, perhaps between 20-30 years of age. In support of this 
assumption, our subjects achieved nearly 96% of maximum phalangeal BMD between 
different BMD levels. Although further studies can be performed to ascertain the 
timing of skeletal maturation of different skeletal sites, they are unlikely to provide 
additional clinically relevant information. For practical purposes we could consider 
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central-type DXA are needed in Sri Lanka to check the reproducibility of our data. This 
a platform for future studies and to infer the health status of the Sri Lankan 
Further, we believe that, our prevalence data can be used to convince health policy 
30-40 years. Previous studies found a variation of the timing of PBM accrual based on 
ethnicity and skeletal site [13-15,16]. Peripheral sites such as phalanx and forearm 
20-30 years, and individuals between 20-30 and 31-40 years did not have significantly 
  
that nearly 96% of PBM is achieved by 20-30 years and all measures to improve bone 
health should be focused on younger age groups. However, further 4-6% of BMD 
increment is still feasible when the desired BMD level has not been achieved by the 
age of 30 years.   
 
There are many determinants of PBM. Factors such as protein-energy nutrition, 
calcium intake, vitamin D status and physical activity are proven to be associated with 
at primary care level when designing preventive measures. As most of these 
determinants have their maximum influence on growing skeleton than on the mature 
skeleton, the “window of opportunity” can be determined based on the timing of PBM 
in the population. Health promoters in Sri Lanka should encourage measures that 
promote achieving higher PBM for people below 40 years knowing that certain parts 
of the skeleton can potentially be modified until that age.          
 
There are many life-style modifications that are proven to influence bone health. Hind 
and Burrows, in a systematic review of clinical trials on exercise, found a positive 
association between exercise and bone mineral accrual in children and adolescents 
[19]. Exercise has other health benefits as well. A school-based, high-impact exercise 
intervention implemented three times a week for 12 minutes showed positive effects 
both on lean mass and indices of hip geometry [20].  
 
Nutrients at different periods in life are known to influence BMD. Intake of calcium 
and vitamin D in childhood positively influences BMD. School girls who were 
supplemented with high calcium milk for a period of two years were able to maintain 
higher sitting height than their controls after one year of withdrawing the supplements 
bone mineral content (BMC) and overall growth [22].  
 
Health policy makers in Sri Lanka should use this information to design a health 
promotional package consisted of life-style modifications for people under 40 years. 
Apart from other health benefits associated with physical activity inculcated early in 
life, this will allow them to acquire a higher PBM which in turn helps to maintain a 
higher BMD during old age.   
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[21]. Apart from calcium, other nutrients such as protein have positive influence on 
PBM [17-19]. These factors are potentially modifiable and can be incorporated 
  
Accuracy, precision and patient positioning  
 
Hip BMD measurement is routinely included in the evaluation of postmenopausal 
osteoporosis as hip BMD is the best predictor of hip fracture [23]. All DXA 
manufacturers use hip positioning aids to rotate femur internally, to counteract the 
automatic anteversion of the hip joint. We highlight the importance of maintaining the 
same degree of leg rotation in replicate DXA scans. Our data show that internal 
rotation of femur by 10 degrees between two scans is associated with a change in 
BMD, in excess of the Least Significant Change (LSC) in 24% of subjects while 
external rotation by the same degree is associated with a significant change in BMD 
in 16% of subjects [24]. Although malrotation of leg, either internally or externally, 
did not compromise the diagnostic classification, a significant effect on the precision 
of BMD estimations was evident. This indicates that technician should achieve the 
correct rotation of femur to maintain the accuracy of BMD estimation and then 
achieve the same degree of rotation in all subsequent scans in order to maintain the 
precision. Technician will not have an insight to the degree of femur rotation as it 
cannot be determined externally. As a crude and qualitative guide, the lesser 
trochanter of the femur can be used to estimate the degree of femur rotation. The 
lesser trochanter which is a posterior structure should be just visible at the upper inner 
border of the femoral shaft to indicate adequate retroversion of femur [25]. 
Technicians should routinely check for this bony landmark to make sure that the same 
degree of hip rotation has been achieved in all scans. Two other studies examining the 
effect of leg rotation on hip BMD have generated similar results and support our 
 
Leg elevation and spine BMD  
 
We examined whether the same accuracy of spine BMD can be obtained on a Hologic 
machine, when patients keep their legs flat while scanning. When 54 postmenopausal 
spine BMD estimations to be similar [28]. Furthermore, there was a very high degree 
of correlation between the BMD values measured in the two positions and the 
regression intercept was close to zero (0.02). These data indicate that keeping legs flat 
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findings [26,27].  
women were measured with their legs flat or elevated, we found the accuracy of the 
on the table or elevated on the leg block, while measuring spine BMD, does not 
 essentially affect the accuracy of data. Although there are no published data, Norland 
manufacturer would have examined the difference in spine BMD when measured with 
Lunar scanner showed similar results to ours. Simonelli et al in their study, found 
high correlations of BMDs measured with and without leg elevation. Furthermore, in 
the regression analysis, the slope and intercept values they observed are highly 
comparable to ours [29]. Similar to our analysis, Yang et al, using a Hologic QDR 
there was no significant difference between the mean BMDs estimated in the two 
2
was noted.  
 
In our study, although BMD remained unchanged, there was a significant change in 
the region of interest (ROI) and BMC between scans obtained in the two positions. 
This is understandable as positioning of legs would determine the degree of lumbar 
lordosis, and subsequently the bone image [31]. However, we have shown that BMD 
values remain unchanged as BMC and the ROI both changed to the same extent and 
in the same direction.  
 
It is interesting to see whether all DXA manufacturers would come to a uniform 
agreement about leg positioning while scanning the lumbar spine. With growing 
evidence manufacturers should agree on a uniform recommendation regarding the use 
of the leg cushion. As we showed, scanning legs flat will allow technicians to perform 
both spine and hip scans in the same setting, thus reducing the scanning time and 
avoiding the inconvenience caused by leg positioning without compromising the 
accuracy or precision of the measurement.  
 
It can be argued that as the reference datasets which are in current use have been 
developed using leg elevation, it is logical to maintain the same position when 
patients are evaluated using these datasets. However, we will not be able to sustain 
such argument as new datasets based on current Lunar machines, which use leg-flat 
position, are added to public domain. It is interesting to see whether one will have to 
select the reference dataset to suit the leg positioning when analyzing patients in 
future. Our data shows that no difference is made to the WHO categorization of 
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legs elevated or legs flat and decided to maintain the state of quo. A study based on 
4500 scanner estimated spine BMDs with or without leg elevation[30]. In this study, 
positions (0.907 vs 0.922 g/cm ) and only 0.13 SD difference in the mean T scores 
 subjects or T score calculation when subjects are scanned legs flat and analyzed in 
reference to currently available datasets which have been acquired using conventional 
leg positioning. However, our sample size was limited to 54 individuals, not allowing 
us to evaluate this, and should be tested in a larger sample.  
 
Although, osteoarthritis is associated with obesity and osteoporosis with low BMI, the 
coexistence of the two diseases; osteoporosis and osteoarthritis has been 
documented[32]. Patients with osteoarthritic changes in lower limb joints may 
experience difficulty in keeping their legs elevated during scanning. This practical 
limitation would be more applicable to DXA machines using a pencil-beam as they 
take a relatively longer time to complete a scan when compared to a fan-beam 
scanner. Pencil-beam scanners are still in use and all Norland machines use this 
technology.  
 
The lumbar spine is an important site when making clinical decisions in osteoporosis. 
Owing to its higher content of trabecular bone, spine shows a greater BMD change 
than hip in response to metabolic bone diseases [33]; thus all attempts should be taken 
to include it in routine patient scanning. Furthermore, spine has a better ability to 
monitor therapy given for osteoporosis [33]. However, when a patient with limited hip 
mobility is referred for DXA scanning on a machine which requires leg positing, 
spine may be overlooked due to practical reasons. 
 
during spine scan, he can be allowed to maintain a lesser degree of hip flexion without 
compromising the accuracy of BMD estimations or WHO categorization [28]. 
However, the effect of varying degree of hip flexion on the precision of the BMD 
estimation was evident as variation of 20-30 degrees of hip flexion was associated 
with change in BMD, in excess of the LSC, in 32% subjects. This means that a 
variation in hip flexion by 20-30 degrees between two scans could cause an erroneous 
change in BMD which could be interpreted as a real and significant change in 32% of 
subjects.  Even though a lesser degree hip flexion does not compromise the WHO 
diagnostic category, the technician should clearly state the change made to the 
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Our data show that if a subject has a difficulty in maintaining 90 degree hip flexion 
positioning and recommends that same position be maintained in future scanning 
to avoid systematic errors in precision.  
  
When replicate BMD estimations are made, the technician should procure assessing 
previous images to maintain consistency in patient positioning and in defining the 
ROIs. However, it will be difficult to assess if a difference in hip flexion was made in 
the previous scan. A clear record should be made in case notes if a difference was 
made to hip flexion and previous records should be perused when performing repeat 
scans.  
 
Hip geometry  
 
In a group of women, selected randomly from our university study area in the Galle 
district, we observed a gradual and significant decline in some measures of hip 
geometry such as femoral neck BMD, cross-sectional area (CSA), and section 
modulus (SM)[34].  In the same group of women there was a non-significant 
expansion of the femoral neck width, adjusted for height and weight. Our results are 
similar with those by Beck et al who observed a similar behavior of hip geometry 
indices among women in the NHANES cohort [35]. Among women in the NHANES 
cohort, a significant reduction in narrow-neck BMD, CSA, and SM was evident while 
narrow-neck width expanded gradually. Limited studies exist in other populations 
which evaluate the patterns of variation in hip geometry indices.    
 
Some indices of hip geometry such as the hip axis length (HAL) can predict fractures 
independent of BMD [36]. When combining the HAL with BMD, they predict 
fractures better than BMD alone [37] which is not the case for other hip geometry 
indices [38, 39]. Age-related changes in hip geometry provide an insight to the 
[35]and ours[34], femoral neck BMD and CSA which represents the cortical bone 
equivalent of the ROI, decline with advancing age.   
 
Although expansion of subperiosteal diameter of the neck could possibly offset the 
structural failure induced by declining BMD, the degree of expansion observed in 
these studies is not sufficient to prevent the mechanical failure entirely. While 
subperiosteeal bone apposition leads to neck expansion, endosteal bone resorption 
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mechanism of structural failure of different ROIs. According to the data of Beck et al, 
causes thinning of the cortical envelop and expansion of the medullary cavity[40] . 
  
As the rate of endosteal bone resorption exceeds that of bone apposition, especially in 
old age, the cortical envelop becomes critically thin making it more susceptible for 
buckling [41] which is probably the most predicting property picked up by the BMD 
measurement [39].     
 
There is a paucity of studies examining age trends in hip geometry in other 
populations. Current literature on hip geometry is largely limited to case-control and 
comparison studies where two groups of different characteristics have been compared. 
Compared to Caucasian women, women of African descent have greater cortical 
thickness, shorter neck length and smaller inter-trochanteric width [42]. Furthermore, 
Japanese women have shorter femoral neck length and narrower neck-shaft angle 
when compared to white Americans [43]. Differences in hip geometry have also been 
shown in three ethnic groups in Singapore. These differences possibly account for the 
differential fracture risk seen across ethnic groups [44].  
 
Age-related decline in BMD is the plausible explanation for the increased fracture risk 
seen in old age [45]. As BMD gradually declines with advancing age, osteoporosis-
related fracture risk rises, exponentially [46]. BMD differences alone, however, are 
unable to explain the geographical and ethnic variation in fracture incidence reported 
earlier [47]. Furthermore, Asians, despite having lower BMD compared to Europeans, 
experience less fracture incidence [48]. The reasons for this paradoxical phenomenon 
are not entirely clear and age-related changes in hip geometry may help to explain this 
disparity. It may be that the bending rigidity of proximal femur is preserved to a 
greater extent in Asians than Europeans, thus protecting them from fractures in old 
age.  
 
There is no sufficient data, however, to compare the behavior of hip geometry indices 
between Asians and other races. Our data [34] do not support the theory that Asian 
women have preserved hip geometry in old age. Our study sample is not 
representative of the country’s population as they were drawn from a selected area. 
More studies should be done using representative samples from the local population 
and also from other Asian countries to examine this possibility.   
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 Using a UK cohort we were able to demonstrate that growth in early life influences 
mechanical strength of proximal femur later in adult life [49]. People who were 
shorter in early life as assessed by different body measurements had poorer 
mechanical strength in the proximal femur during adult life, independent of their adult 
body measurements. This suggests that events in early life have long lasing effects on 
the adult skeleton. This may partly account for the relationship previously observed 
between hip fracture risk and poor intrauterine or infant growth [50]. 
 
Genetic factors and influences in early period of life may play a role in the 
associations observed. It appears that most of the risk factors of non-communicable 
diseases have undergone programming in early life. Similarly, it has been shown that 
adult BMD and risk of hip fracture may have undergone similar programming 
possibly, programmed in early period of life. According to our data [49], poor growth 
in early years has lasting effects on femoral shape and reduces mechanical strength of 
the proximal femur in adult life.  
 
Many feel that there are "critical periods" during mammalian development which 
determine the normal development of a particular anatomical structure or its function 
[52]. Environmental stimuli operating at these critical periods can have lasting effect 
on these bodily functions. Gale et al previously showed an association between adult 
whole body BMC, lean mass and birth weight among men and women, aged 70-75 
years and still living in Sheffield in the UK  [51]. This positive association between 
adult BMC and birth weight was independent of adult height, sex, age, smoking 
habits, alcohol consumption, calcium intake and physical activity indicating that BMC 
in adult life is partly determined in early age [51]. Our data would add to the existing 
 
Further, similar to BMD and the indices of hip geometry, lean mass is also possibly 
programmed in early age [51]. Among Indians, Sachdev et al showed that birth 
weight or BMI gain in infancy are related to adult lean mass [53]. Hediger et al 
showed that infants of shorter gestation period remained smaller and infants of longer 
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[50,51]. We were able to demonstrate that certain indices of hip geometry are, 
body of evidence that adult BMD, indices of hip geometry and fracture risk in adult-
-hood are programmed in early life.
  
gestation period remained larger in their early childhood but these differences in 
weight were mostly attributable to fat mass variation [54].  
 
BMD and associations  
 
We observed that BMD is associated with diverse, still clinically relevant variables 
in the UK, BMD showed a positive association with FEV1 and this association was 
independent of smoking habits, alcohol intake, disease prevalence and drug usage 
inverse association with serum lipids in a group of pre-menopausal women selected 
 
contributions made by non-genetic factors such as physical activity and nutrition to 
the remaining 30% variation are not clear. In our data, a unit increase in FEV1 (1L per 
second) was associated with an increase of BMD by 0.066 to 0.076 g/cm2 in the hip 
[55, 56]. In a different population, a change of lean body mass by 1 kg was associated 
with change in BMD between 0.004 and 0.008 g/cm2 [57].  In contrast to both lean 
mass and FEV1 which showed positive association with BMD, serum LDL showed a 
 
Previous studies have shown gender differences in many osteoporosis-related health 
issues. Hip fractures are predominantly seen in women and only about 20-25% of hip 
fractures occur in men [61]. The overall mortality following hip fracture is about 20% 
in the first 12 months and is higher in men than in women [62]. Gender differences 
appear to extend beyond BMD and fracture. Nieves et al reported gender differences 
in hip geometry where males had significantly greater tibial BMC, volumetric BMD, 
cortical area and cortical thickness compared with females. After controlling for lean 
mass, males still had 8% higher hip BMD and 5.3% higher total tibial BMD than 
women [63].  
 
92
[55-58]. In a group of community-dwelling men and women selected from a community
[55,56]. Furthermore, BMD showed a positive correlation with the lean mass and an 
from the Galle district in Sri Lanka [57,58].  
Although nearly 70% of BMD variation is genetically determined [59,60], individual 
negative correlation with BMD [58]. Furthermore, we also described a gender 
difference in the strength of the association between BMD and FEV1 [55,56].  
 The associations observed between BMD with other functional measurements of 
different body systems can have many explanations. It is possible that several organs 
or metabolic pathways could be subjected to same group of stimuli during intrauterine 
or early postnatal period and undergo programming together, thus allowing them to be 
inter-related in old age. Similar to BMD, BMC and lean mass, respiratory functions 
and lipid metabolism may have undergone programming, perhaps simultaneously, to 
maintain a relationship between them in adult age. 
 
The association between hip BMD and FEV1 could be indirect and mediated through 
a third factor. Although hypoxia is known to have negative influence on BMD [64], it 
is an unlikely explanation for the observed association as the association was 
independent of disease prevalence and seen at normal FEV1 range, which is unlikely 
 
Physical activity is a more plausible explanation for most of the associations we 
observed. There are many studies to support that physical activity may be the link 
between BMD, lean mass and lipid levels. Morris et al reported high impact physical 
activities in young age to have positive effects both on BMD and lean mass [65]. 
When compared with a control group, subjects in the exercise group gained 
significantly more lean mass, less body fat content, greater shoulder, knee and grip 
multiple regression analysis, change in lean mass was the primary determinant of 
BMD accrual. Further, Carels et al reported the beneficial effects of increased 
physical activity on cardio-respiratory fitness, body weight, fat mass, both systolic 
and diastolic blood pressures, total cholesterol, triglycerides, and LDL cholesterol 
[66]. Beneficial effects of physical activity have also been reported in Asian 
populations. In 1996, Suzuki et al reported a positive effect of long-term physical 
training of moderate intensity on body composition, cardiovascular function and 
 
Apart from physical activity, vitamin D may play an intermediate role in these 
associations. Vitamin D is required for bone health and proper functioning of skeletal 
muscles. As lean mass is directly related to respiratory functions [68, 69], the link 
between BMD and FEV1 could operate through differences in vitamin D levels. An 
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to be associated with hypoxia.      
strength, and greater BMDs in total body, lumbar spine and femoral neck [65]. In 
serum lipids in mildly obese middle-aged Japanese men and women [67]. 
  
association has been described between vitamin D level and respiratory functions, 
genetic and environmental factors [71], genetic factors are more likely to make 
would have similar effects on all subjects within the community.  
 
In support of vitamin D theory, Black et al, in 2005 demonstrated a strong 
relationship between serum concentrations of 25-hydroxy vitamin D, FEV1, and FVC 
[70]. When compared with subjects in the lowest quintile of 25-hydroxy vitamin D, 
those in the highest quintile had significantly higher FEV1 and FVC and this 
difference was independent of age, gender, height, body mass index, ethnicity, and 
smoking history. Furthermore, adjusting data for physical activity, intake of vitamin D 
supplements, milk intake, and the level of serum antioxidants did not essentially 
change the results indicating that the association observed between serum vitamin D 
levels and respiratory functions is independent of physical activities and other 
confounders [70].   
 
The association observed between BMD and lipids may also operate via vitamin D 
status. Recent studies have shown an association between vitamin D level and 
comparison to the highest quartile of serum 25-hydroxy vitamin D, those in the lowest 
quartile had significantly higher prevalence of hypertension (odds ratio=1.30), 
diabetes mellitus (odd ratio= 1.98), obesity (odd ratio=2.29), and high serum 
triglyceride levels (odd ratio= 1.47) [73]. Furthermore, in the US general population, 
an independent inverse association was found between vitamin D levels and insulin 
resistance [74]. These data support the theory that vitamin D status is a plausible link 
between BMD, respiratory functions, lean mass and lipid levels. 
  
Although physical activity and nutrition appear to have positive effects on BMD [75] 
and skeletal muscles [76], thereby establishing a positive association between BMD 
and lean mass, this association may breakdown in old age due to various factors. As 
discussed above, physical activity [76] and vitamin D nutrition [77] are crucial factors 
in maintaining lean mass and both these may become critical in old age. Studies have 
shown vitamin D deficiency to be prevalent among elderly in many communities [78]. 
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previously [70]. Although vitamin D levels in the community are determined by 
interpersonal variations in vitamin D levels [72] than seasonal variations which  
cardiovascular risk factors [73,74]. In 2007, Martins et al demonstrated that, in 
 Lack of physical activity and hypovitaminosis D in old age may disrupt the 
association observed between lean mass and BMD in middle age. In support of this, 
previous studies have shown a stronger correlation between BMD and fat mass in 
which indirectly reflects lean mass was much stronger in young women than in older 
 
The coexistence of low BMD and high cardiovascular risk has many clinical and 
assess both cardiovascular and fracture risk in a given patient before interventions. 
When advising on life-style modifications, such as physical activity and cessation of 
smoking, benefits on both cardiac and skeletal systems must be considered. 
Furthermore, when prescribing drugs, clinicians should consider secondary benefits 
such as skeletal effects of lipid lowering therapy [81] and lipid lowering properties of 
antiresorptive agents [82]. At community level, information can be used to motivate 
people to engage in life-style modifications, such as proper nutrition and physical 
 
Summary 
 
In this thesis, many aspects related to bone health are discussed. They span from 
osteoporosis prevalence, operational factors, determinants of BMD and co-morbidity 
in osteoporosis. Although the information has been generated using different 
populations, the conclusions are broadly generalizable.  
 
The community study conducted in seven provinces in Sri Lanka provides an insight 
to BMD changes with advancing age in this South Asian population. Although the 
study has limitations due to inclusion of one solitary skeletal site and possible 
selection bias, information gathered from this study can be used in designing health 
promotion programs to reduce fracture burden in the future. Our data would indicate 
the time frame available to apply community based interventions to optimize the bone 
mass in this population. The true prevalence of postmenopausal osteoporosis in Sri 
Lankan community could be materially different from what we have reported from 
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older subjects [79,80]. Also in our results, the association between BMD and FEV1 
subjects [55,56].  
epidemiological implications. Clinician will have to make a holistic approach and 
activity which have positive cardiac and skeletal effects.  
 this study and more studies are needed to estimate the prevalence in more clinically 
relevant sites such as the lumbar spine or the proximal femur. Until such studies are 
done, our data can be used to convince health policy makers about the high 
up.  
 
Precision and accuracy are the key issues when measuring BMD using DXA 
technology and technicians should take all precautions to ensure them. Although 
recommendations are made by the manufacturers of DXA regarding patient 
positioning during routine DXA scanning, they are to date not evidence-based. This is 
highlighted by the varying recommendations given by different manufacturers of 
DXA. Our results indicate that specific leg positioning during lumbar spine BMD 
measurements can be avoided without compromising the accuracy of the 
measurements. Our data will add to the growing body of evidence that leg positioning 
during spine scanning is essentially not required. If hip positioning is considered to be 
essential, then less degree of hip flexion can be allowed in people with poor mobility 
of lower limb joints. Although, the lesser degree of hip flexion, we allowed, did not 
alter the accuracy of BMD estimations, the effect on long-term precision was evident. 
Hence, it is important to maintain the same degree of hip flexion in subsequent scans. 
Similarly, our data showed that leg rotation has clear clinical implications when 
repeated BMD measurements are made. To minimize these systematic errors, 
technicians should ensure that repeated scans also have the same patient positioning 
as the previous scans. Recall of previous scan images would help specially in hip 
scans while changes made during lumbar spine scan should be clearly documented.   
 
The indices of hip geometry among our study subjects, selected from a local area, 
study examining age trends in hip geometry among South Asians, more studies are 
needed to replicate our findings.  
 
We observed an association between BMD, respiratory function, lean mass and 
geometry and measurements in the postnatal period. Disease prevalence and drug 
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prevalence of the disease among Sri Lankan women. Also, these findings could be 
a platform for launching future larger studies of prospective nature and long follow-
followed similar patterns as those described in American women. As ours is the first 
cardiovascular risk factors. Also there is an association between the indices of hip 
  
usage are unlikely to be the underlying cause of these associations as they were 
mostly observed in healthy subjects. Smoking habits and alcohol use are also unlikely 
explanations as these associations were independent of such substance use. Nutrition, 
physical activity, vitamin D status and simultaneous programming are the most 
plausible underlying mechanism for these associations.  
 
Some of these findings may interest clinicians when evaluating their patients. When 
assessing a patient with osteoporosis, clinicians should be aware of the mortality or 
morbidity associated to co-existing diseases and detailed examination should be 
pursued to assess them. Similarly, when a patient presents with cardiovascular or 
respiratory illness, the likelihood of having low BMD and the risk of future fracture 
should be analyzed. This holistic approach in patient care would allow clinician to 
estimate the overall risk of future major non-communicable diseases and measures 
can be implemented to mitigate them. Physical activity and cessation of smoking 
could be beneficial for many such diseases. In selecting drugs, attention should be 
paid to their multiple effects on co-morbid diseases. Furthermore, the role of vitamin 
D and calcium as a mediator of these associations should be further studied. In 
conclusion, this thesis has assessed operational factors surrounding the BMD 
measurement, etiological relationships of skeletal parameters and the intricate 
relationship between bone health with functional parameters of the cardiovascular and 
respiratory system. Overall, the knowledge derived from this thesis has targeted the 
improvement of medical attention of patients with osteoporosis in Sri Lanka and 
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 This thesis addresses factors that are related to validity of BMD measurements in the 
detection of osteoporosis or fracture risk. Studies in this area are scarce and many 
questions still remain unanswered. Based on DXA images, we assessed the hip geometry 
indices and examined how they vary with age and also according to measurements in 
early period of life.  
 
In addition, recent studies indicate that BMD is related to functions of other vital organs 
or bodily systems in humans. Associations with extra-skeletal outcomes would help to 
understand the variations in BMD and co-morbidity seen among patients with 
osteoporosis. In this thesis the associations between BMD and indices of cardiovascular 
health and respiratory function were also assessed.  
 
Data related to the prevalence of osteoporosis or women at risk of fracture are paramount 
important for a country to initiate preventive strategies and to plan future health care 
facilities. Furthermore, the time at which peak BMD is achieved has a direct impact on 
fracture risk.  This information is particularly relevant in recognizing age groups that 
should be targeted by population or community-based preventive programs.  
 
In Chapter 2.1 we report 44.9% prevalence of osteoporosis among postmenopausal 
findings on a larger community sample selected to represent a wider population of Sri 
Lanka. Although our figures are similar to those reported in neighboring countries, the 
true prevalence could be different considering that we did not measure BMD in key 
skeletal sites such as spine and hip in all subjects and that selection bias could have 
occurred when we recruited subjects for this study. Despite these limitations this 
estimation can be used as a ball park figure of the prevalence of osteoporosis in the 
country and could provide a platform to design future studies and apply country-wide 
interventions.  
 
In Chapter 2.2 we found both men and women to achieve the peak BMD around 30-40 
years of age. This was based on phalangeal BMD estimations and peak BMD acquisition 
can be different in more clinically relevant sites such as the lumbar spine or the proximal 
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women in the Sri Lankan community. This was estimated extrapolating central DXA 
femur. In addition, previous studies have shown wide ethnic and geographical variation in 
peak BMD acquisition. Although a large USA based study showed that peak BMD is 
reached between 20-30 years, studies done in other countries have shown a substantial 
20-30 year age group and only further 5% increase occurred during the next 10 years.  
 
Operational properties of the BMD measurement are important to be considered in the 
context of the clinical applications discussed above. According to our observations in 
Chapters 3.1 and 3.2, the accuracy of spine BMD estimations is not affected by the degree 
of hip flexion. The effect was seen more in the interpretation of replicate BMD 
estimations where a significant change in spine BMD could occur purely due to variation 
in positioning. The same degree of accuracy can be obtained by maintaining a lesser 
degree of hip flexion facilitating the measurement in patients with difficulties in keeping 
legs flexed (e.g. elderly or disabled people). Nevertheless, the technician performing 
DXA scan should procure that subsequent scans use the same degree of hip flexion. 
Hence, we suggest that the amount of hip flexion maintained during scanning should 
clearly be documented in the patient notes.  
 
In Chapter 3.3 we confirmed that the leg of the measured side should be rotated internally 
to maintain the correct positioning of the proximal femur during hip scanning. We found 
that variation of leg rotation by100 (either internally or externally) can cause a major 
impact on the BMD measurements. The effect was seen more in precision of BMD 
estimations. If the same degree of leg rotation is not maintained during repeated DXA 
measurements, a change of BMD could be considered significant while it being purely the 
consequence of differences in leg positioning. Similar to the recommendation for hip 
flexion in lumbar spine scans, technicians performing DXA measurements of the hip 
should be aware of this technical limitation and try to achieve the same degree of leg 
rotation in all repeated scans. We also suggest using the lesser trochanter as a guide to the 
degree of leg rotation in previous scans.  
 
Similar to BMD, indices of hip geometry show age-related trends. In Chapter 4.1 we 
found that indices of bone strength such as cross sectional area (CSA), cross-sectional 
moment of inertia (CSMI) and section modulus (SM) show gradual decline with 
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delay in BMD accrual. In our survey, nearly 95% of peak BMD acquisition occurred in 
advancing age in women in Sri Lanka. While CSA measures the cortical bone equivalent 
in the cross section of the bone, both CSMI and SM are indicative of the bending strength 
of the bone. We also observed tendency (not statistically significant) for expansion of the 
femoral neck width in postmenopausal women during old age. These patterns of 
geometrical change help understanding the underlying mechanism leading to structural 
failure of the femoral neck and increased risk of fracture at advanced ages. Based on these 
findings we confirm that the expanding femoral neck is a structural adaptation to 
counteract the decrease in bone strength consequence to reduction in the CSA and 
thinning of the cortical envelop.  
 
In Chapter 4.2 we found that ‘unfavorable” indices of hip geometry in men and women 
during adulthood were associated with smaller body size at 1 year, suggesting potential 
early life programming for the vulnerability to sustain hip fractures later in life. These 
findings support the existing body of evidence that many organs and bodily functions are 
programmed in early period of life and clinical outcomes such as fracture or myocardial 
infarction may be determined early in life.  
 
In Chapter 5.1 we report an association between BMD and lean mass among a group of 
premenopausal women selected from the community in Sri Lanka. Furthermore, in 
Chapter 5.2, in the same group of women we report an association between BMD and 
lipids. In our study population, women with lower BMD had higher total and LDL lipid 
levels. Recent evidence suggests that bone metabolism is not an isolated series of events 
but it has cross linking with other metabolic pathways such as lipids. This observation has 
diverse potential clinical implications. It may help to understand the higher cardiovascular 
mortality and morbidity seen in women with osteoporosis or suffering from fractures. 
Also, based on them we can recommend clinicians to take a holistic approach when 
evaluating patients to estimate the total risk profile of their patients involving several 
systems. Physical exercises as a non-pharmacological intervention may be beneficial in 
these patients presenting with co-morbidities. Additional data especially arising from 
interventional trials are required to evaluate the benefits of improving muscle mass in 
these patients.  
 
In Chapters 5.3 and 5.4 we report a positive association between BMD of the proximal 
femur and FEV1 which is a measure of pulmonary function. This association was seen in 
young, middle aged and old women but to a lesser extent in men. The association seen 
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between FEV1 and BMD was independent of diseases prevalence, drug usage, body 
proportions and smoking habits. These findings postulate the co-existence of 
compromised lung function (low FEV1) and osteoporosis (low hip BMD) in the same 
underlying mechanism of this association was not clear, physical activity and vitamin D 
status appear as the most plausible explanations.  
 
Finally, in the general discussion in Chapter 5 general aspects of these operational 
characteristics and disease associations are discussed in the context of clinical practice. 
Further, the findings reported on this thesis are placed in perspective of future research 
and clinical applications involving the measurement of BMD.  
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person indicating the possibility of a link between these two conditions. Although the 
 Deze thesis richt zich voornamelijk op factoren die betrekking hebben op de geldigheid van 
BMD metingen in de opsporing van risico van osteoporose of breuk. Studies op dit gebied 
zijn schaars en vele vragen nog onbeantwoord. Op basis van MB4 beelden, beoordeelden we 
de  indicatoren van de heup geometrie en onderzochten hoe ze verschillen met leeftijd en ook 
volgens metingen in de vroege periode van het leven.  
 
Uit recente studies blijkt bovendien dat BMD gerelateerd is aan de functies van andere vitale 
organen of lichaamssystemen bij de mens. Vergelijking met extra- skeletale resultaten zou 
helpen om de variaties in BMD en comorbiditeit die gezien wordt bij patiënten met 
osteoporose te begrijpen. In deze thesis werden ook de associaties tussen BMD en 
indexcijfers van de cardiovasculaire gezondheid en ademhalingsfunctie beoordeeld.  
Gegevens met betrekking tot de prevalentie van osteoporose bij vrouwen met het risico van 
breuk zijn essentieel, en zijn buitengewoon belangrijk om preventieve strategieën te initiëren 
en bij het ontwerpen en maken van plannen voor toekomstige instellingen voor landelijke 
gezondheidszorg. Bovendien, de tijd op welke het hoogtepunt van BMD is bereikt heeft een 
rechtstreekse invloed op risico’s van breuk.  
 
Deze informatie is bijzonder relevant met betrekking tot het herkennen van de 
leeftijdsgroepen waarop bijzondere aandacht moet worden gericht onder de, op de bevolking 
of, gemeenschap gebaseerde preventieve programma's.  
 
In hoofdstuk 2.1 rapporteren we 44,9% prevalentie van osteoporose bij postmenopauzale 
vrouwen in de Sri Lankaanse Gemeenschap. Dit werd bereikt door het extrapoleren van 
centrale MB4 bevindingen door middel van een steekproef onder een grotere 
onderzoeksgroep die geselecteerd werd om een brede bevolkingsgroep van Sri Lanka te 
vertegenwoordigen. Hoewel onze cijfers vergelijkbaar zijn met cijfers die in naburige landen 
gemeld zijn, kunnen er werkelijke prevalentie verschillen gezien worden die anders zijn, 
omdat we niet BMD in belangrijke skeletal sites zoals rug en heup in alle personen gemeten 
hebben en dat selectie bias kon hebben plaatsgevonden toen we de personen voor deze studie 
hebben aangeworven. Ondanks deze beperkingen kan deze schatting worden gebruikt als een 
basis figuur van de prevalentie van osteoporose in het land en gebruikt worden als een 
Samenvatting  
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platform voor het ontwerpen van toekomstige studies en zouden voor interventies op 
nationaal nivo van toepassing kunnen zijn.  
 
In hoofdstuk 2.2 vonden we dat zowel mannen als vrouwen de piek BMD bereiken in de 
leeftijdsgroep van ongeveer 30-40 jaar oud. Dit was gebaseerd op phalangeale BMD 
schattingen en omdat piek BMD schattingen kunnen verschillen in meer klinisch relevante 
plaatsen zoals de lumbale wervelkolom of de proximale dijbeen. Bovendien, hebben vorige 
studies aangetoond dat er grote etnische en geografische verschillen in de piek BMD 
acquisitie zijn. Hoewel uit een grote in de VS gebaseerde studie bleek dat de piek BMD  daar 
bereikt wordt tussen 20-30 jaar, hebben studies die in andere landen gedaan werden 
aangetoond dat er daar een aanzienlijke vertraging in BMD accural plaatsvindt. In onze 
enquête, werd gezien dat bijna 95% van de piek BMD overname heeft plaatsgevonden in de 
leeftijdsgroep van 20-30 jaar en er alleen een verdere verhoging van 5% is opgetreden tijdens 
de komende 10 jaar.  
 
Operationele eigenschappen van de BMD meting zijn belangrijk om te worden beschouwd in 
het kader van de klinische toepassingen van hetgeen hierboven besproken werd. Volgens onze 
waarnemingen in hoofdstukken 3.1 en 3.2, wordt de nauwkeurigheid van wervelkolom BMD 
schattingen niet beïnvloed door de mate van de heup flexie. Het effect dat gezien werd kwam 
meer voort uit de interpretatie van het repliceren van de BMD schattingen waar door een 
belangrijke wijziging in de wervelkolom BMD puur als gevolg van variatie in de 
positionering kan optreden. Dezelfde mate van nauwkeurigheid kan worden verkregen door 
het behoud van een mindere mate van heup flexie, en het vergemakkelijken van de meting in 
patiënten met problemen bij het gebogen houden van de benen (bijvoorbeeld ouderen of 
gehandicapten mensen). Niettemin, de technicus die de MB4 scan uitvoert moet er voor 
zorgen dat bij latere scans dezelfde mate van heup flexie gebruikt word. Vandaar, dat wij 
voorstellen dat de mate  van heup flexie die gehandhaafd word tijdens het scannen duidelijk 
moet worden gedocumenteerd in de notities over de patiënt.  
 
In hoofdstuk 3.3 bevestigd we dat het been van de gemeten kant intern moet worden gedraaid 
om de juiste plaatsing van het proximale dijbeen te verkrijgen tijdens het scannen van de 
heup. We vonden dat variatie van been rotatie met 10
0
 (intern of extern) een grote invloed kan 
hebben op de metingen van het BMD. Het effect was duidelijk te zien in de precisie van BMD 
schattingen. Als dezelfde mate van rotatie van het  been niet wordt gehandhaafd tijdens 
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herhaalde MB4 metingen, moet worden overwogen dat een wijziging van BMD meting 
aanzienlijke kan verschillen terwijl het louter een gevolg is van het verschillen in de 
positionering van het been. Vergelijkbaar met de aanbeveling voor de heup flexie in lumbale 
wervelkolom scans, moeten technici MB4 bij het meten van de heup zich bewust zijn van 
deze technische beperking en zullen zij moeten proberen om een zelfde mate van been rotatie 
te bereiken in alle herhaalde scans. Ook raden we u aan de mindere trochanter als een gids 
voor de mate van been rotatie in eerdere scans te gebruiken. Gelijkaardig aan BMD, laten de 
indexcijfers van heup geometrie leeftijd -gerelateerde trends zien.  
 
In hoofdstuk 4.1 vonden we dat de indexcijfers van de sterkte van de botten zoals kruis 
doorsnede (CSA), transversale traagheidsmoment (CSMI) en sectie modulus (SM) een 
geleidelijke daling aantonen met het voort schreiden van de leeftijd in vrouwen uit het 
Verenigd Koninkrijk. Terwijl CSA het equivalent in de corticale doorsnede van het bot meet, 
zijn zowel CSMI als SM indicatief voor de buigende sterkte van het bot. Wij hebben ook een 
tendens waargenomen (niet statistisch significant) voor uitbreiding van de femorale nek 
breedte bij postmenopauzale vrouwen tijdens hogere ouderdom. Deze patronen van 
geometrische verandering helpen bij het begrijpen van de onderliggende mechanisme die 
leiden tot het structurele falen van de femorale nek en de verhoogde risico van breuk op 
gevorderde leeftijd. Op basis van deze bevindingen bevestigen wij dat de groeiende femorale 
nek een structurele aanpassing is om de daling in bot sterkte en het gevolg van een 
vermindering van de CSA en het dunner worden van de corticale envelop tegen te gaan.  
 
In hoofdstuk 4.2 geven we verslag van de gevonden “ ongunstige" indexcijfers van heup 
geometrie in mannen en vrouwen tijdens de volwassenheid die werden geassocieerd met 
kleiner lichaams grote op 1 jarige leeftijd, deze suggereren en ondersteunen een potentiële 
vroege programmering voor de kwetsbaarheid voor heupfracturen later in het leven. Deze 
bevindingen ondersteunen de bestaande hoeveelheid van bewijs dat vele organen en 
lichaamsfuncties zijn geprogrammeerd in de vroege periode van leven en klinische resultaten 
zoals fractuur of myocardiaal infarct al vroeg in het leven zijn vastgelegd.  
 
In hoofdstuk 5.1 verslaan wij een samenhang tussen BMD en vetvrije massa onder een groep 
van premenopausal vrouwen geselecteerd uit de Gemeenschap in Sri Lanka. Bovendien, in 
hoofdstuk 5.2, in dezelfde groep van vrouwen vonden wij een samenhang tussen BMD en 
lipiden. In onze studie onder deze bevolkingsgroep hadden vrouwen met lagere BMD, hogere 
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totaal en LDL lipide niveaus. Recent bewijs suggereert dat bot metabolisme niet een 
geïsoleerde reeks van gebeurtenissen is, maar dat het gekoppeld is aan andere 
stofwisselingsroutes zoals lipiden. Deze constatering heeft diverse potentiële klinische 
implicaties.  
 
Het kan helpen bij het begrijpen van de hogere cardiovasculaire mortaliteit en morbiditeit 
gezien bij vrouwen met osteoporose of bij hen die lijden aan fracturen. Ook, op basis daarvan 
kunnen wij clinici aanbevelen een meer holistische aanpak te gebruiken bij de evaluatie van 
patiënten, en het inschatten van het totale risicoprofiel van hun patiënten, met gebruik van 
verschillende systemen. Om Fysieke oefeningen aan te bevelen als niet-farmacologische 
interventies en aan deze patiënten aan te bieden bij het behandelingsaanbod zou zeer 
voordelig kunnen zijn. Aanvullende gegevens die met name voortvloeien uit Interventionele 
proeven moeten worden gebruikt om het evalueren van de voordelen bij meer spiermassa in 
deze patiënten te verbeteren.  
 
In de hoofdstukken 5.3 en 5.4 verslaan wij een positieve associatie tussen BMD van het 
proximale dijbeen en FEV1 die een meting van de pulmonale functie is. Deze samenhang 
werd gezien in de jonge, de middelbare leeftijd groep en onder oudere vrouwen, maar in 
mindere mate bij mannen. De samenhang gezien tussen FEV1 en BMD was onafhankelijk 
van de prevalentie van de ziekten, druggebruik, lichaamsverhoudingen en rookgedrag. Deze 
bevindingen postuleren de co-existentie van gecompromitteerd longfunctie (lage FEV1) en 
osteoporose (lage heup BMD) in dezelfde personen die de mogelijkheid van een verband 
tussen deze twee voorwaarden aangeeft. Hoewel het onderliggende mechanisme van deze 
samenhang niet duidelijk was, lijken lichaamsbeweging en vitamine D-status hiervoor de 
meest waarschijnlijke uitleg.  
 
Ten slotte, in de algemene discussie in hoofdstuk 5 worden de algemene aspecten van deze 
operationele kenmerken en samenhang met de ziektes besproken in het kader van de klinische 
praktijk. Verder, worden de bevindingen die in deze stelling gerapporteerd worden met 
betrekking tot de meting van BMD in het perspectief van toekomstig onderzoek en klinische 
toepassingen geplaatst. 
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